var title_f43_6_44128="Phonocardiogram of bicuspid AS at apex";
var content_f43_6_44128=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1265px;\">",
"  <div class=\"videoplayer\" h264=\"./images/CARD/72877/as_bapex_conv.mp4?title=Phonocardiogram+of+bicuspid+AS+at+apex\" style=\"width:564px;height:378px\">",
"  </div>",
"  <div class=\"figure\" style=\"width: 581px\">",
"   <div class=\"ttl\">",
"    Carotid artery pulse tracing and phonocardiogram of aortic stenosis with bicuspid AS",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 561px; height: 221px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Carotid artery pulse tracing and phonocardiogram of aortic stenosis as heard at the apex. S1 (mitral and tricuspid valve closure) is followed by an ejection click from the opening of the stenotic aortic valve. A faint mid systolic murmur of aortic stenosis is heard. S2 is single as a result of delayed aortic valve closure which occurs simultaneously with closure of the pulmonic valve.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Provided by John M Criley, MD, The Physiological Origins of Heart Sounds and Murmurs, Little, Brown, Boston, 1996, 1-800-527-0145. This program contains a complete interactive tutorial integrating over 200 heart sounds and murmurs with cineangiographic, echo-Doppler, and hemodynamic motion picture sequences.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f43_6_44128=[""].join("\n");
var outline_f43_6_44128=null;
var title_f43_6_44129="Peritoneal calcification";
var content_f43_6_44129=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F60172&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F60172&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Focal peritoneal calcification",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 380px; height: 266px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Left parasagittal view of fetus at 22 weeks gestational age shows a focal calcification in the peritoneal cavity with shadowing.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Deborah Levine, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f43_6_44129=[""].join("\n");
var outline_f43_6_44129=null;
var title_f43_6_44130="Intermediate case 5 with answer";
var content_f43_6_44130=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F67255&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F67255&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Subendocardial ischemia",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 422px; height: 127px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Sinus tachycardia with marked (5 mm) ST depression that is horizontal or downsloping. This finding is consistent with severe subendocardial ischemia.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Ary Goldberger, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f43_6_44130=[""].join("\n");
var outline_f43_6_44130=null;
var title_f43_6_44131="Flow B cell ALL";
var content_f43_6_44131=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F83238&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F83238&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 563px\">",
"   <div class=\"ttl\">",
"    Flow cytometric histograms in B cell acute lymphoblastic leukemia",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 543px; height: 384px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Flow cytometric histograms show dual staining of CD10 and CD19, positive CD34 and TdT, partial positive CD13.33, but negative CD7, kappa, and lambda.",
"    <div class=\"footnotes\">",
"     SS: side scatter; PC5: phycoerythrin-cyanin 5; RD1: rhodamine; FITC: fluorescein isothiocyanate; TdT: terminal deoxynucleotidyl transferase; PE: phycoerythrin.",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Sun T. Clinical application. In: Flow Cytometry, Immunochemistry, and Molecular Genetics for Hematologic Neoplasms, 2nd ed, Lippincott Williams &amp; Wilkins, Philadelphia 2012. Copyright &copy; 2012 Lippincott Williams &amp; Wilkins.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f43_6_44131=[""].join("\n");
var outline_f43_6_44131=null;
var title_f43_6_44132="Abatacept: Pediatric drug information";
var content_f43_6_44132=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Abatacept: Pediatric drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_general\" href=\"mobipreview.htm?18/14/18662?source=see_link\">",
"    see \"Abatacept: Drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?1/52/1861?source=see_link\">",
"    see \"Abatacept: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F2452297\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Orencia&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F5663024\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Orencia&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F3072298\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Therapeutic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Antirheumatic, Disease Modifying",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block dos drugH1Div\" id=\"F3072308\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Usual",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?18/14/18662?source=see_link\">",
"      see \"Abatacept: Drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     I.V.:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Children &ge;6 years and &lt;75 kg: 10 mg/kg; dose is repeated at 2 weeks and 4 weeks after initial dose and every 4 weeks thereafter",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Children &gt;6 years and &gt;75 kg: Use adult dosing (maximum dose: 1000 mg); dose is repeated at 2 weeks and 4 weeks after initial dose and every 4 weeks thereafter",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Adults: Dose is based on body weight range; repeat dose at 2 weeks and 4 weeks after initial dose, and every 4 weeks thereafter:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &lt;60 kg: 500 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     60-100 kg: 750 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &gt;100 kg: 1000 mg",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F2452751\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, powder for reconstitution [preservative free]:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Orencia&reg;: 250 mg [contains maltose]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, solution [preservative free]:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Orencia&reg;: 125 mg/mL (1 mL) [contains sucrose 170 mg/mL]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F2452299\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F3072309\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     I.V.: Prepare abatacept using only the silicone-free disposable syringe provided with each vial [for information on obtaining additional silicone-free disposable syringes contact Bristol-Myers Squibb at (800) 673-6242]. Following reconstitution, remove an equal volume of solution from a 100 mL NS infusion bag before adding the abatacept dose to the bag with the silicone-free syringe. Mix gently; do not shake. Administer through a 0.2-1.2 micron low protein-binding filter. Infuse over 30 minutes at a final concentration not to exceed 10 mg/mL.",
"    </p>",
"   </div>",
"   <div class=\"block scp drugH1Div\" id=\"F2452328\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Compatibility",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Stable in NS.",
"    </p>",
"   </div>",
"   <div class=\"block sta drugH1Div\" id=\"F3072305\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Stability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Store intact vial at 2&deg;C to 8&deg;C (36&deg;F to 46&deg;F); protect from light. Reconstitute vial with 10 mL SWI using a silicone-free disposable syringe (translucent particles may develop in solutions prepared with a siliconized syringe). After further dilution in NS, store for up to 24 hours at room temperature or refrigerate. Use within 24 hours of reconstitution.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F3072299\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of moderately- to severely-active rheumatoid arthritis; used as monotherapy or in combination with other DMARDs (FDA approved in adults). Treatment of moderately- to severely-active polyarticular juvenile idiopathic arthritis (used as monotherapy or concomitantly with methotrexate) (FDA approved in ages &ge;6-17 years).",
"     <b>",
"      Note:",
"     </b>",
"     Abatacept should not be used in combination with TNF antagonists or with other biologic rheumatoid arthritis drugs, such as anakinra.",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F5663023\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Orencia&reg; may be confused with Oracea&reg;",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block arm drugH1Div\" id=\"F2452317\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Note:",
"     </b>",
"     COPD patients experienced a higher frequency of COPD-related adverse reactions (COPD exacerbation, cough, dyspnea, pneumonia, rhonchi)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">",
"     Cardiovascular: Hypertension",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Central nervous system: Dizziness, fever, headache",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dermatologic: Rash",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Gastrointestinal: Abdominal pain, diarrhea, dyspepsia, nausea",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Genitourinary: Urinary tract infection",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Local: Injection site reaction",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Neuromuscular &amp; skeletal: Back pain, limb pain",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Respiratory: Bronchitis, cough, nasopharyngitis, pneumonia, rhinitis, sinusitis, upper respiratory tract infection",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Miscellaneous: Antibody formation, herpes simplex, immunogenicity, infection, influenza, infusion-related reactions",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Rare but important or life-threatening: Acute lymphocytic leukemia, anaphylaxis, anaphylactoid reactions, cellulitis, COPD exacerbation, disease flare, diverticulitis, dyspnea, flushing, hypersensitivity, hypotension, joint wear, lung cancer, lymphoma; malignancies (including bile duct, bladder, breast, cervical, melanoma, myelodysplastic syndrome, prostate, renal, skin, thyroid and uterine); ovarian cyst, pruritus, pyelonephritis, rhonchi, urticaria, varicella infection, vasculitis (including cutaneous vasculitis and leukocytoclastic vasculitis), wheezing",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F3072301\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to abatacept or any component",
"    </p>",
"   </div>",
"   <div class=\"block pre drugH1Div\" id=\"F7989677\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Precautions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Use with caution in patients with chronic obstructive pulmonary disease. May cause hypersensitivity, anaphylaxis, or anaphylactoid reactions; medications for the treatment of hypersensitivity reactions should be readily available for immediate use. Patients should be brought up-to-date with all immunizations before initiating therapy. Live vaccines should not be given concurrently or within 3 months of discontinuation of therapy. Injection formulation contains maltose which may result in falsely-elevated serum glucose readings on the day of infusion.",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F3072302\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Use caution when considering the use of abatacept in patients with a history of recurrent infections; with conditions that predispose them to infections; or with chronic, latent, or localized infections. Closely monitor patients who develop a new infection while undergoing treatment. If a patient develops a serious infection, discontinue abatacept. Patients should be evaluated for latent tuberculosis with a tuberculin skin test prior to starting abatacept. Treatment of latent tuberculosis should be initiated before abatacept is used; safety in tuberculosis-positive patients has not been established.  Reactivation of hepatitis B may occur in chronic carriers of the virus; evaluate prior to etanercept initiation and during treatment in patients at risk for hepatitis B infection. Patients receiving abatacept in combination with TNF antagonists had higher rates of infections than patients on TNF antagonists alone (concurrent use with TNF antagonists is not recommended). Due to the effect of T-cell inhibition on host defenses, abatacept may affect immune responses against infections and malignancies.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13298627\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F2452322\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Anakinra: May enhance the adverse/toxic effect of Abatacept.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Anti-TNF Agents: May enhance the adverse/toxic effect of Abatacept. An increased risk of serious infection during concomitant use has been reported.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     BCG: Immunosuppressants may diminish the therapeutic effect of BCG.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Belimumab: Abatacept may enhance the adverse/toxic effect of Belimumab.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Coccidioidin Skin Test: Immunosuppressants may diminish the diagnostic effect of Coccidioidin Skin Test.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Denosumab: May enhance the adverse/toxic effect of Immunosuppressants. Specifically, the risk for serious infections may be increased.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Echinacea: May diminish the therapeutic effect of Immunosuppressants.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Leflunomide: Immunosuppressants may enhance the adverse/toxic effect of Leflunomide. Specifically, the risk for hematologic toxicity such as pancytopenia, agranulocytosis, and/or thrombocytopenia may be increased.  Management: Consider not using a leflunomide loading dose in patients receiving other immunosuppressants.  Patients receiving both leflunomide and another immunosuppressant should be monitored for bone marrow suppression at least monthly.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Natalizumab: Immunosuppressants may enhance the adverse/toxic effect of Natalizumab. Specifically, the risk of concurrent infection may be increased.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pimecrolimus: May enhance the adverse/toxic effect of Immunosuppressants.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     RiTUXimab: May enhance the adverse/toxic effect of Abatacept.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Roflumilast: May enhance the immunosuppressive effect of Immunosuppressants.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sipuleucel-T: Immunosuppressants may diminish the therapeutic effect of Sipuleucel-T.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tacrolimus (Topical): May enhance the adverse/toxic effect of Immunosuppressants.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tocilizumab: May enhance the adverse/toxic effect of Abatacept.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tofacitinib: Abatacept may enhance the adverse/toxic effect of Tofacitinib.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Trastuzumab: May enhance the neutropenic effect of Immunosuppressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vaccines (Inactivated): Immunosuppressants may diminish the therapeutic effect of Vaccines (Inactivated).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vaccines (Live): Immunosuppressants may enhance the adverse/toxic effect of Vaccines (Live). Vaccinial infections may develop. Immunosuppressants may diminish the therapeutic effect of Vaccines (Live).  Management: Avoid use of live organism vaccines with immunosuppressants; live-attenuated vaccines should not be given for at least 3 months after immunosuppressants.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block foi drugH1Div\" id=\"F7989705\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Food Interactions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Avoid echinacea (has immunostimulant properties)",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F2452305\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F2452306\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Teratogenic effects were not observed in animal studies. There are no adequate and well-controlled studies in pregnant women. Due to the potential risk for development of autoimmune disease in the fetus, use during pregnancy only if clearly needed. A pregnancy registry has been established to monitor outcomes of women exposed to abatacept during pregnancy (1-877-311-8972).",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F3072310\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Signs and symptoms of infection; signs and symptoms of infusion reaction; hepatitis and TB screening prior to therapy initiation",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F3072306\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Inhibits T-cell (T-lymphocyte) activation by binding to CD80 and CD86 on antigen presenting cells (APC), thus blocking the required CD28 interaction between APCs and T-cells. Abatacept also blocks the production of inflammatory mediators such as TNF-&alpha;, IL-2, and interferon-&gamma;.",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F3072307\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacokinetics (Adult data unless noted)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Distribution: V",
"     <sub>",
"      dss",
"     </sub>",
"     : 0.07 L/kg (range: 0.02-0.13 L/kg)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Half-life elimination: RA: 13.1 days (range: 8-25 days)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Clearance: 0.22-0.23 mL/hour/kg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     Children 6-17 years: 0.4 mL/hour/kg (increases with baseline body weight)",
"    </p>",
"   </div>",
"   <div class=\"block pai drugH1Div\" id=\"F3072311\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Patient Information",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?1/52/1861?source=see_link\">",
"      see \"Abatacept: Patient drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Notify physician if you have symptoms of infection (cough, feeling tired, fever, flu-like symptoms, night sweats, weight loss), hypersensitivity reaction (chest tightness, difficulty breathing, hives, or swollen eyelids, face, lips, throat, tongue), or infusion-related reaction  (headache, hypertension or hypotension, lightheadedness). Patient should be informed to discontinue previous anti-TNF-&alpha; therapy prior to starting abatacept due to increased risk of serious infection.",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Bruce SP and Boyce EG, \"Update on Abatacept: A Selective Costimulation Modulator for Rheumatoid Arthritis,\"",
"      <i>",
"       Ann Pharmacother",
"      </i>",
"      , 2007, 41(7):1153-62.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?43/6/44132/abstract-text/17609234/pubmed\" id=\"17609234\" target=\"_blank\">",
"        17609234",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Ruperto N, Lovell DJ, Quartier P, et al, \"Abatacept in Children With Juvenile Idiopathic Arthritis: A Randomised, Double-Blind, Placebo-Controlled Withdrawal Trial,\"",
"      <i>",
"       Lancet",
"      </i>",
"      , 2008, 372(9636):383-91.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?43/6/44132/abstract-text/18632147/pubmed\" id=\"18632147\" target=\"_blank\">",
"        18632147",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12731 Version 31.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1103-201.75.47.146-274201436B-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f43_6_44132=[""].join("\n");
var outline_f43_6_44132=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2452297\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5663024\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3072298\">",
"      Therapeutic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3072308\">",
"      Dosing: Usual",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2452751\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2452299\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3072309\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2452328\">",
"      Compatibility",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3072305\">",
"      Stability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3072299\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5663023\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2452317\">",
"      Adverse Reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3072301\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F7989677\">",
"      Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3072302\">",
"      Warnings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13298627\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2452322\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F7989705\">",
"      Food Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2452305\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2452306\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3072310\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3072306\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3072307\">",
"      Pharmacokinetics (Adult data unless noted)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3072311\">",
"      Patient Information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_PED/12731\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_PED/12731|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?18/14/18662?source=related_link\">",
"      Abatacept: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?1/52/1861?source=related_link\">",
"      Abatacept: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f43_6_44133="Dyshidrotic eczema severe";
var content_f43_6_44133=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F83006&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F83006&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    A severe form of dyshidrotic eczema",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f43_6_44133=[""].join("\n");
var outline_f43_6_44133=null;
var title_f43_6_44134="Factors that modify breast cancer risk in women";
var content_f43_6_44134=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"topicTitle\">",
"   Patient information: Factors that modify breast cancer risk in women (Beyond the Basics)",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?43/6/44134/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/6/44134/contributors\">",
"     Wendy Y Chen, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?43/6/44134/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/6/44134/contributors\">",
"     Daniel F Hayes, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?43/6/44134/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/6/44134/contributors\">",
"     Rosemary B Duda, MD, MPH, FACS",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?43/6/44134/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 15, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;About 240,000 women in the United States are diagnosed with breast cancer each year. However, not all women have the same risk of developing breast cancer during their lifetime. Studies have shown that certain factors, called risk factors, increase the likelihood that a woman will develop breast cancer. This topic review discusses the individual factors that increase a woman's risk of developing breast cancer and also reviews those factors that are thought to protect against the development of breast cancer.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H303730530\">",
"    <span class=\"h1\">",
"     RISK FACTORS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many risk factors associated with breast cancer are not reversible, but some can be modified. The presence of breast cancer risk factors does",
"    <strong>",
"     not",
"    </strong>",
"    mean that cancer is inevitable; many women with risk factors never develop breast cancer. Instead, risk factors help to identify women who may benefit most from screening or other preventive measures. Individual women should work with their clinicians to determine their own personal risk of breast cancer, based upon their own circumstances.",
"   </p>",
"   <p>",
"    It is important to remember that breast cancer can also occur in women who have no identifiable risk factors. The average woman has about a 10 to 15 percent chance of developing breast cancer if she lives into her 90s. On the other hand, the risk of developing breast cancer in a woman with a strong family history of the disease who has inherited one of the genes that predispose her to breast cancer is over 50 percent. All women should discuss guidelines for breast cancer screening with their clinicians, even if they have a low risk for breast cancer based upon their risk factor profile.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H883961599\">",
"    <span class=\"h1\">",
"     STANDARD RISK FACTORS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Increasing age",
"    </span>",
"    &nbsp;&mdash;&nbsp;The primary risk factor for breast cancer in most women is older age. The incidence of breast cancer rises sharply with age until the age of 45 to 50, at which point the rise is less steep. At age 75 to 80, the incidence rates flatten out and then start to decline after this.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H303730545\">",
"    <span class=\"h2\">",
"     Gender",
"    </span>",
"    &nbsp;&mdash;&nbsp;Breast cancer is the most common cancer in women and occurs 100 times more commonly in women than in men.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H303730553\">",
"    <span class=\"h2\">",
"     Race/ethnicity",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the United States, white women have the highest rate of breast cancer; for every 100,000 women, there are 124 cases diagnosed. The rate of breast cancer is lower in black women (113 per 100,000), American",
"    <span class=\"nowrap\">",
"     Indians/Alaska",
"    </span>",
"    natives (92 per 100,000), and Hispanic women (90 per 100,000). It is lowest in Asian",
"    <span class=\"nowrap\">",
"     Americans/Pacific",
"    </span>",
"    Islanders (82 per 100,000).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H883961612\">",
"    <span class=\"h2\">",
"     Weight",
"    </span>",
"    &nbsp;&mdash;&nbsp;The impact of both weight gain and obesity is mostly associated with an increased risk of postmenopausal breast cancer. A higher body mass index (BMI) is associated with a lower risk of premenopausal breast cancer, although the mechanism behind this association is not clear.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26677408\">",
"    <span class=\"h2\">",
"     Tall stature",
"    </span>",
"    &nbsp;&mdash;&nbsp;Tall stature is associated with an increased risk of breast cancer. In studies, women who were at least 69 inches were more likely to develop breast cancer compared to women less than 63 inches tall. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H883961626\">",
"    <span class=\"h2\">",
"     Increased estrogen exposure",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H303730561\">",
"    <span class=\"h2\">",
"     Benign breast disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;In addition to breast cancer, women can develop abnormal breast findings. These breast abnormalities can develop because of excessive growth of the glandular breast tissue (also known as proliferative lesions) or comprised of increases in fibrous tissue, ductal enlargement, or cyst formations (known as nonproliferative lesions). Women with a history of proliferative breast lesions have an increased risk for breast cancer, particularly if the cells appear abnormal (atypical hyperplasia).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H883961639\">",
"    <span class=\"h3\">",
"     Breast density on mammography",
"    </span>",
"    &nbsp;&mdash;&nbsp;Women whose mammograms show many dense areas of tissue have an increased risk of breast cancer compared to women whose mammograms reveal mainly fat tissue.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26677439\">",
"    <span class=\"h3\">",
"     High bone density",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bone contains estrogen receptors and is sensitive to circulating estrogen. Therefore, bone mineral density (BMD) is considered a surrogate marker to circulating estrogen levels. In studies, women with a high BMD have a higher risk of breast cancer.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26677447\">",
"    <span class=\"h2\">",
"     Other hormonal factors",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26677460\">",
"    <span class=\"h3\">",
"     Androgens",
"    </span>",
"    &nbsp;&mdash;&nbsp;Elevated testosterone levels in women are associated with an increased risk of breast cancer with some studies suggesting an elevated risk specifically for hormone receptor-positive disease.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26677467\">",
"    <span class=\"h3\">",
"     Insulin",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other hormones that may influence breast cancer risk include high levels of insulin and growth factors related to the insulin pathway.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26677474\">",
"    <span class=\"h3\">",
"     In utero exposure to diethystilbestrol",
"    </span>",
"    &nbsp;&mdash;&nbsp;Before 1971, several million women were exposed in utero to diethylstilbestrol (DES) that was given to their mothers to prevent pregnancy complications. Whether these women are also at an increased risk for breast cancer is unclear with one study suggesting in utero exposure increased the risk of breast cancer, while another study found there was no excess risk among these patients.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26677495\">",
"    <span class=\"h2\">",
"     Menopausal hormonal therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;As a woman ages, the breast's glandular tissue, the tissue in which breast cancer arises, is gradually replaced by fat. Menopausal hormonal therapy includes estrogen, which slows or reverses this process. A large clinical trial has found that long-term use of combined estrogen-progestin (approximately five years) in women ages 50 to 79 increases a woman's risk of breast cancer, as well as heart disease, stroke, and clots in the legs. The risk of breast cancer when estrogen is used alone does not appear to be increased, especially when used for a short time. (See",
"    <a class=\"medical medical_patient\" href=\"mobipreview.htm?32/4/32835?source=see_link\">",
"     \"Patient information: Postmenopausal hormone therapy (Beyond the Basics)\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Beyond menopausal hormonal therapy, the administration of exogenous hormones as oral contraceptives or for the purpose of ovulation induction is not clearly associated with an increased risk of breast cancer.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26677534\">",
"    <span class=\"h2\">",
"     Reproductive factors",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26677541\">",
"    <span class=\"h3\">",
"     Age at time of menses starts and at menopause",
"    </span>",
"    &nbsp;&mdash;&nbsp;Both a younger age when menses begins and a later age at onset of menopause increase the breast cancer risk. This is likely due to the overall exposure to estrogen in a woman&rsquo;s lifetime.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26677548\">",
"    <span class=\"h3\">",
"     Pregnancy and breastfeeding",
"    </span>",
"    &nbsp;&mdash;&nbsp;Women who have never given birth are more likely to develop breast cancer after menopause than women who have given birth multiple times. In addition, the younger a woman is at her first full-term pregnancy the lower her risk of breast cancer. Breastfeeding has been found to be protective against developing breast cancer.",
"   </p>",
"   <p>",
"    <strong>",
"     Abortion",
"    </strong>",
"    is not associated with a risk of breast cancer.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H303730575\">",
"    <span class=\"h2\">",
"     Personal history of breast cancer",
"    </span>",
"    &nbsp;&mdash;&nbsp;Women with a prior history of cancer in one breast have an increased risk of developing cancer in the other breast. If a woman has a prior history of ductal carcinoma in situ (DCIS), this risk is as high as five percent in the next 10 years. However, if there is a personal history of an invasive breast cancer, the risk is one percent per year for premenopausal women and 0.5 percent per year for postmenopausal women.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Family history",
"    </span>",
"    &nbsp;&mdash;&nbsp;Family history is an important risk factor for breast cancer, although a history of breast cancer involving a first-degree relative is only reported by 20 percent of women with breast cancer. Overall, less than 10 percent of all breast cancers are associated with inherited genetic mutations. One of the main factors responsible for this elevated risk is an inherited genetic mutation in one of two genes, called BRCA1 and BRCA2. For women who have a BRCA1 or BRCA2 mutation, the lifetime risk of breast cancer ranges from 50 to 85 percent. Genetic testing for the BRCA mutation is discussed in detail elsewhere. (See",
"    <a class=\"medical medical_patient\" href=\"mobipreview.htm?30/15/30963?source=see_link\">",
"     \"Patient information: Genetic testing for breast and ovarian cancer (Beyond the Basics)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H303730582\">",
"    <span class=\"h1\">",
"     LIFESTYLE FACTORS",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of modifiable risk factors have been identified that are associated with an increased risk of breast cancer. These include the following:",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H303730626\">",
"    <span class=\"h2\">",
"     Physical inactivity",
"    </span>",
"    &nbsp;&mdash;&nbsp;While there is no direct evidence that inactivity is associated with an increased risk of breast cancer, physical exercise appears to protect against breast cancer in both premenopausal and postmenopausal women.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26677702\">",
"    <span class=\"h2\">",
"     Alcohol",
"    </span>",
"    &nbsp;&mdash;&nbsp;There appears to be a significant relationship between alcohol consumption and an increased risk of breast cancer, which begins with alcohol intake as low as three drinks per week. The risk appears to increase with greater alcohol consumption and additive with the use of menopausal hormone therapy. There does not appear to be a difference by type of alcohol (wine versus beer versus liquor).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H303730634\">",
"    <span class=\"h2\">",
"     Smoking",
"    </span>",
"    &nbsp;&mdash;&nbsp;Both passive and active tobacco smoking has been associated with an increased risk of breast cancer, especially among premenopausal women. This risk is associated with early initiation, longer duration,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    higher pack-years of smoking. It also appears to be higher in genetically susceptible subgroups.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H303730649\">",
"    <span class=\"h1\">",
"     DIETARY FACTORS",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of dietary factors have been reported to increase the risk of breast cancer. Among them, alcohol intake has the strongest association to breast cancer incidence.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26677710\">",
"    <span class=\"h2\">",
"     Dietary pattern",
"    </span>",
"    &nbsp;&mdash;&nbsp;While some studies have shown that high consumption of a diet composed predominantly of fruits and vegetables resulted in a lower risk of breast cancer, there was no influence on the risk of breast cancer among women who reported a high intake of",
"    <span class=\"nowrap\">",
"     red/processed",
"    </span>",
"    meats, refined grains, sweets, and high-fat dairy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H303730665\">",
"    <span class=\"h2\">",
"     Dietary fat intake",
"    </span>",
"    &nbsp;&mdash;&nbsp;An association between high intake of dietary fat and breast cancer has been seen in some studies, although the overall effect appears modest at best.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H303730673\">",
"    <span class=\"h2\">",
"     Consumption of red meat",
"    </span>",
"    &nbsp;&mdash;&nbsp;Eating more than five servings of red meat per week may be associated with an increased risk of hormone-positive premenopausal breast cancer.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1524717\">",
"    <span class=\"h2\">",
"     Calcium/Vitamin D",
"    </span>",
"    &nbsp;&mdash;&nbsp;Diets low in calcium and vitamin D have been associated with an increased breast cancer risk in premenopausal but not in postmenopausal women. However, one study of women who supplemented their diet with vitamin D and calcium did not show a difference in the number of women diagnosed with breast cancer.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1524724\">",
"    <span class=\"h2\">",
"     Antioxidants",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is no evidence for an effect of intake of vitamin A, E, or C or",
"    <a class=\"drug drug_patient\" href=\"mobipreview.htm?37/32/38403?source=see_link\">",
"     beta-carotene",
"    </a>",
"    on breast cancer risk.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26677717\">",
"    <span class=\"h2\">",
"     Soy/Phytoestrogens",
"    </span>",
"    &nbsp;&mdash;&nbsp;Phytoestrogens are naturally occurring plant substances with a chemical structure similar to estrogen. They consist mainly of isoflavones (found in high concentrations in soy beans and other legumes) and lignans (found in a variety of fruits, vegetables, and cereal products). There is low quality evidence that soy-rich diets in Western women prevent breast cancer.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26677724\">",
"    <span class=\"h2\">",
"     Caffeine",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of studies have failed to show any association between caffeine intake and breast cancer risk.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H883961788\">",
"    <span class=\"h1\">",
"     ENVIRONMENTAL FACTORS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26677731\">",
"    <span class=\"h2\">",
"     Geopgraphic residence",
"    </span>",
"    &nbsp;&mdash;&nbsp;Within the United States, geographic clusters with a high incidence of breast cancer have been described. Although these clusters are most likely due to regional differences in established breast cancer risk factors, studies are ongoing to better understand them.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H303730810\">",
"    <span class=\"h2\">",
"     Exposure to ionizing radiation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Exposure to ionizing radiation of the chest at a young age, as occurs with treatment of Hodgkin lymphoma or in survivors of atomic bomb or nuclear plant accidents, is associated with an increased risk of breast cancer.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H883961796\">",
"    <span class=\"h2\">",
"     Night shift work",
"    </span>",
"    &nbsp;&mdash;&nbsp;Night shift work is recognized by International Agency for Research on Cancer and the World Health Organization",
"    <span class=\"nowrap\">",
"     (IARC/WHO)",
"    </span>",
"    as a probable carcinogen. Women who work at night have a higher risk of breast cancer compared to women who do not do night-shifts. The primary reason for this remains under study but may be tied to the hormone melatonin, which is normally produced at night.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H303730817\">",
"    <span class=\"h2\">",
"     Miscellaneous factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Organochlorines include polychlorinated biphenyls (PCBs), dioxins, and organochlorine pesticides such as dichlorodiphenyltrichloroethane (DDT). These compounds are weak estrogens, highly lipophilic, and capable of persisting in body tissues for years. However, an association with breast cancer has not been demonstrated. In addition, cosmetic breast implants, electromagnetic fields, electric blankets, and hair dyes have not been associated with breast cancer risk.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26677739\">",
"    <span class=\"h1\">",
"     MEDICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several medication classes may have a modifying effect on breast cancer risk although their association to breast cancer is weak at best.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26677784\">",
"    <span class=\"h2\">",
"     Nonsteroidal anti-inflammatory drugs",
"    </span>",
"    &nbsp;&mdash;&nbsp;The data are mixed in showing an association between nonsteroidal anti-inflammatory drugs and breast cancer risk. While some studies show that patients who used",
"    <a class=\"drug drug_patient\" href=\"mobipreview.htm?6/12/6342?source=see_link\">",
"     aspirin",
"    </a>",
"    or",
"    <a class=\"drug drug_patient\" href=\"mobipreview.htm?14/17/14614?source=see_link\">",
"     ibuprofen",
"    </a>",
"    had a lower risk of breast cancer, others have not.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26677800\">",
"    <span class=\"h2\">",
"     Bisphosphonates",
"    </span>",
"    &nbsp;&mdash;&nbsp;Oral bisphosphonates are commonly used for the treatment of osteoporosis and for women with breast cancer with evidence of bone loss attributed to aromatase inhibitors. Whether their use is a true protective factor against breast cancer is unclear.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     REDUCING BREAST CANCER RISK",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although screening mammography does not reduce the risk of developing breast cancer, screening significantly decreases the risk of dying from breast cancer. (See",
"    <a class=\"medical medical_patient\" href=\"mobipreview.htm?35/40/36481?source=see_link\">",
"     \"Patient information: Breast cancer screening (Beyond the Basics)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Lifestyle changes",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of lifestyle changes may reduce breast cancer risk:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Planning for first birth before the age of 30",
"     </li>",
"     <li>",
"      Breastfeeding for at least six months",
"     </li>",
"     <li>",
"      Avoidance or limited duration of use of postmenopausal hormone therapy",
"     </li>",
"     <li>",
"      Avoidance of unnecessary exposure to radiation (eg, inappropriate use of computed tomography)",
"     </li>",
"     <li>",
"      Avoidance or cessation of smoking",
"     </li>",
"     <li>",
"      Limiting alcohol intake",
"     </li>",
"     <li>",
"      Maintenance of a healthy weight",
"     </li>",
"     <li>",
"      Limiting nocturnal shift work",
"     </li>",
"     <li>",
"      Adopting a physically active lifestyle. This should include at least 150 minutes of weekly moderate intensity activity, 75 minutes of weekly vigorous intensity activity, or at least some physical activity above one&rsquo;s usual routine, in addition to limiting sedentary behavior.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Medication",
"    </span>",
"    &nbsp;&mdash;&nbsp;Women at an increased risk of developing breast cancer should discuss whether chemoprevention is right for them. This topic is discussed separately. (See",
"    <a class=\"medical medical_patient\" href=\"mobipreview.htm?0/31/499?source=see_link\">",
"     \"Patient information: Medications for the prevention of breast cancer (Beyond the Basics)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h1\">",
"     ESTIMATING RISK",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although breast cancer risk assessment tools are available, their accuracy for individual women is only modest, partly because not all important risks have been identified and partly because accurate risk stratification requires strong risk factors and most risk factors for breast cancer are relatively weak and common in the population. (See",
"    <a class=\"medical medical_patient\" href=\"mobipreview.htm?35/40/36481?source=see_link\">",
"     \"Patient information: Breast cancer screening (Beyond the Basics)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h1\">",
"     WHERE TO GET MORE INFORMATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Your healthcare provider is the best source of information for questions and concerns related to your medical problem.",
"   </p>",
"   <p>",
"    This article will be updated as needed on our web site (",
"    <a class=\"external\" href=\"file://www.uptodate.com/patients\">",
"     www.uptodate.com/patients",
"    </a>",
"    ). Related topics for patients, as well as selected articles written for healthcare professionals, are also available. Some of the most relevant are listed below.",
"    <br/>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H241\">",
"    <span class=\"h2\">",
"     Patient level information",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H431451\">",
"    <span class=\"h3\">",
"     The Basics",
"    </span>",
"    &nbsp;&mdash;&nbsp;The Basics patient education pieces answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials.",
"   </p>",
"   <p>",
"    <a class=\"medical medical_basics\" href=\"mobipreview.htm?2/19/2357?source=see_link\">",
"     Patient information: Breast cancer (The Basics)",
"    </a>",
"    <br/>",
"    <a class=\"medical medical_basics\" href=\"mobipreview.htm?18/59/19379?source=see_link\">",
"     Patient information: Breast cancer screening (The Basics)",
"    </a>",
"    <br/>",
"    <a class=\"medical medical_basics\" href=\"mobipreview.htm?5/62/6115?source=see_link\">",
"     Patient information: Common breast problems (The Basics)",
"    </a>",
"    <br/>",
"    <a class=\"medical medical_basics\" href=\"mobipreview.htm?26/26/27043?source=see_link\">",
"     Patient information: Genetic testing for breast and ovarian cancer (The Basics)",
"    </a>",
"    <br/>",
"    <a class=\"medical medical_basics\" href=\"mobipreview.htm?3/26/3492?source=see_link\">",
"     Patient information: Ductal carcinoma in situ (DCIS) (The Basics)",
"    </a>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H431466\">",
"    <span class=\"h3\">",
"     Beyond the Basics",
"    </span>",
"    &nbsp;&mdash;&nbsp;Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    <a class=\"medical medical_patient\" href=\"mobipreview.htm?35/40/36481?source=see_link\">",
"     Patient information: Breast cancer screening (Beyond the Basics)",
"    </a>",
"    <br/>",
"    <a class=\"medical medical_patient\" href=\"mobipreview.htm?30/15/30963?source=see_link\">",
"     Patient information: Genetic testing for breast and ovarian cancer (Beyond the Basics)",
"    </a>",
"    <br/>",
"    <a class=\"medical medical_patient\" href=\"mobipreview.htm?0/31/499?source=see_link\">",
"     Patient information: Medications for the prevention of breast cancer (Beyond the Basics)",
"    </a>",
"    <br/>",
"    <a class=\"medical medical_patient\" href=\"mobipreview.htm?32/4/32835?source=see_link\">",
"     Patient information: Postmenopausal hormone therapy (Beyond the Basics)",
"    </a>",
"    <br/>",
"    <a class=\"medical medical_patient\" href=\"mobipreview.htm?4/23/4468?source=see_link\">",
"     Patient information: Risks and benefits of alcohol (Beyond the Basics)",
"    </a>",
"    <br/>",
"    <a class=\"medical medical_patient\" href=\"mobipreview.htm?31/16/32001?source=see_link\">",
"     Patient information: Nonhormonal treatments for menopausal symptoms (Beyond the Basics)",
"    </a>",
"    <br/>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Professional level information",
"    </span>",
"    &nbsp;&mdash;&nbsp;Professional level articles are designed to keep doctors and other health professionals up-to-date on the latest medical findings. These articles are thorough, long, and complex, and they contain multiple references to the research on which they are based. Professional level articles are best for people who are comfortable with a lot of medical terminology and who want to read the same materials their doctors are reading.",
"   </p>",
"   <p>",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/17/28954?source=see_link\">",
"     Factors that modify breast cancer risk in women",
"    </a>",
"    <br/>",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/35/39482?source=see_link\">",
"     Breast imaging: Mammography and ultrasonography",
"    </a>",
"    <br/>",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/15/24825?source=see_link\">",
"     Breast masses and other common breast problems",
"    </a>",
"    <br/>",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?4/60/5064?source=see_link\">",
"     Genetic risk assessment for individuals at risk for hereditary breast and ovarian cancer syndromes",
"    </a>",
"    <br/>",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/31/32249?source=see_link\">",
"     Genetic testing for hereditary breast and ovarian cancer syndrome",
"    </a>",
"    <br/>",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/0/17418?source=see_link\">",
"     Management of hereditary breast and ovarian cancer syndrome and patients with BRCA mutations",
"    </a>",
"    <br/>",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/63/44025?source=see_link\">",
"     Characteristics of hereditary breast and ovarian cancer syndromes",
"    </a>",
"    <br/>",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/49/41754?source=see_link\">",
"     Screening for breast cancer",
"    </a>",
"    <br/>",
"    <br/>",
"    The following organizations also provide reliable health information.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      National Cancer Institute",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    &nbsp; &nbsp; &nbsp; 1-800-4-CANCER",
"    <br/>",
"    &nbsp; &nbsp; &nbsp; (",
"    <a class=\"external\" href=\"file://www.nci.nih.gov/\">",
"     www.nci.nih.gov",
"    </a>",
"    )",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      People Living With Cancer: The official patient information website of the American Society of Clinical Oncology",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    (",
"    <a class=\"external\" href=\"file://www.cancer.net/portal/site/patient\">",
"     www.cancer.net/portal/site/patient",
"    </a>",
"    )",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      National Comprehensive Cancer Network",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    &nbsp; &nbsp; &nbsp;(",
"    <a class=\"external\" href=\"file://www.nccn.com/\">",
"     www.nccn.com",
"    </a>",
"    )",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      American Cancer Society",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    &nbsp; &nbsp; &nbsp; 1-800-ACS-2345",
"    <br/>",
"    &nbsp; &nbsp; &nbsp;(",
"    <a class=\"external\" href=\"file://www.cancer.org/\">",
"     www.cancer.org",
"    </a>",
"    )",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      National Library of Medicine",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    &nbsp; &nbsp; &nbsp;(",
"    <a class=\"external\" href=\"file://www.nlm.nih.gov/medlineplus/healthtopics.html\">",
"     www.nlm.nih.gov/medlineplus/healthtopics.html",
"    </a>",
"    )",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Susan G. Komen Breast Cancer Foundation",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    &nbsp; &nbsp; &nbsp; (",
"    <a class=\"external\" href=\"file://www.komen.org/\">",
"     www.komen.org",
"    </a>",
"    )",
"   </p>",
"   <p>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/6/44134/abstract/1-5\">",
"     1-5",
"    </a>",
"    ]",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H524458839\">",
"    <span class=\"h1\">",
"     ACKNOWLEDGMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The editorial staff at UpToDate, Inc. would like to acknowledge Dr. Mary Costanza, who contributed to an earlier version of this topic review",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/6/44134/abstract/1\">",
"      Hulka BS, Stark AT. Breast cancer: cause and prevention. Lancet 1995; 346:883.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/6/44134/abstract/2\">",
"      Olsen O, G&oslash;tzsche PC. Cochrane review on screening for breast cancer with mammography. Lancet 2001; 358:1340.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/6/44134/abstract/3\">",
"      Freedman DA, Petitti DB, Robins JM. On the efficacy of screening for breast cancer. Int J Epidemiol 2004; 33:43.",
"     </a>",
"    </li>",
"    <li>",
"     National Cancer Institute. Breast Cancer (PDQ&reg;): Screening. cancer.gov/cancertopics/pdq/screening/breast/healthprofessional (Accessed on April 16, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/6/44134/abstract/5\">",
"      K&ouml;sters JP, G&oslash;tzsche PC. Regular self-examination or clinical examination for early detection of breast cancer. Cochrane Database Syst Rev 2003; :CD003373.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 875 Version 11.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0502-218.189.88.190-50AA3700D9-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f43_6_44134=[""].join("\n");
var outline_f43_6_44134=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H303730530\">",
"      RISK FACTORS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H883961599\">",
"      STANDARD RISK FACTORS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Increasing age",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H303730545\">",
"      Gender",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H303730553\">",
"      Race/ethnicity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H883961612\">",
"      Weight",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26677408\">",
"      Tall stature",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H883961626\">",
"      Increased estrogen exposure",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H303730561\">",
"      Benign breast disease",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H883961639\">",
"      - Breast density on mammography",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H26677439\">",
"      - High bone density",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26677447\">",
"      Other hormonal factors",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H26677460\">",
"      - Androgens",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H26677467\">",
"      - Insulin",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H26677474\">",
"      - In utero exposure to diethystilbestrol",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26677495\">",
"      Menopausal hormonal therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26677534\">",
"      Reproductive factors",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H26677541\">",
"      - Age at time of menses starts and at menopause",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H26677548\">",
"      - Pregnancy and breastfeeding",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H303730575\">",
"      Personal history of breast cancer",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Family history",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H303730582\">",
"      LIFESTYLE FACTORS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H303730626\">",
"      Physical inactivity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26677702\">",
"      Alcohol",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H303730634\">",
"      Smoking",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H303730649\">",
"      DIETARY FACTORS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26677710\">",
"      Dietary pattern",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H303730665\">",
"      Dietary fat intake",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H303730673\">",
"      Consumption of red meat",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1524717\">",
"      Calcium/Vitamin D",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1524724\">",
"      Antioxidants",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26677717\">",
"      Soy/Phytoestrogens",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26677724\">",
"      Caffeine",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H883961788\">",
"      ENVIRONMENTAL FACTORS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26677731\">",
"      Geopgraphic residence",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H303730810\">",
"      Exposure to ionizing radiation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H883961796\">",
"      Night shift work",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H303730817\">",
"      Miscellaneous factors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26677739\">",
"      MEDICATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26677784\">",
"      Nonsteroidal anti-inflammatory drugs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26677800\">",
"      Bisphosphonates",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      REDUCING BREAST CANCER RISK",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Lifestyle changes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Medication",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      ESTIMATING RISK",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      WHERE TO GET MORE INFORMATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H241\">",
"      Patient level information",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H431451\">",
"      - The Basics",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H431466\">",
"      - Beyond the Basics",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Professional level information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H524458839\">",
"      ACKNOWLEDGMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/35/39482?source=related_link\">",
"      Breast imaging: Mammography and ultrasonography",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/15/24825?source=related_link\">",
"      Breast masses and other common breast problems",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/63/44025?source=related_link\">",
"      Characteristics of hereditary breast and ovarian cancer syndromes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/17/28954?source=related_link\">",
"      Factors that modify breast cancer risk in women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?4/60/5064?source=related_link\">",
"      Genetic risk assessment for individuals at risk for hereditary breast and ovarian cancer syndromes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/31/32249?source=related_link\">",
"      Genetic testing for hereditary breast and ovarian cancer syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?17/0/17418?source=related_link\">",
"      Management of hereditary breast and ovarian cancer syndrome and patients with BRCA mutations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?2/19/2357?source=related_link\">",
"      Patient information: Breast cancer (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?35/40/36481?source=related_link\">",
"      Patient information: Breast cancer screening (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?18/59/19379?source=related_link\">",
"      Patient information: Breast cancer screening (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?5/62/6115?source=related_link\">",
"      Patient information: Common breast problems (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?3/26/3492?source=related_link\">",
"      Patient information: Ductal carcinoma in situ (DCIS) (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?30/15/30963?source=related_link\">",
"      Patient information: Genetic testing for breast and ovarian cancer (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?26/26/27043?source=related_link\">",
"      Patient information: Genetic testing for breast and ovarian cancer (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?0/31/499?source=related_link\">",
"      Patient information: Medications for the prevention of breast cancer (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?31/16/32001?source=related_link\">",
"      Patient information: Nonhormonal treatments for menopausal symptoms (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?32/4/32835?source=related_link\">",
"      Patient information: Postmenopausal hormone therapy (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?4/23/4468?source=related_link\">",
"      Patient information: Risks and benefits of alcohol (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/49/41754?source=related_link\">",
"      Screening for breast cancer",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f43_6_44135="Investigational immunosuppressive drugs and approaches in clinical kidney transplantation";
var content_f43_6_44135=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Investigational immunosuppressive drugs and approaches in clinical kidney transplantation",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?43/6/44135/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/6/44135/contributors\">",
"     John Vella, MD, FACP, FRCP, FASN",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?43/6/44135/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/6/44135/contributors\">",
"     Daniel C Brennan, MD, FACP",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?43/6/44135/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/6/44135/contributors\">",
"     Alice M Sheridan, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?43/6/44135/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Oct 18, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The introduction of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    in the early 1980s improved renal allograft survival by approximately 15 percent at one year posttransplant [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/6/44135/abstract/1\">",
"     1",
"    </a>",
"    ]. However, cyclosporine failed to enhance long-term graft survival because of the inability to suppress the chronic and progressive loss of functioning renal tissue arising from antigen dependent and independent immunologic factors [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/6/44135/abstract/2-4\">",
"     2-4",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/61/34778?source=see_link\">",
"     \"Chronic renal allograft nephropathy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The administration of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/14/32992?source=see_link\">",
"     tacrolimus",
"    </a>",
"    may also exacerbate this process because of direct nephrotoxicity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/6/44135/abstract/5,6\">",
"     5,6",
"    </a>",
"    ]. In addition, renal transplant recipients are at risk for significant side effects due to immunosuppression, including infection, cardiovascular disease, hypertension, and malignancy. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/61/41945?source=see_link\">",
"     \"Cyclosporine and tacrolimus nephrotoxicity\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    These limitations constitute the rationale for the continued development of new immunosuppressive agents [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/6/44135/abstract/7-11\">",
"     7-11",
"    </a>",
"    ]. This topic will review the status of some of the new drugs that are currently under evaluation for use in renal transplantation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     UNDER DEVELOPMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;This section will review those drugs",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    approaches undergoing current investigation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Eculizimab",
"    </span>",
"    &nbsp;&mdash;&nbsp;Eculizimab is a complement inhibitory monoclonal antibody that inhibits assembly of the membrane attack complex via C5. The drug is licensed for the treatment of paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome. It has been used &ldquo;off label&rdquo; to treat refractory antibody mediated rejection in a very limited number of patients, although with impressive efficacy. Additional study is required before even preliminary recommendations can be made about its administration to transplant recipients. Cost is a major limitation to the use of this agent as it is extraordinarily expensive.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Alefacept",
"    </span>",
"    &nbsp;&mdash;&nbsp;To overcome costimulation blockade resistance, one possible approach is to target T memory cells by interfering with the interaction between CD2 and LFA-3 with alefacept, which is humanized LFA-3-Ig. A study in nonhuman primates who underwent kidney transplantation found that alefacept, when combined with CTLA-4-IgG and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?5/39/5753?source=see_link\">",
"     sirolimus",
"    </a>",
"    , significantly prolonged kidney allograft survival [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/6/44135/abstract/12\">",
"     12",
"    </a>",
"    ]. Clinical trials are required to better understand the possible role of this agent.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Voclosporine (ISA247)",
"    </span>",
"    &nbsp;&mdash;&nbsp;An isomeric",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    A analog mixture, ISA247, may be a more potent immunosuppressive agent than cyclosporine. In vitro studies have found that this agent significantly dampened lymphocyte proliferation and activation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/6/44135/abstract/13\">",
"     13",
"    </a>",
"    ]. In addition, ISA247 was safe and effective in a phase 2 trial in patients with chronic psoriasis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/6/44135/abstract/14\">",
"     14",
"    </a>",
"    ]. There is an ongoing phase IIIb study of ISA247 versus",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/14/32992?source=see_link\">",
"     tacrolimus",
"    </a>",
"    <span class=\"nowrap\">",
"     (file://www.clinicaltrials.gov/ct/show/NCT00270634?order=1).",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Sotrastaurin (AEB071)",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sotrastaurin",
"    (AEB071) is an oral protein kinase C inhibitor that inhibits T cell activation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/6/44135/abstract/11\">",
"     11",
"    </a>",
"    ]. Preliminary studies in non-human primates suggest that renal allograft survival is prolonged [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/6/44135/abstract/15\">",
"     15",
"    </a>",
"    ]. A phase 2 clinical kidney transplant trial found that an initial regimen of sotrastaurin and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/14/32992?source=see_link\">",
"     tacrolimus",
"    </a>",
"    was effective and tolerated but the conversion from tacrolimus to mycophenolic acid to achieve a calcineurin-free immunosuppression regimen was relatively ineffective [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/6/44135/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Tasocitinib (CP690550) Jak 3 inhibitor",
"    </span>",
"    &nbsp;&mdash;&nbsp;CP-690550, a novel JAK 3 inhibitor, is an immunosuppressive agent that appears to selectively reduce natural killer and T cell subsets [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/6/44135/abstract/17\">",
"     17",
"    </a>",
"    ]. This agent is currently undergoing phase 2 trials in kidney transplant patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/6/44135/abstract/11\">",
"     11",
"    </a>",
"    ]. A randomized, pilot study compared CP-690,550 (15 mg BID and 30 mg BID) with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/14/32992?source=see_link\">",
"     tacrolimus",
"    </a>",
"    in de novo kidney allograft recipients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/6/44135/abstract/18\">",
"     18",
"    </a>",
"    ]. At 15 mg BID, the",
"    <span class=\"nowrap\">",
"     efficacy/",
"    </span>",
"    safety profile was comparable to the tacrolimus control group, other than a higher rate of viral infection. However, coadministration of CP-690,550 30 mg BID with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?4/29/4569?source=see_link\">",
"     mycophenolate",
"    </a>",
"    mofetil associated with overimmunosuppression.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Bortozemib",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bortozemib is an inhibitor of the 26S proteosome that disrupts cellular homeostasis and induces cell death. It is currently licensed for the treatment of myeloma. A number of studies presented in abstract form suggested that this novel agent may have some utility in the management of the highly sensitized patient and also for treatment of antibody mediated rejection. Additional study is required before even preliminary recommendations can be made about administration to transplant recipients.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Photopheresis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Photopheresis is a form of extracorporeal photochemotherapy in which peripheral lymphocytes are collected via apheresis and treated with 8-methoxypsoralen and ultraviolet light [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/6/44135/abstract/19\">",
"     19",
"    </a>",
"    ]. The process appears to downregulate activated T cell clones.",
"   </p>",
"   <p>",
"    Preliminary evidence suggests that photopheresis may decrease the frequency of rejection in both cardiac and renal transplant recipients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/6/44135/abstract/20,21\">",
"     20,21",
"    </a>",
"    ]. In one report, four patients with renal allograft rejection uncontrolled with aggressive immunosuppressive therapy underwent a six-month course of photopheresis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/6/44135/abstract/21\">",
"     21",
"    </a>",
"    ]. All patients became rejection-free and, in three of the four, a reduction in corticosteroid dose was successfully performed. Further study in a larger number of individuals is required to clarify the role of photopheresis in transplant recipients.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     No maintenance immunosuppression",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are a few case reports of excellent long-term kidney allograft function in patients who received combined kidney and hematopoietic stem-cell transplant and did not require chronic maintenance immunosuppression:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      After a nonmyeloablative preparative regimen, combined bone marrow and kidney transplantations from HLA single-haplotype mismatched living related donors was performed in five patients with end-stage renal disease [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/6/44135/abstract/22\">",
"       22",
"      </a>",
"      ]. After immunosuppression was discontinued in four recipients (9 to 14 months after surgery), stable kidney function continued at follow-up of 2 to 5.3 years after transplantation. The kidney allograft was rejected in one individual.",
"     </li>",
"     <li>",
"      Combined kidney and hematopoietic-cell transplantation from a HLA-matched donor was successful in one individual, which was based in part upon a post-transplantation conditioning regimen consisting of total lymphoid irradiation and antithymocyte globulin [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/6/44135/abstract/23\">",
"       23",
"      </a>",
"      ]. After discontinuation of all immunosuppressive medication, kidney allograft function has been adequate for 28 months.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Although the exact mechanisms underlying tolerance in these cases are unclear, the persistence of mixed hematopoietic chimerism appears to be the principal factor permitting the induction of immunologic tolerance for the donor organ [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/6/44135/abstract/24\">",
"     24",
"    </a>",
"    ]. Further study is required to characterize the feasibility of this approach.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     STALLED DEVELOPMENT",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Humanized OKT3",
"    </span>",
"    &nbsp;&mdash;&nbsp;OKT3 remains the only non-humanized mouse antibody licensed for the therapy of allograft rejection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/6/44135/abstract/25\">",
"     25",
"    </a>",
"    ]. However, the drug has been recently withdrawn by the manufacturer due to declining sales. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?4/52/4938?source=see_link\">",
"     \"Acute renal allograft rejection: Treatment\"",
"    </a>",
"    .) The administration of OKT3 is associated with frequent and occasionally serious adverse effects. There is a common first-dose reaction that may include fever (70 to 100 percent), rigors (30 percent), nausea, vomiting, diarrhea (15 to 20 percent), hypotension, chest pain, dyspnea and wheezing (10 to 20 percent). Since OKT3 is a T cell mitogen, most of these symptoms are thought to be mediated by T cell release of cytokines via CD3 binding [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/6/44135/abstract/26\">",
"     26",
"    </a>",
"    ]. Other serious complications, arising from the more intense immunosuppression, include infection and an increased incidence of lymphoproliferative disease.",
"   </p>",
"   <p>",
"    Another difficulty with OKT3 is the possible induction of human anti-mouse antibodies (HAMA). These antibodies, if present, diminish the efficacy of repeated courses of OKT3.",
"   </p>",
"   <p>",
"    To reduce the side effects and the antigenicity of murine OKT3, a non-mitogenic \"humanized\" variant has been developed [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/6/44135/abstract/27\">",
"     27",
"    </a>",
"    ]. The humanized hybrid molecule was engineered by transferring the complementary determining regions of OKT3 onto a human IgG framework, and then mutating single amino acids to reduce the affinity of the \"humanized\" anti-CD3 monoclonal antibodies.",
"   </p>",
"   <p>",
"    Both in vitro and in vivo studies have found that the humanized variant of OKT3 does not activate human T cells, but retains significant immunosuppressive properties [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/6/44135/abstract/28\">",
"     28",
"    </a>",
"    ]. A phase I trial involving seven patients with acute rejection, five kidney and two kidney-pancreas transplants, found that the administration of the humanized variant reversed rejection in five, with recurrent rejection occurring in one [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/6/44135/abstract/29\">",
"     29",
"    </a>",
"    ]. Prior to the first dose, patients received only 500 mg of methylprednisolone. The drug was well tolerated with minimal first dose reactions (including lack of IL-2 release); induction of antibodies against OKT3 was not observed. Because it is less immunogenic, the half-life of humanized variant, 142 hours, is much longer than that of conventional OKT3. Similar findings were reported in a phase I trial of another humanized variant [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/6/44135/abstract/30\">",
"     30",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    No recent data have been published on this agent. Development appears to be stalled.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     T10B9.1A monoclonal antibody",
"    </span>",
"    &nbsp;&mdash;&nbsp;T10B9.1A is a murine monoclonal antibody directed against an epitope of the T cell receptor",
"    <span class=\"nowrap\">",
"     alpha/beta",
"    </span>",
"    heterodimer [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/6/44135/abstract/31\">",
"     31",
"    </a>",
"    ]. Since T10B9.1A is nonmitogenic, it does not produce the cytokine-mediated side effects observed with OKT3 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/6/44135/abstract/32\">",
"     32",
"    </a>",
"    ]. An additional benefit may include a more rapid reversal of rejection-related renal failure [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/6/44135/abstract/32\">",
"     32",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The finding of fewer side effects with T10B9.1A was reconfirmed in a phase two randomized trial [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/6/44135/abstract/33\">",
"     33",
"    </a>",
"    ]. This study directly compared the efficacy and adverse reactions of T10B9.1A and OKT3 in 76 patients with biopsy-confirmed acute renal allograft rejection. Patients in whom the first monoclonal antibody was ineffective were administered the second antibody. No significant differences between the three groups were observed in graft or patient survival (at four year follow-up) and serum creatinine concentrations (at three years); however, the patients given OKT3 experienced significantly more adverse side effects.",
"   </p>",
"   <p>",
"    Unfortunately, the development of human antimouse antibodies with T10B9.1A occurs with the same frequency as with OKT3 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/6/44135/abstract/33\">",
"     33",
"    </a>",
"    ]. However, since there is little crossreactivity among those treated with both monoclonal antibodies, a possible alternative therapy among patients in whom OKT3 fails is the administration of T10B9.1A [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/6/44135/abstract/33\">",
"     33",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Nevertheless, there have been no subsequent reports on further development of T10B9.1A. It is assumed that this agent will not reach the marketplace.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Anti-ICAM-1 antibodies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several adhesion molecules contribute to the interaction between T cells and antigen presenting or target cells. One critical adhesive receptor-counterreceptor combination is leukocyte function-associated molecule-1 (LFA-1) and intercellular adhesion molecule-1 (ICAM-1) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/6/44135/abstract/34\">",
"     34",
"    </a>",
"    ]. An overview of adhesion molecules can be found elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/54/36711?source=see_link\">",
"     \"Leukocyte-endothelial adhesion in the pathogenesis of inflammation\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Early animal studies with murine monoclonal antibodies directed against ICAM-1 found that these antibodies delayed but did not prevent acute rejection when used alone [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/6/44135/abstract/35\">",
"     35",
"    </a>",
"    ]. Studies evaluating these agents in humans have been performed. A phase I clinical trial of 18 patients who received cadaveric renal allografts at high risk for delayed graft function evaluated the efficacy of an anti-ICAM-1 antibody in preventing primary nonfunction and prolonging graft survival [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/6/44135/abstract/36\">",
"     36",
"    </a>",
"    ]. In the anti-ICAM-1 antibody-treated group, no instances of primary nonfunction occurred and graft survival was 78 percent at a follow-up period of 16 to 30 months; by comparison, among those who had received kidneys from the same cadaveric donors but were treated with conventional immunosuppressive therapy, three cases of primary nonfunction and a 56 percent graft survival rate were observed.",
"   </p>",
"   <p>",
"    The efficacy of an anti-ICAM-1 antibody (enlimomab) in reducing the rates of acute rejection and delayed graft function, and in enhancing graft and patient survival was evaluated in a multicenter study of 262 recipients of cadaveric allografts randomized to enlimomab (given for six days) or placebo; all patients received",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?38/3/38967?source=see_link\">",
"     azathioprine",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/48/33536?source=see_link\">",
"     prednisolone",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/6/44135/abstract/37\">",
"     37",
"    </a>",
"    ]. No statistical difference in the incidence of any clinical endpoint was observed between the two groups.",
"   </p>",
"   <p>",
"    Whether these antibodies may be beneficial in a subset of patients (such as high-risk individuals) or if administered in a different regimen is unclear. Concerns about the relative lack of efficacy of this agent seem to have stalled further development.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Anti-LFA-1 antibodies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Therapeutic trials evaluating the effectiveness of anti-LFA-1 antibodies have also been performed or are underway [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/6/44135/abstract/38\">",
"     38",
"    </a>",
"    ]. A multicenter renal transplant trial compared the efficacy of a monoclonal antibody directed against the alpha chain of LFA-1 with that of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?2/36/2629?source=see_link\">",
"     rabbit antithymocyte globulin",
"    </a>",
"    (rATG) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/6/44135/abstract/39\">",
"     39",
"    </a>",
"    ]. This evaluation was part of a quadruple sequential protocol in 101 patients undergoing renal transplantation. The clinical tolerance of the monoclonal antibody directed against LFA-1 was superior to that of rATG. However, rejection during the first 10 days was more common in the anti-LFA-1 group (11 versus 0 percent). However, the incidence and severity of acute rejection in the first three months, graft survival at one year (96 and 92 percent, respectively), and the incidence and severity of infection (whatever the origin) were similar in the two groups.",
"   </p>",
"   <p>",
"    A multicenter phase",
"    <span class=\"nowrap\">",
"     I/II",
"    </span>",
"    trial evaluated two doses of efalizumab, a humanized anti-LFA-1 antibody, plus maintenance therapy with either full dose",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?4/29/4569?source=see_link\">",
"     mycophenolate",
"    </a>",
"    and steroids or half dose cyclosporine,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?5/39/5753?source=see_link\">",
"     sirolimus",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?37/43/38585?source=see_link\">",
"     prednisone",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/6/44135/abstract/40\">",
"     40",
"    </a>",
"    ]. At six months, patient and allograft survival were 97 and 95 percent, respectively. However, PTLD developed in three patients (8 percent), all of whom received the higher dose of efalizumab and full dose cyclosporine. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/50/23338?source=see_link\">",
"     \"Treatment and prevention of post-transplant lymphoproliferative disorders\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Fingolimod (FTY720)",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?26/11/26806?source=see_link\">",
"     Fingolimod",
"    </a>",
"    (FTY720) is a sphingosine analogue that functions as an immunosuppressant by altering normal lymphocyte homing patterns [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/6/44135/abstract/41\">",
"     41",
"    </a>",
"    ]. This agent interferes with the exit of lymphocytes from the thymus into the blood and from the tissue of secondary lymphoid organs into the efferent lymphatics. It may also reduce the risk of malignancy after transplantation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/6/44135/abstract/42\">",
"     42",
"    </a>",
"    ]. It has recently been approved for treatment of multiple sclerosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/6/44135/abstract/43\">",
"     43",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Clinically,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?26/11/26806?source=see_link\">",
"     fingolimod",
"    </a>",
"    has been associated with a decreased incidence of biopsy-proven acute rejection of renal allografts, as well as lymphopenia and bradycardia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/6/44135/abstract/44\">",
"     44",
"    </a>",
"    ]. A one-year phase II study reported that fingolimod plus Neoral and fingolimod plus reduced dose",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    were effective and safe [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/6/44135/abstract/45\">",
"     45",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Unfortunately, the results of one phase III clinical trial indicated that",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?26/11/26806?source=see_link\">",
"     fingolimod",
"    </a>",
"    was inferior to",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    at preventing rejection. In addition, a portion of patients developed macular edema, a potentially sight-threatening complication. A similar increase in cases of macular edema was noted in another large phase III trial from Europe and Australasia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/6/44135/abstract/46\">",
"     46",
"    </a>",
"    ]. A case report also noted that this complication may be reversible [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/6/44135/abstract/47\">",
"     47",
"    </a>",
"    ]. Because of this complication, further development has ceased.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     FK778, metabolite of leflunomide",
"    </span>",
"    &nbsp;&mdash;&nbsp;FK778, an analogue of the active metabolite of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?18/36/19015?source=see_link\">",
"     leflunomide",
"    </a>",
"    , appears to suppress elements of both the cellular and humoral immune response. In a multicenter phase II study, 149 renal transplant recipients receiving",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/14/32992?source=see_link\">",
"     tacrolimus",
"    </a>",
"    plus corticosteroids were randomly assigned to placebo, or high or low doses of FK778 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/6/44135/abstract/48\">",
"     48",
"    </a>",
"    ]. Acute rejection was lower in the group receiving high doses of FK778, but there were dose-dependent adverse effects including anemia, hypokalemia, symptomatic ischemic heart disease, and esophagitis.",
"   </p>",
"   <p>",
"    Abstracts have been presented suggesting that",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?18/36/19015?source=see_link\">",
"     leflunomide",
"    </a>",
"    may be useful in managing chronic allograft nephropathy and BK virus nephropathy. There are few published data that confirm these observations. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/61/34778?source=see_link\">",
"     \"Chronic renal allograft nephropathy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?6/7/6266?source=see_link\">",
"     \"Clinical manifestations and diagnosis of BK virus-induced (polyomavirus-induced) nephropathy in kidney transplantation\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/45/42712?source=see_link\">",
"     \"Management of BK virus-induced (polyomavirus-induced) nephropathy in kidney transplantation\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Further development of FK778 has been halted in the United States because of clinical trial data indicating the drug is not superior to conventional therapy at preventing allograft rejection (or preventing BK nephropathy).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H93499119\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Novel immunosuppressive agents continue to be evaluated because of the limitations of existing therapies that relate more to the risk of serious adverse effects than lack of efficacy. The choice of immunotherapy is dictated more by the risk of adverse effects as all regimens are largely effective for most (although not all) individuals and none are free from the potential of life and kidney threatening side effects. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Agents currently under development include",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?27/63/28662?source=see_link\">",
"       eculizumab",
"      </a>",
"      , alefacept, voclosporine, sotrastaurin, tasocitinib, and bortozemib. The roles for bortozemib and eculizumab in the management of antibody mediated rejection remain to be defined. All of the other agents discussed in this topic review either have had their development discontinued or remain in early phase clinical trials. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Under development'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H13\">",
"       'Stalled development'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Cecka, JM, Terasaki, PI. The UNOS Scientific Renal Transplant Registry. In: Clinical Transplants 1995, p. 1.",
"    </li>",
"    <li>",
"     Terasaki, PI, McClelland, JD, Yuge, J, et al. Advances in kidney transplantation. In: Clinical Transplants, 1995, p. 487.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/6/44135/abstract/3\">",
"      Carpenter CB. Long-term failure of renal transplants: adding insult to injury. Kidney Int Suppl 1995; 50:S40.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/6/44135/abstract/4\">",
"      Tullius SG, Tilney NL. Both alloantigen-dependent and -independent factors influence chronic allograft rejection. Transplantation 1995; 59:313.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/6/44135/abstract/5\">",
"      Vella JP, Sayegh MH. Current and future immunosuppressive therapies: impact on chronic allograft dysfunction. J Nephrol 1997; 10:229.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/6/44135/abstract/6\">",
"      Vella JP, Sayegh MH. Maintenance pharmacological immunosuppressive strategies in renal transplantation. Postgrad Med J 1997; 73:386.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/6/44135/abstract/7\">",
"      Denton MD, Magee CC, Sayegh MH. Immunosuppressive strategies in transplantation. Lancet 1999; 353:1083.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/6/44135/abstract/8\">",
"      Gummert JF, Ikonen T, Morris RE. Newer immunosuppressive drugs: a review. J Am Soc Nephrol 1999; 10:1366.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/6/44135/abstract/9\">",
"      Kanmaz, T, Knechtle, SJ. Novel agents or strategies for immunosuppression after renal transplantation. Curr Opin Organ Transplant 2003; 8:172.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/6/44135/abstract/10\">",
"      Kahan BD. Individuality: the barrier to optimal immunosuppression. Nat Rev Immunol 2003; 3:831.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/6/44135/abstract/11\">",
"      Tedesco Silva H Jr, Pinheiro Machado P, Rosso Felipe C, Medina Pestana JO. Immunotherapy for De Novo renal transplantation: what's in the pipeline? Drugs 2006; 66:1665.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/6/44135/abstract/12\">",
"      Weaver TA, Charafeddine AH, Agarwal A, et al. Alefacept promotes co-stimulation blockade based allograft survival in nonhuman primates. Nat Med 2009; 15:746.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/6/44135/abstract/13\">",
"      B&icirc;rsan T, Dambrin C, Freitag DG, et al. The novel calcineurin inhibitor ISA247: a more potent immunosuppressant than cyclosporine in vitro. Transpl Int 2005; 17:767.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/6/44135/abstract/14\">",
"      Bissonnette R, Papp K, Poulin Y, et al. A randomized, multicenter, double-blind, placebo-controlled phase 2 trial of ISA247 in patients with chronic plaque psoriasis. J Am Acad Dermatol 2006; 54:472.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/6/44135/abstract/15\">",
"      The first-in-class oral protein kinase C (pkc) inhibitor nvp-aeb071 (aeb) prolongs renal allograft survival in non-human primates (nhp) and suppresses lymphocyte proliferation at safe exposures in human proof-of-concept studies (abstract). Transplantation 2006; 82(Suppl2):86.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/6/44135/abstract/16\">",
"      Budde K, Sommerer C, Becker T, et al. Sotrastaurin, a novel small molecule inhibiting protein kinase C: first clinical results in renal-transplant recipients. Am J Transplant 2010; 10:571.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/6/44135/abstract/17\">",
"      Kudlacz E, Perry B, Sawyer P, et al. The novel JAK-3 inhibitor CP-690550 is a potent immunosuppressive agent in various murine models. Am J Transplant 2004; 4:51.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/6/44135/abstract/18\">",
"      Busque S, Leventhal J, Brennan DC, et al. Calcineurin-inhibitor-free immunosuppression based on the JAK inhibitor CP-690,550: a pilot study in de novo kidney allograft recipients. Am J Transplant 2009; 9:1936.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/6/44135/abstract/19\">",
"      Dall'Amico R, Livi U, Milano A, et al. Extracorporeal photochemotherapy as adjuvant treatment of heart transplant recipients with recurrent rejection. Transplantation 1995; 60:45.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/6/44135/abstract/20\">",
"      Costanzo-Nordin MR, McManus BM, Wilson JE, et al. Efficacy of photopheresis in the rescue therapy of acute cellular rejection in human heart allografts: a preliminary clinical and immunopathologic report. Transplant Proc 1993; 25:881.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/6/44135/abstract/21\">",
"      Dall'Amico R, Murer L, Montini G, et al. Successful treatment of recurrent rejection in renal transplant patients with photopheresis. J Am Soc Nephrol 1998; 9:121.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/6/44135/abstract/22\">",
"      Kawai T, Cosimi AB, Spitzer TR, et al. HLA-mismatched renal transplantation without maintenance immunosuppression. N Engl J Med 2008; 358:353.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/6/44135/abstract/23\">",
"      Scandling JD, Busque S, Dejbakhsh-Jones S, et al. Tolerance and chimerism after renal and hematopoietic-cell transplantation. N Engl J Med 2008; 358:362.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/6/44135/abstract/24\">",
"      Starzl TE. Immunosuppressive therapy and tolerance of organ allografts. N Engl J Med 2008; 358:407.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/6/44135/abstract/25\">",
"      Kuypers DR, Vanrenterghem YF. Monoclonal antibodies in renal transplantation: old and new. Nephrol Dial Transplant 2004; 19:297.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/6/44135/abstract/26\">",
"      Abramowicz D, Schandene L, Goldman M, et al. Release of tumor necrosis factor, interleukin-2, and gamma-interferon in serum after injection of OKT3 monoclonal antibody in kidney transplant recipients. Transplantation 1989; 47:606.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/6/44135/abstract/27\">",
"      Woodle ES, Thistlethwaite JR, Jolliffe LK, et al. Humanized OKT3 antibodies: successful transfer of immune modulating properties and idiotype expression. J Immunol 1992; 148:2756.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/6/44135/abstract/28\">",
"      Alegre ML, Peterson LJ, Xu D, et al. A non-activating \"humanized\" anti-CD3 monoclonal antibody retains immunosuppressive properties in vivo. Transplantation 1994; 57:1537.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/6/44135/abstract/29\">",
"      Woodle ES, Xu D, Zivin RA, et al. Phase I trial of a humanized, Fc receptor nonbinding OKT3 antibody, huOKT3gamma1(Ala-Ala) in the treatment of acute renal allograft rejection. Transplantation 1999; 68:608.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/6/44135/abstract/30\">",
"      Friend PJ, Hale G, Chatenoud L, et al. Phase I study of an engineered aglycosylated humanized CD3 antibody in renal transplant rejection. Transplantation 1999; 68:1632.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/6/44135/abstract/31\">",
"      Waid TH, Lucas BA, Amlot P, et al. T10B9.1A-31 anti-T-cell monoclonal antibody: preclinical studies and clinical treatment of solid organ allograft rejection. Am J Kidney Dis 1989; 14:61.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/6/44135/abstract/32\">",
"      Brown SA, Lucas BA, Waid TH, et al. T10B9 (MEDI-500) mediated immunosuppression: studies on the mechanism of action. Clin Transplant 1996; 10:607.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/6/44135/abstract/33\">",
"      Waid TH, Lucas BA, Thompson JS, et al. Treatment of renal allograft rejection with T10B9.1A31 or OKT3: final analysis of a phase II clinical trial. Transplantation 1997; 64:274.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/6/44135/abstract/34\">",
"      Rabb H, Bonventre JV. Leukocyte adhesion molecules in transplantation. Am J Med 1999; 107:157.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/6/44135/abstract/35\">",
"      Cosimi AB, Conti D, Delmonico FL, et al. In vivo effects of monoclonal antibody to ICAM-1 (CD54) in nonhuman primates with renal allografts. J Immunol 1990; 144:4604.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/6/44135/abstract/36\">",
"      Haug CE, Colvin RB, Delmonico FL, et al. A phase I trial of immunosuppression with anti-ICAM-1 (CD54) mAb in renal allograft recipients. Transplantation 1993; 55:766.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/6/44135/abstract/37\">",
"      Salmela K, Wramner L, Ekberg H, et al. A randomized multicenter trial of the anti-ICAM-1 monoclonal antibody (enlimomab) for the prevention of acute rejection and delayed onset of graft function in cadaveric renal transplantation: a report of the European Anti-ICAM-1 Renal Transplant Study Group. Transplantation 1999; 67:729.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/6/44135/abstract/38\">",
"      Nicolls MR, Gill RG. LFA-1 (CD11a) as a therapeutic target. Am J Transplant 2006; 6:27.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/6/44135/abstract/39\">",
"      Hourmant M, Bedrossian J, Durand D, et al. A randomized multicenter trial comparing leukocyte function-associated antigen-1 monoclonal antibody with rabbit antithymocyte globulin as induction treatment in first kidney transplantations. Transplantation 1996; 62:1565.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/6/44135/abstract/40\">",
"      Vincenti F, Mendez R, Pescovitz M, et al. A phase I/II randomized open-label multicenter trial of efalizumab, a humanized anti-CD11a, anti-LFA-1 in renal transplantation. Am J Transplant 2007; 7:1770.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/6/44135/abstract/41\">",
"      Kunzendorf U, Ziegler E, Kabelitz D. FTY720--the first compound of a new promising class of immunosuppressive drugs. Nephrol Dial Transplant 2004; 19:1677.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/6/44135/abstract/42\">",
"      Guba M, Graeb C, Jauch KW, Geissler EK. Pro- and anti-cancer effects of immunosuppressive agents used in organ transplantation. Transplantation 2004; 77:1777.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/6/44135/abstract/43\">",
"      Guasch A, Roy-Chaudhury P, Woodle ES, et al. Assessment of efficacy and safety of FK778 in comparison with standard care in renal transplant recipients with untreated BK nephropathy. Transplantation 2010; 90:891.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/6/44135/abstract/44\">",
"      Tedesco-Silva H, Mourad G, Kahan BD, et al. FTY720, a novel immunomodulator: efficacy and safety results from the first phase 2A study in de novo renal transplantation. Transplantation 2004; 77:1826.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/6/44135/abstract/45\">",
"      Mulgaonkar S, Tedesco H, Oppenheimer F, et al. FTY720/cyclosporine regimens in de novo renal transplantation: a 1-year dose-finding study. Am J Transplant 2006; 6:1848.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/6/44135/abstract/46\">",
"      Salvadori M, Budde K, Charpentier B, et al. FTY720 versus MMF with cyclosporine in de novo renal transplantation: a 1-year, randomized controlled trial in Europe and Australasia. Am J Transplant 2006; 6:2912.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/6/44135/abstract/47\">",
"      Saab G, Almony A, Blinder KJ, et al. Reversible cystoid macular edema secondary to fingolimod in a renal transplant recipient. Arch Ophthalmol 2008; 126:140.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/6/44135/abstract/48\">",
"      Vanrenterghem Y, van Hooff JP, Klinger M, et al. The effects of FK778 in combination with tacrolimus and steroids: a phase II multicenter study in renal transplant patients. Transplantation 2004; 78:9.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7307 Version 10.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-60.18.131.125-8F74BD76B3-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f43_6_44135=[""].join("\n");
var outline_f43_6_44135=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H93499119\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      UNDER DEVELOPMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Eculizimab",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Alefacept",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Voclosporine (ISA247)",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Sotrastaurin (AEB071)",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Tasocitinib (CP690550) Jak 3 inhibitor",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Bortozemib",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Photopheresis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      No maintenance immunosuppression",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      STALLED DEVELOPMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Humanized OKT3",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      T10B9.1A monoclonal antibody",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Anti-ICAM-1 antibodies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Anti-LFA-1 antibodies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Fingolimod (FTY720)",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      FK778, metabolite of leflunomide",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H93499119\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?4/52/4938?source=related_link\">",
"      Acute renal allograft rejection: Treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/61/34778?source=related_link\">",
"      Chronic renal allograft nephropathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?6/7/6266?source=related_link\">",
"      Clinical manifestations and diagnosis of BK virus-induced (polyomavirus-induced) nephropathy in kidney transplantation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/61/41945?source=related_link\">",
"      Cyclosporine and tacrolimus nephrotoxicity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/54/36711?source=related_link\">",
"      Leukocyte-endothelial adhesion in the pathogenesis of inflammation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?41/45/42712?source=related_link\">",
"      Management of BK virus-induced (polyomavirus-induced) nephropathy in kidney transplantation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/50/23338?source=related_link\">",
"      Treatment and prevention of post-transplant lymphoproliferative disorders",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f43_6_44136="Management of the short bowel syndrome in adults";
var content_f43_6_44136=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Management of the short bowel syndrome in adults",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?43/6/44136/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/6/44136/contributors\">",
"     Jon A Vanderhoof, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/6/44136/contributors\">",
"     Rosemary J Pauley-Hunter, NP-C, MS, RN",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?43/6/44136/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/6/44136/contributors\">",
"     J Thomas LaMont, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?43/6/44136/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/6/44136/contributors\">",
"     Shilpa Grover, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?43/6/44136/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Dec 12, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Short bowel syndrome is a malabsorptive state that may follow massive resection of the small intestine [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/6/44136/abstract/1\">",
"     1",
"    </a>",
"    ]. It is a functional definition implying a significant amount of malabsorption, which may involve both macronutrients and micronutrients. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/56/30601?source=see_link\">",
"     \"Pathophysiology of the short bowel syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Short bowel syndrome in adults usually results from surgical resection for Crohn's disease, malignancy, radiation, or vascular insufficiency. In infants and small children, the major causes are necrotizing enterocolitis and congenital intestinal anomalies.",
"   </p>",
"   <p>",
"    The type and severity of clinical manifestations are variable. In some patients, caloric and protein needs can be adequately met enterally, but vitamin and mineral deficiencies may still occur. In others, fluid and electrolyte losses are the predominant clinical problems while nutrient absorption may be adequate.",
"   </p>",
"   <p>",
"    In many cases, the process of intestinal adaptation may ultimately permit transition to oral feeding. Intestinal failure is a new term commonly being used to describe the state when gastrointestinal function is inadequate to maintain the nutrient and hydration status of the person without intravenous or enteral supplementation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/6/44136/abstract/2\">",
"     2",
"    </a>",
"    ]. The process of intestinal adaptation is lengthy but actions taken in the first few months after resection have a significant role in the ultimate outcome. Because quality of life in patients with short bowel syndrome is decreased due to chronic fatigue and ongoing gastrointestinal symptoms special attention to the process of intestinal adaptation is critical [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/6/44136/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    An overview of the management of patients with short bowel syndrome will be provided here. The pathogenesis of this disorder, and the chronic complications that may occur (eg, liver disease, gallstones, bacterial overgrowth, and hyperoxaluria) are presented separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/56/30601?source=see_link\">",
"     \"Pathophysiology of the short bowel syndrome\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/37/18007?source=see_link\">",
"     \"Chronic complications of the short bowel syndrome in adults\"",
"    </a>",
"    .) The American Gastroenterological Association (AGA) guideline for short bowel syndrome and intestinal transplantation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/6/44136/abstract/4\">",
"     4",
"    </a>",
"    ], as well as other AGA guidelines, can be accessed through the AGA web site at",
"    <a class=\"external\" href=\"file://www.gastro.org/practice/medical-position-statements\">",
"     www.gastro.org/practice/medical-position-statements",
"    </a>",
"    .",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     LIKELIHOOD OF RESUMING AN ORAL DIET",
"    </span>",
"    &nbsp;&mdash;&nbsp;The likelihood of successful transition to enteral feeding in short bowel syndrome depends upon several factors:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      The length of remaining small bowel",
"     </li>",
"     <li>",
"      The remaining segments of small bowel",
"     </li>",
"     <li>",
"      Presence of the colon and an intact ileocecal valve",
"     </li>",
"     <li>",
"      Intestinal adaptation",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Length of remaining small intestine",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most adult patients with an intact duodenum, a jejunal length greater than 200 cm, and an intact colon can eventually be managed on oral intake alone. However, patients estimated to have less than 200 cm of jejunum remaining after surgery should not necessarily be excluded from an attempt at enteral feeding. The length of remaining small bowel may be underestimated during surgery due to a variable amount of intestinal spasm during laparotomy. Furthermore, intestinal adaptation may sufficiently compensate in some individuals with shorter segments of remaining jejunum to eventually permit oral feeding. Even patients who are destined to require long-term parenteral nutrition (PN) support (those with less than 50 to 60 cm or only a duodenum remaining) may be able to tolerate some degree of enteral nutrition, which can have important social and psychological benefits.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h3\">",
"     Citrulline concentrations",
"    </span>",
"    &nbsp;&mdash;&nbsp;Measurement of plasma citrulline concentrations (a non-protein amino acid produced by intestinal mucosa) has been proposed to predict permanent versus transient intestinal failure [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/6/44136/abstract/5,6\">",
"     5,6",
"    </a>",
"    ]. In a study of 57 patients with nonmalignant short bowel syndrome who were followed for at least two years, a level &lt;20",
"    <span class=\"nowrap\">",
"     micromol/L",
"    </span>",
"    identified patients destined to have permanent intestinal failure with positive and negative predictive values of 95 and 86 percent, respectively. A study in children with SBS demonstrated that plasma citrulline levels were strong predictors of parenteral nutrition and correlated well with a patient's recorded bowel length. A cutoff level of 15",
"    <span class=\"nowrap\">",
"     micromol/L",
"    </span>",
"    was found to be an accurate prognostic measure regarding the likelihood of future PN independence [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/6/44136/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Segment of remaining intestine",
"    </span>",
"    &nbsp;&mdash;&nbsp;The segment of remaining intestine is important for determining the metabolic consequences of the short bowel syndrome. The proximal small intestine is primarily responsible for the absorption of proteins, carbohydrates, and fats. However, the ileum is able to compensate for absorption of these nutrients following loss of the proximal small intestine.",
"   </p>",
"   <p>",
"    In contrast, resection of the ileum may be relatively more problematic than loss of the proximal small intestine since the jejunum is less able to compensate for the specialized absorptive functions of the ileum.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The ileum is the selective site for absorption of vitamin B12 and bile salts. Resection of more than 60 cm of ileum is associated with malabsorption of intrinsic factor bound vitamin B12 [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/6/44136/abstract/8\">",
"       8",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?11/32/11786?source=see_link\">",
"       \"Etiology and clinical manifestations of vitamin B12 and folate deficiency\"",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      The liver is able to compensate for the loss of bile salts when less than 100 cm of ileum has been resected. In such cases, however, patients may develop diarrhea due to excessive presentation of bile salts in the colon, which can stimulate a secretory diarrhea (called cholerheic enteropathy). Resection of more than 100 cm of ileum is associated with insufficient bile salt concentrations in the duodenum for optimal fat absorption, leading to fat and fat soluble vitamin malabsorption.",
"     </li>",
"     <li>",
"      Unabsorbed lipids reaching the ileum cause delay in gastric emptying, which facilitates absorption of nutrients within the small intestine [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/6/44136/abstract/9\">",
"       9",
"      </a>",
"      ]. Ileal resection may be associated with loss of this compensatory mechanism, which may contribute to the diarrhea observed in short bowel syndrome.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Presence of a colon",
"    </span>",
"    &nbsp;&mdash;&nbsp;The colon is responsible for water and electrolyte absorption. Loss of the colon in combination with extensive small bowel resection is poorly tolerated, and is likely to lead to dehydration and electrolyte depletion. Such patients usually require long-term parenteral nutrition.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Presence of an intact ileocecal valve",
"    </span>",
"    &nbsp;&mdash;&nbsp;Loss of the ileocecal valve reduces small intestinal transit time, which may impair nutrient absorption. In addition, the ileocecal valve serves as a barrier to the translocation of colonic bacteria into the terminal ileum. Small bowel bacterial overgrowth following ileocecal valve resection may be associated with malabsorption of fats, vitamin B12, and bile salts. The latter may also contribute to diarrhea. More severe complications of bacterial overgrowth including arthritis and colitis can also occur [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/6/44136/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Intestinal adaptation",
"    </span>",
"    &nbsp;&mdash;&nbsp;The clinical features of the short bowel syndrome depend upon the physiology of the remaining intestine and the process of adaptation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/6/44136/abstract/11,12\">",
"     11,12",
"    </a>",
"    ]. The process is characterized by lengthening of the intestinal villi, which is associated with an increase in their absorptive capacity, rather than upregulation of specific transporters. Small bowel dilation may further increase the overall absorptive surface area.",
"   </p>",
"   <p>",
"    Intestinal adaptation in short bowel syndrome occurs gradually. In one series, 11 of 21 surviving infants with short bowel syndrome achieved complete intestinal adaptation, but required 148 to 727 days of parenteral nutrition support [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/6/44136/abstract/13\">",
"     13",
"    </a>",
"    ]. Data in adult patients are less encouraging since fewer than 20 percent of those receiving parenteral nutrition at home achieve parenteral independence [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/6/44136/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Adaptation depends upon exposure of enterocytes to luminal nutrients, and is regulated by several enterocyte-derived mediators. An example is glucagon-like peptide 2, which, in animal models, induces marked villus hyperplasia within four days of administration [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/6/44136/abstract/15\">",
"     15",
"    </a>",
"    ]. The use of specific growth factors in animal models of short bowel syndrome and in small studies on humans is under intense study (see",
"    <a class=\"local\" href=\"#H17\">",
"     'Pharmacologic therapy'",
"    </a>",
"    below)&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/6/44136/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    At present, enteral nutrition is the cornerstone of management in patients with short bowel syndrome [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/6/44136/abstract/1,17\">",
"     1,17",
"    </a>",
"    ]. Enteral feeding stimulates a combination of functional and hormonal, biliary and pancreatic secretions, which enhance mucosal adaptation. Studies of parenterally-fed animal models of short bowel syndrome have demonstrated that adaptation requires enteral feeding, and will not occur if there is total reliance on parenteral nutrition [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/6/44136/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Intestinal rehabilitation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Intestinal rehabilitation refers to a multidisciplinary process aimed at improving intestinal function with the hope of liberating patients from parenteral nutrition. A few specialized institutions have developed comprehensive centers of expertise using nutrition, pharmacologic, and in some cases surgical approaches to achieve this objective. Many of these programs exist within centers that also perform intestinal transplantation; ideally, however, they should be functionally independent to ensure patients reach their maximal functional capacity.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     EARLY MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;During the early period after lengthy intestinal resection, the predominant goals are the administration of parenteral nutrition and prevention of fluid and electrolyte abnormalities. Most patients are kept fasting and supported with a standard parenteral nutrition solution, which can be administered at home if long-term therapy is anticipated [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/6/44136/abstract/19-21\">",
"     19-21",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Large volume gastric or proximal small bowel fluid losses are relatively common in the early phase. As a result, fluid replacement protocols with sodium,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?33/57/34711?source=see_link\">",
"     potassium chloride",
"    </a>",
"    , and magnesium are important during this phase. Stomal and fecal losses should be measured and replaced every two hours with a solution separate from the nutrition solution.",
"   </p>",
"   <p>",
"    An H2 blocker should be given intravenously to suppress gastric hypersecretion, which may improve nutrient absorption, and reduce fluid losses [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/6/44136/abstract/22,23\">",
"     22,23",
"    </a>",
"    ]. Patients with short bowel syndrome often develop gastric acid hypersecretion, which may be associated with deactivation of pancreatic enzymes, a reduction in the optimal pH needed for fat absorption, and increased intestinal fluid losses. Although not as well studied, an oral proton pump inhibitor also may be effective [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/6/44136/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The safety and efficacy of a fish oil-based intravenous lipid emulsion in the treatment of parenteral nutrition-associated liver disease has been shown to reduce mortality and need for liver transplantation in children with short bowel syndrome [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/6/44136/abstract/25\">",
"     25",
"    </a>",
"    ]. Studies in adults are ongoing but it has been suggested as a safe option for preventive therapy against liver disease associated with long-term parenteral nutrition.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     ENTERAL FEEDING",
"    </span>",
"    &nbsp;&mdash;&nbsp;Slow introduction of enteral feeding is indicated once the patient stabilizes. Complex diets are known to enhance greater adaptation than elemental diets; however, elemental diets have a role when intestinal inflammation is present. Continuous tube feeding (exclusively or in conjunction with oral feeding) in the postoperative period has been shown to significantly increase net absorption of lipids, proteins, and energy compared with oral feeding [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/6/44136/abstract/26\">",
"     26",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Composition",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many enteral feeding formulations, especially amino acid solutions, are high in carbohydrate content. This is often a disadvantage in short bowel syndrome because carbohydrates create a much higher osmotic load in the small intestine than fats or proteins. Children, especially infants, are more likely to be intolerant of large concentrations of carbohydrates and do much better on a formula higher in fat content. The negative effects of dietary carbohydrates are less apparent in adults, especially those with large segments of retained colon who are more capable of fermenting malabsorbed carbohydrates to short-chain fatty acids, which can be absorbed and serve as a calorie source [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/6/44136/abstract/27\">",
"     27",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Protein hydrolysate diets often contain a higher, more physiologic percentage of fat and are frequently better tolerated (",
"    <a class=\"graphic graphic_table graphicRef56459 \" href=\"mobipreview.htm?17/17/17692\">",
"     table 1",
"    </a>",
"    ). Fiber supplementation also may be helpful by enhancing adaptation via increased short-chain fatty acid production and providing an additional calorie source in patients with a reasonable amount of colon. In addition, fiber supplementation may decrease the watery nature of the stools by adsorbing stool water. This can be helpful if frequent stooling causes perineal skin breakdown.",
"   </p>",
"   <p>",
"    Other additions to the enteral regimen are less useful. As an example, medium-chain triglycerides are frequently given because they are more water soluble than long-chain triglycerides and better absorbed in the presence of bile acid or pancreatic insufficiency. However, they have a slightly lower caloric density, exert a greater osmotic load in the small intestine, and, since patients with short bowel syndrome typically have normal pancreatic and biliary function, are of limited value.",
"   </p>",
"   <p>",
"    Lactose restriction is often not necessary in patients with short bowel syndrome. Many such patients tolerate lactose well as it is absorbed in the proximal small bowel, and dairy products are good sources of fat, calories, and calcium. Oxalate restriction is important in those with an intact colon and fat malabsorption to avoid stone formation.",
"   </p>",
"   <p>",
"    Several enteral feeding formulations are commercially available, and some are better suited for particular cases. In older children and adults, protein allergy is uncommon, and the use of an elemental or predigested formula on a routine basis is more difficult to justify, particularly since complex nutrients are required for stimulating intestinal adaptation. Enteral formulations that contain a relatively high fat content or added fiber are generally better tolerated. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/52/34631?source=see_link\">",
"     \"Food protein-induced proctitis/colitis and enteropathy of infancy\"",
"    </a>",
"    .) Oral electrolyte solutions may be useful adjuncts especially in those with feeding tube and high output fluid losses.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Frequency of feeding",
"    </span>",
"    &nbsp;&mdash;&nbsp;Continuous enteral feeding via a nasogastric or gastrostomy feeding tube is initially advantageous. Continuous feeding permits constant saturation of carrier transport proteins, taking full advantage of the absorptive surface area available. For the same reason, small frequent feedings are preferable to infrequent large feedings.",
"   </p>",
"   <p>",
"    The primary benefit of continuous enteral feeding is that it facilitates intestinal adaptation, thereby accelerating the progression to oral feeding in patients in whom a transition to oral feeding is expected. This was illustrated in a randomized crossover study that compared three-day net absorption following isocaloric tube feeding with oral feeding in 15 patients with short bowel syndrome three months after surgery [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/6/44136/abstract/26\">",
"     26",
"    </a>",
"    ]. Continuous tube feeding significantly increased net absorption of lipids, proteins, and energy, as compared with oral feeding. In the immediate post-resection period, transition to bolus or oral feedings should be slow and stepwise and may extend over a period of weeks to months. Even patients in whom there is little potential for ultimate transition to total enteral feeding may be able to achieve some pleasurable enteral tolerance if continuous enteral feeding is used to maximize adaptation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Tapering of parenteral nutrition",
"    </span>",
"    &nbsp;&mdash;&nbsp;Enteral feedings should be advanced slowly, and parenteral calories concomitantly and isocalorically decreased to maintain nutritional status, control fluid losses, and ensure gut adaptation. It is important not to be overly aggressive, and to make small frequent increases in enteric feeding as the small intestine adapts to increased nutrient administration.",
"   </p>",
"   <p>",
"    One approach is to initiate enteral feedings by providing approximately 5 percent of the patient's total daily caloric intake, and making slow incremental advances every three to seven days as tolerated beyond this point. The rate of advancement depends heavily upon the amount of remaining intestine, the patient's size and age, and the patient's total absorptive capacity.",
"   </p>",
"   <p>",
"    The success of enteral feeding can be assessed by measurement of enteral fluid loss, which reflects the degree of carbohydrate malabsorption. Carbohydrate malabsorption can be estimated directly by testing the stool or ostomy fluid for glucose (eg, with a Clinitest tablet).",
"   </p>",
"   <p>",
"    However, direct measurement of stool carbohydrate is usually unnecessary, since marked increases in fluid losses almost always indicate significant carbohydrate malabsorption. Fat malabsorption does not result in osmotic diarrhea, and the protein content in enteral feeding formulas is usually insufficient to produce a significant osmotic load. Thus, if enteral losses suddenly increase during advancement of enteral feedings, intestinal absorption has probably reached its maximum. Enteral feedings should not be increased until further adaptation occurs.",
"   </p>",
"   <p>",
"    As enteral nutrition is gradually increased, the duration of infusion of parenteral nutrition can be reduced, giving patients greater freedom. Gradual weaning to oral feedings and a regular diet can also be performed at this time. Patients tend to tolerate complex carbohydrates much better than simple ones; fatty foods are usually not a problem. The important elements of chronic enteral nutrition are:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Small frequent feedings (every two to three hours in adults).",
"     </li>",
"     <li>",
"      A reasonable mixture of protein, carbohydrates and fats; ideally, 40 percent of the patient's caloric intake should be provided in the form of fat.",
"     </li>",
"     <li>",
"      Avoidance of hypertonic beverages (eg, sodas and fruit juices).",
"     </li>",
"     <li>",
"      Avoidance of high carbohydrate feedings; those with simple carbohydrates often result in sudden osmotic fluid losses and dehydration and all forms of carbohydrate increase bacterial proliferation.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Limited ileal resection",
"    </span>",
"    &nbsp;&mdash;&nbsp;The response to enteral feedings is in large part a function of the amount of functioning bowel. Patients with limited ileal resection (&lt;100 cm) can resume intake of solid food in the late postoperative phase. Specific issues to be addressed include secretory diarrhea due to bile salt malabsorption, and fat and vitamin B12 malabsorption. Each of these problems requires specific therapy.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?35/33/36374?source=see_link\">",
"       Cholestyramine",
"      </a>",
"      will often improve diarrhea associated with bile salt malabsorption. Lack of improvement suggests that bile salt malabsorption is probably not the principal cause of diarrhea.",
"     </li>",
"     <li>",
"      Documented vitamin B12 malabsorption with low serum cobalamin concentrations requires life-long vitamin B12 supplementation. This is usually accomplished with monthly intramuscular injections; however, experience with a nasal preparation of vitamin B12 looks encouraging [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/6/44136/abstract/28\">",
"       28",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?5/0/5130?source=see_link\">",
"       \"Diagnosis and treatment of vitamin B12 and folate deficiency\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Extensive small bowel resection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with extensive small bowel resection are at risk for nutrient, mineral, and vitamin deficiencies because of the loss of absorptive surface. The risk of nutrient deficiency is greatest during and after the transition to enteral feeding, since the degree of intestinal adaptation and the absorption of nutrients are unpredictable. Serum levels of calcium, magnesium, zinc,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?13/37/13907?source=see_link\">",
"     selenium",
"    </a>",
"    , and the fat soluble vitamins (A, D, E, and K) should be monitored every three months. In addition, patients who have had more than 60 cm of ileum resected may become deficient in vitamin B12 despite adequate calorie and protein absorption, and supplementation may be required.",
"   </p>",
"   <p>",
"    Once on an oral diet, patients may have fat malabsorption, which can usually be controlled with dietary modifications [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/6/44136/abstract/29\">",
"     29",
"    </a>",
"    ]. Some patients (such as adults who have undergone colectomy and small children) should not be transitioned to high carbohydrate diet, since it may induce osmotic diarrhea. If significant, fat malabsorption may result in increased oxalate absorption with potential stone formation. Treatment of fat malabsorption rarely benefits from pancreatic enzymes but may improve on a low fat diet if it can be tolerated without excessive fluid losses.",
"   </p>",
"   <p>",
"    Patients with less than 100 cm of remaining jejunum, especially those who have also had a colectomy, are unlikely to be successfully transitioned to oral feeding alone. Indications for continued parenteral nutrition include rapid weight loss and extensive stomal fluid and electrolyte losses which cannot be replaced orally. However, in some patients, progressive intestinal adaptation may allow conversion to enteral intake, although it may require as long as two years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/6/44136/abstract/30\">",
"     30",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Pharmacologic therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of pharmacologic agents have been used to reduce secretory losses in patients whose intake is exceeded by output.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      H2 blockers, proton pump inhibitors, and",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?42/7/43128?source=see_link\">",
"       octreotide",
"      </a>",
"      inhibit excessive gastric or pancreatic secretion with varying success. Octreotide reduces fluid losses but also diminishes splanchnic protein synthesis, which can interfere with the process of adaptation [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/6/44136/abstract/31\">",
"       31",
"      </a>",
"      ]. Octreotide increases small bowel transit time but tachyphylaxis often develops. In addition, octreotide predisposes patients to the development of gallstones for which they are already at high risk.",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?15/53/16214?source=see_link\">",
"       Loperamide",
"      </a>",
"      often results in a decrease in stool output and may be useful in patients without small bowel bacterial overgrowth.",
"     </li>",
"     <li>",
"      Thickening agents are sometimes used but they are primarily carbohydrates, which can act as a prebiotic for intestinal bacteria and thereby exacerbate bacterial overgrowth. As a result, they should be used judiciously.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Growth factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Growth factors have been tried to hasten adaptation and to enhance mucosal growth beyond the normal limits of adaptation.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Glutamine and growth hormone &ndash; Reports have suggested that the combination of glutamine, growth hormone, and a diet high in complex carbohydrates and fiber enhanced the adaptation process and allowed enteral nutrition in patients who had been dependent upon parenteral nutrition [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/6/44136/abstract/32-36\">",
"       32-36",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      The beneficial effect of this regimen is controversial and has not been consistently supported by controlled studies in experimental animals or humans [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/6/44136/abstract/37-42\">",
"       37-42",
"      </a>",
"      ]. In randomized, controlled crossover trials in adults given glutamine and growth hormone with various dietary maneuvers, there was modest improvement in electrolyte absorption but no effect on small bowel morphology, stool losses, or macronutrient absorption occurred [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/6/44136/abstract/38,39\">",
"       38,39",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      Another controlled trial in adults found that treatment with growth hormone and glutamine was more effective than glutamine alone or placebo in weaning patients from parenteral nutrition and that the benefit was maintained (relative to placebo) at three months [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/6/44136/abstract/43\">",
"       43",
"      </a>",
"      ]. In contrast, a double blind, crossover study of oral glutamine administration alone to eight patients with short bowel syndrome demonstrated no benefit [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/6/44136/abstract/40\">",
"       40",
"      </a>",
"      ]. However, the duration of treatment evaluated was short and these regimens remain under investigation.",
"     </li>",
"     <li>",
"      Glucagon-like peptide-2 &ndash; Glucagon-like peptide-2 (GLP-2) an enteroendocrine peptide released in response of luminal nutrients, initiates and maintains small bowel adaptive responses to resection and improves nutrient absorption [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/6/44136/abstract/44-46\">",
"       44-46",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?29/56/30601?source=see_link&amp;anchor=H8#H8\">",
"       \"Pathophysiology of the short bowel syndrome\", section on 'Gut hormones'",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?10/33/10772?source=see_link\">",
"       Teduglutide",
"      </a>",
"      is a safe and well tolerated GLP-2 analogue that has been demonstrated to modestly reduce the volume and number of days of parenteral support required by patients with short bowel syndrome with intestinal failure [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/6/44136/abstract/47,48\">",
"       47,48",
"      </a>",
"      ]. In a phase III randomized controlled trial, 86 patients with short bowel syndrome with intestinal failure were randomized to teduglutide (0.05",
"      <span class=\"nowrap\">",
"       mg/kg/day)",
"      </span>",
"      or placebo for 24 weeks. A significantly higher proportion of patients treated with teduglutide had a 20 percent reduction in the volume of parenteral support as compared with placebo (63 versus 30 percent) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/6/44136/abstract/48\">",
"       48",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      Additional studies are needed to determine whether the intestinal adaptation due to teduglutide is sustained after discontinuation of therapy and if long-term use is associated with an increased risk of colorectal adenomas as seen in animal models [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/6/44136/abstract/49,50\">",
"       49,50",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Other &ndash; Other growth factors have been evaluated in experimental models of massive small bowel resection. In animal studies, hepatocyte growth factor significantly enhances intestinal epithelial cell function and mucosal mass beyond the normal adaptive response [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/6/44136/abstract/51\">",
"       51",
"      </a>",
"      ], and interleukin-11, keratinocyte and epidermal growth factors also have trophic effects [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/6/44136/abstract/52-54\">",
"       52-54",
"      </a>",
"      ]. Microarray technology has identified novel genes involved in the various aspects of the intestinal adaptive process and may provide an additional tool in the evaluation of factors that enhance enteroplasticity [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/6/44136/abstract/55\">",
"       55",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h1\">",
"     DRUG ABSORPTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with short bowel syndrome may be at risk for impaired absorption of oral pharmaceuticals. Most drugs are absorbed in the stomach and proximal intestines, and thus their effect is preserved. Enteric coated drugs, on the other hand, may not be absorbed properly and thus non-enteric coated versions are preferred.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     SMALL BOWEL TRANSPLANTATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Small bowel transplantation has been advocated for certain patients with short bowel syndrome who are not candidates or have developed complications from long-term parenteral nutrition and in whom adequate adaptation cannot occur. Improvements in survival rates after intestinal transplantation have made this alternative a viable option for those with significant complications from parenteral nutrition [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/6/44136/abstract/56\">",
"     56",
"    </a>",
"    ]. However, the use of intestinal transplantation in patients who are otherwise stable on parenteral nutrition or who are capable of ultimately adapting and being weaned from parenteral nutrition should not be referred for transplantation. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?1/29/1497?source=see_link\">",
"     \"Overview of intestinal and multivisceral transplantation\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h1\">",
"     NONTRANSPLANTATION PROCEDURES",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of nontransplant surgical procedures have been described to improve intestinal function in patients with short bowel syndrome (such as improving the surface area or slowing transit). Procedures designed to slow small intestinal transit include reversed segments of bowel or colon interpositioned to slow the delivery of nutrients through the small intestine, and creation of valves that produce a partial obstruction to disrupt the normal flow of contents. Success has been reported in some adult patients, but procedures to slow transit are contraindicated in small children and patients with small bowel bacterial overgrowth [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/6/44136/abstract/57,58\">",
"     57,58",
"    </a>",
"    ]. This type of surgery should only be performed by highly experienced surgeons.",
"   </p>",
"   <p>",
"    Patients with short bowel syndrome, especially those with bacterial overgrowth, commonly have anastomotic strictures. Further resection of already shortened small intestine may be avoided by using tapering enteroplasty, strictureplasty, and even serosal patching [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/6/44136/abstract/58,59\">",
"     58,59",
"    </a>",
"    ]. Relieving a tight anastomosis or stricture often improves flow of luminal contents through the small intestine and reduces bacterial overgrowth. This may occasionally produce dramatic clinical improvement in patients with bacterial overgrowth provided that the patient has normal small bowel motility.",
"   </p>",
"   <p>",
"    Increasing the length of bowel through using serial transverse enteroplasty involves transecting the bowel longitudinally, preserving the blood supply to both sides of the small intestine, thereby creating a segment of bowel twice the length and half the diameter of the original segment [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/6/44136/abstract/60\">",
"     60",
"    </a>",
"    ]. This procedure should be performed only when the small intestine is dilated because it allows reduction of the diameter of the dilated bowel without the loss of surface area. It is primarily a means of reducing bacterial overgrowth, although progressive intestinal dilatation often recurs. A small series demonstrated that repeat intestinal lengthening procedures in adults after previous Bianchi and STEP procedures may provide an opportunity to wean from parenteral nutrition and should be considered in the stable patient [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/6/44136/abstract/61\">",
"     61",
"    </a>",
"    ]. Patients with advanced liver disease are poor candidates for this procedure and should be referred for transplantation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/6/44136/abstract/62\">",
"     62",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Animal studies in tissue engineered small intestine appear promising [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/6/44136/abstract/63-65\">",
"     63-65",
"    </a>",
"    ] but human studies are lacking.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The following summarizes the approach described above (",
"    <a class=\"graphic graphic_table graphicRef78273 \" href=\"mobipreview.htm?34/11/35004\">",
"     table 2",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients with short bowel syndrome should be assessed for the likelihood of resuming an oral diet. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Likelihood of resuming an oral diet'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Complications should be anticipated and addressed based upon the remaining intestinal segments. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?17/37/18007?source=see_link\">",
"       \"Chronic complications of the short bowel syndrome in adults\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Early management mostly involves replacement of fluid and electrolytes. Enteral feeding should begin once the patient stabilizes. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Early management'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Slow introduction of enteral feeding is indicated once the patient stabilizes. We suggest continuous enteral feeding or small frequent feedings (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). Complex, balanced diets with frequent feedings are known to enhance greater adaptation than elemental diets. However, elemental diets have a role when intestinal inflammation is present. Fine-tuning enteral nutrition requires constant reassessment of absorptive state which changes as adaptation continues. &nbsp;(See",
"      <a class=\"local\" href=\"#H11\">",
"       'Enteral feeding'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Small bowel transplantation may be an option in selected patients who are not candidates for or have developed complications from long-term parenteral nutrition. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?1/29/1497?source=see_link\">",
"       \"Overview of intestinal and multivisceral transplantation\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Several nontransplant procedures have been described to improve intestinal function. This type of surgery should only be performed by highly experienced surgeons. (See",
"      <a class=\"local\" href=\"#H21\">",
"       'Nontransplantation procedures'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/6/44136/abstract/1\">",
"      DiBaise JK, Young RJ, Vanderhoof JA. Intestinal rehabilitation and the short bowel syndrome: part 1. Am J Gastroenterol 2004; 99:1386.",
"     </a>",
"    </li>",
"    <li>",
"     Jeejeebhoy K. The Etiology and Mechanism of Intestinal Failure. In: Intestinal Failure and Rehabilitation, Matarese LE, Steiger E, Seidner DL (Eds), CRC Press, New York 2004. p.25.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/6/44136/abstract/3\">",
"      Kalaitzakis E, Carlsson E, Josefsson A, Bosaeus I. Quality of life in short-bowel syndrome: impact of fatigue and gastrointestinal symptoms. Scand J Gastroenterol 2008; 43:1057.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/6/44136/abstract/4\">",
"      American Gastroenterological Association. American Gastroenterological Association medical position statement: short bowel syndrome and intestinal transplantation. Gastroenterology 2003; 124:1105.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/6/44136/abstract/5\">",
"      Crenn P, Coudray-Lucas C, Thuillier F, et al. Postabsorptive plasma citrulline concentration is a marker of absorptive enterocyte mass and intestinal failure in humans. Gastroenterology 2000; 119:1496.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/6/44136/abstract/6\">",
"      Santarpia L, Catanzano F, Ruoppolo M, et al. Citrulline blood levels as indicators of residual intestinal absorption in patients with short bowel syndrome. Ann Nutr Metab 2008; 53:137.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/6/44136/abstract/7\">",
"      Fitzgibbons S, Ching YA, Valim C, et al. Relationship between serum citrulline levels and progression to parenteral nutrition independence in children with short bowel syndrome. J Pediatr Surg 2009; 44:928.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/6/44136/abstract/8\">",
"      Thompson WG, Wrathell E. The relation between ileal resection and vitamin B12 absorption. Can J Surg 1977; 20:461.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/6/44136/abstract/9\">",
"      Welch IM, Cunningham KM, Read NW. Regulation of gastric emptying by ileal nutrients in humans. Gastroenterology 1988; 94:401.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/6/44136/abstract/10\">",
"      Vanderhoof JA, Young RJ, Murray N, Kaufman SS. Treatment strategies for small bowel bacterial overgrowth in short bowel syndrome. J Pediatr Gastroenterol Nutr 1998; 27:155.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/6/44136/abstract/11\">",
"      Dowling RH, Booth CC. Functional compensation after small-bowel resection in man. Demonstration by direct measurement. Lancet 1966; 2:146.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/6/44136/abstract/12\">",
"      Dowling RH, Booth CC. Structural and functional changes following small intestinal resection in the rat. Clin Sci 1967; 32:139.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/6/44136/abstract/13\">",
"      Kurkchubasche AG, Rowe MI, Smith SD. Adaptation in short-bowel syndrome: reassessing old limits. J Pediatr Surg 1993; 28:1069.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/6/44136/abstract/14\">",
"      Vantini I, Benini L, Bonfante F, et al. Survival rate and prognostic factors in patients with intestinal failure. Dig Liver Dis 2004; 36:46.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/6/44136/abstract/15\">",
"      Drucker DJ, Erlich P, Asa SL, Brubaker PL. Induction of intestinal epithelial proliferation by glucagon-like peptide 2. Proc Natl Acad Sci U S A 1996; 93:7911.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/6/44136/abstract/16\">",
"      Weale AR, Edwards AG, Bailey M, Lear PA. Intestinal adaptation after massive intestinal resection. Postgrad Med J 2005; 81:178.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/6/44136/abstract/17\">",
"      Puder M, Valim C, Meisel JA, et al. Parenteral fish oil improves outcomes in patients with parenteral nutrition-associated liver injury. Ann Surg 2009; 250:395.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/6/44136/abstract/18\">",
"      Feldman EJ, Dowling RH, McNaughton J, Peters TJ. Effects of oral versus intravenous nutrition on intestinal adaptation after small bowel resection in the dog. Gastroenterology 1976; 70:712.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/6/44136/abstract/19\">",
"      Moukarzel AA, Haddad I, Ament ME, et al. 230 patient years of experience with home long-term parenteral nutrition in childhood: natural history and life of central venous catheters. J Pediatr Surg 1994; 29:1323.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/6/44136/abstract/20\">",
"      Brown CR, DiBaise JK. Intestinal rehabilitation: a management program for short-bowel syndrome. Prog Transplant 2004; 14:290.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/6/44136/abstract/21\">",
"      O'Keefe SJ, Burnes JU, Thompson RL. Recurrent sepsis in home parenteral nutrition patients: an analysis of risk factors. JPEN J Parenter Enteral Nutr 1994; 18:256.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/6/44136/abstract/22\">",
"      Kato J, Sakamoto J, Teramukai S, et al. A prospective within-patient comparison clinical trial on the effect of parenteral cimetidine for improvement of fluid secretion and electrolyte balance in patients with short bowel syndrome. Hepatogastroenterology 2004; 51:1742.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/6/44136/abstract/23\">",
"      Murphy JP Jr, King DR, Dubois A. Treatment of gastric hypersecretion with cimetidine in the short-bowel syndrome. N Engl J Med 1979; 300:80.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/6/44136/abstract/24\">",
"      Nightingale JM, Walker ER, Farthing MJ, Lennard-Jones JE. Effect of omeprazole on intestinal output in the short bowel syndrome. Aliment Pharmacol Ther 1991; 5:405.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/6/44136/abstract/25\">",
"      Gong JF, Zhu WM, Yu WK, et al. Role of enteral nutrition in adult short bowel syndrome undergoing intestinal rehabilitation: the long-term outcome. Asia Pac J Clin Nutr 2009; 18:155.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/6/44136/abstract/26\">",
"      Joly F, Dray X, Corcos O, et al. Tube feeding improves intestinal absorption in short bowel syndrome patients. Gastroenterology 2009; 136:824.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/6/44136/abstract/27\">",
"      DiBaise JK, Young RJ, Vanderhoof JA. Intestinal rehabilitation and the short bowel syndrome: part 2. Am J Gastroenterol 2004; 99:1823.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/6/44136/abstract/28\">",
"      Slot WB, Merkus FW, Van Deventer SJ, Tytgat GN. Normalization of plasma vitamin B12 concentration by intranasal hydroxocobalamin in vitamin B12-deficient patients. Gastroenterology 1997; 113:430.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/6/44136/abstract/29\">",
"      Byrne TA, Veglia L, Camelio M, et al. Beyond the prescription: Optimizing the diet of patients with short bowel syndrome. Nutr Clin Pract 2000; 15:306.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/6/44136/abstract/30\">",
"      Lennard-Jones JE. Indications and need for long-term parenteral nutrition: implications for intestinal transplantation. Transplant Proc 1990; 22:2427.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/6/44136/abstract/31\">",
"      O'Keefe SJ, Haymond MW, Bennet WM, et al. Long-acting somatostatin analogue therapy and protein metabolism in patients with jejunostomies. Gastroenterology 1994; 107:379.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/6/44136/abstract/32\">",
"      Byrne TA, Morrissey TB, Nattakom TV, et al. Growth hormone, glutamine, and a modified diet enhance nutrient absorption in patients with severe short bowel syndrome. JPEN J Parenter Enteral Nutr 1995; 19:296.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/6/44136/abstract/33\">",
"      Byrne TA, Persinger RL, Young LS, et al. A new treatment for patients with short-bowel syndrome. Growth hormone, glutamine, and a modified diet. Ann Surg 1995; 222:243.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/6/44136/abstract/34\">",
"      Wilmore DW, Lacey JM, Soultanakis RP, et al. Factors predicting a successful outcome after pharmacologic bowel compensation. Ann Surg 1997; 226:288.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/6/44136/abstract/35\">",
"      Seguy D, Vahedi K, Kapel N, et al. Low-dose growth hormone in adult home parenteral nutrition-dependent short bowel syndrome patients: a positive study. Gastroenterology 2003; 124:293.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/6/44136/abstract/36\">",
"      Weiming Z, Ning L, Jieshou L. Effect of recombinant human growth hormone and enteral nutrition on short bowel syndrome. JPEN J Parenter Enteral Nutr 2004; 28:377.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/6/44136/abstract/37\">",
"      Vanderhoof JA, Kollman KA, Griffin S, Adrian TE. Growth hormone and glutamine do not stimulate intestinal adaptation following massive small bowel resection in the rat. J Pediatr Gastroenterol Nutr 1997; 25:327.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/6/44136/abstract/38\">",
"      Scolapio JS, Camilleri M, Fleming CR, et al. Effect of growth hormone, glutamine, and diet on adaptation in short-bowel syndrome: a randomized, controlled study. Gastroenterology 1997; 113:1074.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/6/44136/abstract/39\">",
"      Szkudlarek J, Jeppesen PB, Mortensen PB. Effect of high dose growth hormone with glutamine and no change in diet on intestinal absorption in short bowel patients: a randomised, double blind, crossover, placebo controlled study. Gut 2000; 47:199.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/6/44136/abstract/40\">",
"      Scolapio JS, McGreevy K, Tennyson GS, Burnett OL. Effect of glutamine in short-bowel syndrome. Clin Nutr 2001; 20:319.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/6/44136/abstract/41\">",
"      Glutamine alone or combined with short-chain fatty acids fails to enhance gut adaptation after massive enterectomy in rats. Available from URL: file://www.scielo.br/acb. Acta Cir Bras 2006; 21(Suppl 4):2.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/6/44136/abstract/42\">",
"      Tian J, Hao L, Chandra P, et al. Dietary glutamine and oral antibiotics each improve indexes of gut barrier function in rat short bowel syndrome. Am J Physiol Gastrointest Liver Physiol 2009; 296:G348.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/6/44136/abstract/43\">",
"      Byrne TA, Wilmore DW, Iyer K, et al. Growth hormone, glutamine, and an optimal diet reduces parenteral nutrition in patients with short bowel syndrome: a prospective, randomized, placebo-controlled, double-blind clinical trial. Ann Surg 2005; 242:655.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/6/44136/abstract/44\">",
"      Sigalet DL, Bawazir O, Martin GR, et al. Glucagon-like peptide-2 induces a specific pattern of adaptation in remnant jejunum. Dig Dis Sci 2006; 51:1557.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/6/44136/abstract/45\">",
"      Jeppesen PB, Hartmann B, Thulesen J, et al. Glucagon-like peptide 2 improves nutrient absorption and nutritional status in short-bowel patients with no colon. Gastroenterology 2001; 120:806.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/6/44136/abstract/46\">",
"      Jeppesen PB, Lund P, Gottschalck IB, et al. Short bowel patients treated for two years with glucagon-like Peptide 2: effects on intestinal morphology and absorption, renal function, bone and body composition, and muscle function. Gastroenterol Res Pract 2009; 2009:616054.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/6/44136/abstract/47\">",
"      Jeppesen PB, Gilroy R, Pertkiewicz M, et al. Randomised placebo-controlled trial of teduglutide in reducing parenteral nutrition and/or intravenous fluid requirements in patients with short bowel syndrome. Gut 2011; 60:902.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/6/44136/abstract/48\">",
"      Jeppesen PB, Pertkiewicz M, Messing B, et al. Teduglutide reduces need for parenteral support among patients with short bowel syndrome with intestinal failure. Gastroenterology 2012; 143:1473.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/6/44136/abstract/49\">",
"      Thulesen J, Hartmann B, Hare KJ, et al. Glucagon-like peptide 2 (GLP-2) accelerates the growth of colonic neoplasms in mice. Gut 2004; 53:1145.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/6/44136/abstract/50\">",
"      Compher C, Gilroy R, Pertkiewicz M, et al. Maintenance of parenteral nutrition volume reduction, without weight loss, after stopping teduglutide in a subset of patients with short bowel syndrome. JPEN J Parenter Enteral Nutr 2011; 35:603.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/6/44136/abstract/51\">",
"      Kato Y, Yu D, Schwartz MZ. Enhancement of intestinal adaptation by hepatocyte growth factor. J Pediatr Surg 1998; 33:235.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/6/44136/abstract/52\">",
"      Martin CA, Bernabe KQ, Taylor JA, et al. Resection-induced intestinal adaptation and the role of enteric smooth muscle. J Pediatr Surg 2008; 43:1011.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/6/44136/abstract/53\">",
"      Yang H, Wildhaber BE, Teitelbaum DH. 2003 Harry M. Vars Research Award. Keratinocyte growth factor improves epithelial function after massive small bowel resection. JPEN J Parenter Enteral Nutr 2003; 27:198.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/6/44136/abstract/54\">",
"      Alavi K, Prasad R, Lundgren K, Schwartz MZ. Interleukin-11 enhances small intestine absorptive function and mucosal mass after intestinal adaptation. J Pediatr Surg 2000; 35:371.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/6/44136/abstract/55\">",
"      Drozdowski LA, Clandinin MT, Thomson AB. Morphological, kinetic, membrane biochemical and genetic aspects of intestinal enteroplasticity. World J Gastroenterol 2009; 15:774.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/6/44136/abstract/56\">",
"      Vianna RM, Mangus RS. Present prospects and future perspectives of intestinal and multivisceral transplantation. Curr Opin Clin Nutr Metab Care 2009; 12:281.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/6/44136/abstract/57\">",
"      Thompson JS, Langnas AN. Surgical approaches to improving intestinal function in the short-bowel syndrome. Arch Surg 1999; 134:706.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/6/44136/abstract/58\">",
"      Sudan D. Advances in the nontransplant medical and surgical management of intestinal failure. Curr Opin Organ Transplant 2009; 14:274.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/6/44136/abstract/59\">",
"      Thompson JS, Sudan DA, Gilroy R. Predicting outcome of procedures to slow intestinal transit. Transplant Proc 2006; 38:1838.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/6/44136/abstract/60\">",
"      Sudan D, Thompson J, Botha J, et al. Comparison of intestinal lengthening procedures for patients with short bowel syndrome. Ann Surg 2007; 246:593.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/6/44136/abstract/61\">",
"      Andres AM, Thompson J, Grant W, et al. Repeat surgical bowel lengthening with the STEP procedure. Transplantation 2008; 85:1294.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/6/44136/abstract/62\">",
"      Thompson J, Sudan D. Intestinal lengthening for short bowel syndrome. Adv Surg 2008; 42:49.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/6/44136/abstract/63\">",
"      Grikscheit TC, Siddique A, Ochoa ER, et al. Tissue-engineered small intestine improves recovery after massive small bowel resection. Ann Surg 2004; 240:748.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/6/44136/abstract/64\">",
"      Pahari MP, Brown ML, Elias G, et al. Development of a bioartificial new intestinal segment using an acellular matrix scaffold. Gut 2007; 56:885.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/6/44136/abstract/65\">",
"      Day RM. Epithelial stem cells and tissue engineered intestine. Curr Stem Cell Res Ther 2006; 1:113.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 4773 Version 11.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-202.43.93.2-49404BB9CF-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f43_6_44136=[""].join("\n");
var outline_f43_6_44136=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H22\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      LIKELIHOOD OF RESUMING AN ORAL DIET",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Length of remaining small intestine",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      - Citrulline concentrations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Segment of remaining intestine",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Presence of a colon",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Presence of an intact ileocecal valve",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Intestinal adaptation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Intestinal rehabilitation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      EARLY MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      ENTERAL FEEDING",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Composition",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Frequency of feeding",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Tapering of parenteral nutrition",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Limited ileal resection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Extensive small bowel resection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Pharmacologic therapy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Growth factors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      DRUG ABSORPTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      SMALL BOWEL TRANSPLANTATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      NONTRANSPLANTATION PROCEDURES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"GAST/4773\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/4773|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?17/17/17692\" title=\"table 1\">",
"      SBS adult enteral formulas",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?34/11/35004\" title=\"table 2\">",
"      Mgmt short bowel syndrome adult",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?17/37/18007?source=related_link\">",
"      Chronic complications of the short bowel syndrome in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?5/0/5130?source=related_link\">",
"      Diagnosis and treatment of vitamin B12 and folate deficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?11/32/11786?source=related_link\">",
"      Etiology and clinical manifestations of vitamin B12 and folate deficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/52/34631?source=related_link\">",
"      Food protein-induced proctitis/colitis and enteropathy of infancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?1/29/1497?source=related_link\">",
"      Overview of intestinal and multivisceral transplantation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/56/30601?source=related_link\">",
"      Pathophysiology of the short bowel syndrome",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f43_6_44137="Combined immunodeficiency gene defects and functional categories";
var content_f43_6_44137=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ALLRG%2F77023&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ALLRG%2F77023&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 556px\">",
"   <div class=\"ttl\">",
"    Human gene defects responsible for severe T cell deficiency",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 536px; height: 758px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Genes with mutations that cause monogenic severe T-cell immunodeficiency in humans can be intrinsic to the thymic epithelium or to T cells.",
"    <br/>",
"    (A) Genetic defects that are intrinsic to thymic epithelial cells ultimately affect the antigen-presentation pathway.",
"    <br/>",
"    (B) Genetic defects that are intrinsic to T cells include those that affect T-cell receptor (TCR) signalling, cytokine signalling, somatic recombination or basic cellular processes. Other genes that are important to these pathways or processes but have not been linked to severe T-cell deficiency in humans are shown in grey.",
"    <br/>",
"    (C) The pie chart shows the proportion of defective genes that affect each of these categories.",
"    <div class=\"footnotes\">",
"     ADA: adenosine deaminase; ATM: ataxia-telangiectasia mutated; CBL: Casitas B-lineage lymphoma; CIITA: class II transactivator; DCLRE1C: DNA crosslink repair 1C; DNMT3&beta;: DNA cytosine-5 methyltransferase 3&beta;; ER: endoplasmic reticulum; FOXN1: forkhead box N1; GADS: GRB2-related adaptor protein; IL-2R&Gamma;: IL-2 receptor &Gamma;-chain; IL-7: interleukin-7; IL-7R&alpha;: IL-7 receptor &alpha;-chain; JAK: Janus kinase; LAT: linker for activation of T cells; LIG4: ligase IV; MRE11A: meiotic recombination 11 homologue A; Nibrin: Nijmegen breakage syndrome 1; NP: nucleoside phosphorylase; CRACM1: calcium release-activated calcium modulator 1; RAG: recombination-activating gene; RFX5: regulatory factor X5; RFXANK: RFX-associated ankyrin-containing protein; RFXAP: RFX-associated protein; RMRP: RNA component of mitochondrial RNA-processing endoribonuclease; SLP76: SRC-homology-2-domain-containing leukocyte protein of 76 kDa; SMARCAL1: SWI/SNF-related matrix-associated actin-dependent regulator of chromatin a-like 1; SP110: SP110 nuclear body protein; STAT5B: signal transducer and activator of transcription 5B; TAP: transporter associated with antigen processing; TAPBP: TAP-binding protein; TSAD: T-cell-specific adaptor protein; ZAP70: &zeta;-chain-associated protein kinase of 70 kDa; DNAPKcs: DNA-dependent protein kinase, catalytic subunit; MST1: mammalian sterile 20-like protein kinase 1; DOCK8: dedicator of cytokinesis 8; MAGT1: magnesium transporter protein 1; STIM1: stromal interaction molecule 1.",
"    </div>",
"    <div class=\"reference\">",
"     Adapted by permission from: Macmillan Publishers Ltd: Liston A, Enders A, Siggs OM. Unravelling the association of partial T-cell immunodeficiency and immune dysregulation. Nat Rev Immunol 2008; 8:545.",
"     <a href=\"file://www.nature.com/nri/\" target=\"_blank\">",
"      www.nature.com/nri/",
"     </a>",
"     . Copyright &copy; 2008.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f43_6_44137=[""].join("\n");
var outline_f43_6_44137=null;
var title_f43_6_44138="Contents: General drug information";
var content_f43_6_44138=[" <script type=\"text/javascript\">",
"  $$.inlineInitCustomer(",
"	false);",
"	var quirksmode = document.compatMode == \"CSS1Compat\";",
"	if (quirksmode) {",
"		$(\"html\").addClass(\"ie-standards\");",
"	}",
" </script>",
" <div id=\"message-wrap\">",
"  <div id=\"message-bg\">",
"  </div>",
"  <iframe id=\"message-bk\">",
"  </iframe>",
"  <dl id=\"message-container\">",
"   <dt id=\"message-title\">",
"   </dt>",
"   <dd id=\"message-body\">",
"   </dd>",
"   <dd id=\"message-controls\">",
"   </dd>",
"  </dl>",
" </div>",
" <div id=\"topPanel\">",
"  <div id=\"header\">",
"   <div id=\"header_container\">",
"    <h2 id=\"logo\">",
"     <a href=\"./toc\">",
"      Wolters Kluwer Health UpToDate",
"     </a>",
"    </h2>",
"    <div id=\"header_right\">",
"     <div id=\"searchpanel\">",
"      <a href=\"/login\" id=\"loginbutton\">",
"       Log in",
"      </a>",
"      <div id=\"cmsSearchBox\">",
"       <div class=\"header-search\">",
"        <form action=\"./search\" id=\"cmssearch\" method=\"get\" name=\"SearchForm\">",
"         <div class=\"header-search-left\">",
"          <input autocomplete=\"off\" class=\"searchfield\" id=\"cmsTxtBox\" name=\"search\" placeholder=\"Search UpToDate\" type=\"text\"/>",
"         </div>",
"         <div class=\"header-search-right\">",
"          <input alt=\"Search\" id=\"cmsSearchSubmit\" src=\"/sites/all/themes/uptodate/images/search_button.png\" type=\"image\"/>",
"         </div>",
"         <div class=\"clear\">",
"         </div>",
"        </form>",
"       </div>",
"      </div>",
"      <div id=\"cms_lang_dropdown\">",
"       <form accept-charset=\"UTF-8\" action=\"/\" id=\"lang-dropdown-form\" method=\"post\">",
"        <div class=\"form-item form-type-select form-item-lang-dropdown-select\">",
"         <select class=\"lang-dropdown-select-element form-select\" id=\"edit-lang-dropdown-select\" name=\"lang_dropdown_select\" style=\"width:100px\">",
"          <option selected=\"selected\" value=\"en\">",
"           English",
"          </option>",
"          <option value=\"ja\">",
"           ",
"          </option>",
"         </select>",
"        </div>",
"        <input name=\"lang_dropdown_type\" type=\"hidden\" value=\"language\">",
"         <input name=\"en\" type=\"hidden\" value=\"/\">",
"          <input name=\"ja\" type=\"hidden\" value=\"/ja\">",
"           <noscript>",
"            <div>",
"             <input class=\"form-submit\" id=\"edit-submit\" name=\"op\" type=\"submit\" value=\"Go\"/>",
"            </div>",
"           </noscript>",
"           <input name=\"form_build_id\" type=\"hidden\" value=\"form-on4lUWpxHun_wp6revUkjCG6rK2IBuCGME9Cw0HXeok\">",
"            <input name=\"form_id\" type=\"hidden\" value=\"lang_dropdown_form\">",
"            </input>",
"           </input>",
"          </input>",
"         </input>",
"        </input>",
"       </form>",
"      </div>",
"      <div class=\"clear\">",
"      </div>",
"     </div>",
"     <ul id=\"utility\">",
"      <li class=\"first\">",
"       <a href=\"/home/about-us\">",
"        About Us",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/news-events\">",
"        News &amp; Events",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/contact-us\">",
"        Contact Us",
"       </a>",
"      </li>",
"      <li class=\"last\">",
"       <a href=\"/help\">",
"        Help",
"       </a>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"nav\">",
"    <ul>",
"     <li id=\"productTab\">",
"      <a href=\"/home/product\">",
"       Product",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"editoralTab\">",
"      <a href=\"/home/editorial\">",
"       Editorial",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"whyUptodateTab\">",
"      <a href=\"/home/why-uptodate\">",
"       Why UpToDate",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"supscriptionOptionsTab\">",
"      <a href=\"/home/subscription-options\">",
"       Subscription Options",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"/store\">",
"       Subscribe",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"wkhcsTab\">",
"      <a href=\"/home/wolters-kluwer-health-clinical-solutions\">",
"       Wolters Kluwer Health Clinical Solutions",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"    </ul>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"greyBar\">",
"    <div id=\"greyBarTitle\">",
"     <span class=\"emphasis\">",
"      <a href=\"mobipreview.htm?3/3/3134\">",
"       Contents",
"      </a>",
"     </span>",
"     <img src=\"./../images/space_arrows.myextg\">",
"      <a href=\"mobipreview.htm?32/20/33101\">",
"       Drug Information",
"      </a>",
"      <img src=\"./../images/space_arrows.myextg\">",
"       General drug information",
"      </img>",
"     </img>",
"    </div>",
"    <div id=\"greyBarButtons\">",
"     <div id=\"printGB\">",
"      <a class=\"icontxt\" href=\"?view=print\">",
"       <img align=\"middle\" alt=\"Print this page\" border=\"0\" height=\"20\" src=\"./../images/icn_print.myextg\" width=\"24\"/>",
"      </a>",
"      <a class=\"icontxt\" href=\"?view=print\" title=\"Print this page\">",
"       Print",
"      </a>",
"     </div>",
"    </div>",
"   </div>",
"   <!-- menuMessage.jsp -->",
"   <!-- /menuMessage.jsp -->",
"  </div>",
"  <!-- header -->",
" </div>",
" <!-- topPanel -->",
" <div id=\"leftPanel\">",
"  <ul>",
"   <li>",
"    <a href=\"mobipreview.htm?3/45/3806\">",
"     Specialties",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?18/22/18798\">",
"     Patient Information",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?3/13/3294\">",
"     What's New",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?0/37/606\">",
"     Calculators",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?0/40/654\">",
"     Authors and Editors",
"    </a>",
"   </li>",
"  </ul>",
" </div>",
" <!-- leftPanel -->",
" <div id=\"rightPanel\">",
"  <noscript>",
"   <div id=\"javascriptDisabled\">",
"    It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"   </div>",
"  </noscript>",
"  <div id=\"printHeader\">",
"   <div id=\"printHeaderLogo\">",
"    <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"    </img>",
"   </div>",
"   <div id=\"printHeaderText\">",
"    Official reprint from UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"    <a href=\"file://www.uptodate.com\">",
"     www.uptodate.com",
"    </a>",
"    <br>",
"     &copy;2013 UpToDate",
"     <sup>",
"      &reg;",
"     </sup>",
"    </br>",
"   </div>",
"   <div id=\"printHeaderLinks\">",
"    <a href=\"#\" id=\"printHeaderPrint\" rel=\"\" title=\"Click here to print\">",
"     Print",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"     Back",
"    </a>",
"   </div>",
"  </div>",
"  <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" id=\"tocTable\" width=\"100%\">",
"   <trs>",
"    <tds>",
"     <h1>",
"      Contents:",
"			General drug information",
"     </h1>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds valign=\"top\">",
"     <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\">",
"      <trs>",
"       <tds>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/4/3141\">",
"           Abacavir and lamivudine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/42/10918\">",
"           Abacavir, lamivudine, and zidovudine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/63/31734\">",
"           Abacavir: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/14/18662\">",
"           Abatacept: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/15/6392\">",
"           Abciximab: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?43/29/44503\">",
"           Abiraterone: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/16/12549\">",
"           AbobotulinumtoxinA (botulinum toxin type A, Dysport): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/62/40929\">",
"           Absorbable collagen (dental): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/4/18499\">",
"           Absorbable gelatin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/22/1381\">",
"           Acamprosate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?43/10/44197\">",
"           Acarbose: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/11/37047\">",
"           Acebutolol: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/63/11256\">",
"           Acenocoumarol: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/27/15802\">",
"           Acetaminophen (paracetamol): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/5/10328\">",
"           Acetaminophen and codeine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/16/33030\">",
"           Acetaminophen and diphenhydramine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/3/7220\">",
"           Acetaminophen and pamabrom: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/20/43332\">",
"           Acetaminophen and phenylephrine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/57/38806\">",
"           Acetaminophen and phenyltoloxamine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/54/16229\">",
"           Acetaminophen and pseudoephedrine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/26/23975\">",
"           Acetaminophen and tramadol: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/1/30743\">",
"           Acetaminophen, aspirin, and caffeine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/45/5847\">",
"           Acetaminophen, caffeine, and dihydrocodeine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/45/21204\">",
"           Acetaminophen, chlorpheniramine, phenylephrine, and phenyltoloxamine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/48/17157\">",
"           Acetaminophen, chlorpheniramine, phenylephrine, and phenyltoloxamine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/8/42118\">",
"           Acetaminophen, codeine, and doxylamine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/27/35254\">",
"           Acetaminophen, dextromethorphan, and doxylamine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/5/4182\">",
"           Acetaminophen, dextromethorphan, and phenylephrine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/37/40534\">",
"           Acetaminophen, diphenhydramine, and phenylephrine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/32/23045\">",
"           Acetaminophen, isometheptene, and dichloralphenazone: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/39/5752\">",
"           Acetazolamide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/25/34194\">",
"           Acetic acid, propylene glycol diacetate, and hydrocortisone: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/36/19011\">",
"           Acetic acid: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/39/42610\">",
"           Acetic acid: Pediatric drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/25/27027\">",
"           Acetohydroxamic acid: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/35/6707\">",
"           Acetylcholine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/1/20504\">",
"           Acetylcysteine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/1/39958\">",
"           Acitretin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/28/13764\">",
"           Aclidinium: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/30/23013\">",
"           Aclidinium: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/59/31669\">",
"           Acrivastine and pseudoephedrine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/52/39750\">",
"           Activated charcoal: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/61/37844\">",
"           Activated prothrombin complex concentrates (factor VIII inhibitor bypassing activity): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/40/37512\">",
"           Acyclovir (systemic): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/27/1460\">",
"           Acyclovir (topical): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/35/16947\">",
"           Acyclovir and hydrocortisone: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/56/39811\">",
"           Acyclovir and hydrocortisone: Pediatric drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/7/31856\">",
"           Acyclovir: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/24/39303\">",
"           Adalimumab: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/18/9507\">",
"           Adapalene and benzoyl peroxide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/60/17348\">",
"           Adapalene: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/44/10949\">",
"           Adefovir: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/34/10789\">",
"           Adefovir: Pediatric drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?43/26/44454\">",
"           Adenosine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/19/9524\">",
"           Adenovirus (types 4, 7) vaccine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/58/20387\">",
"           Adenovirus (types 4, 7) vaccine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?11/16/11527\">",
"           Ado-trastuzumab emtansine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/41/9877\">",
"           Ado-trastuzumab emtansine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/18/27939\">",
"           Aflibercept (ophthalmic): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/44/25283\">",
"           Aflibercept (ophthalmic): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/18/2342\">",
"           Aflibercept (ziv-aflibercept) (systemic): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/41/37524\">",
"           Aflibercept (ziv-aflibercept) (systemic): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/28/37312\">",
"           Aflibercept: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/32/39424\">",
"           Aflibercept: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/61/38867\">",
"           Agalsidase alfa: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/34/8741\">",
"           Agalsidase beta: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/6/24678\">",
"           Albendazole: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/59/27574\">",
"           Albumin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/61/16344\">",
"           Albuterol (salbutamol): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/24/38274\">",
"           Alcaftadine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/15/19700\">",
"           Alclometasone: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/33/30231\">",
"           Aldesleukin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/25/26008\">",
"           Alemtuzumab: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/14/24806\">",
"           Alendronate and cholecalciferol: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/10/24743\">",
"           Alendronate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/14/37093\">",
"           Alfacalcidol: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/9/3223\">",
"           Alfentanil: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/55/26485\">",
"           Alfuzosin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?43/44/44741\">",
"           Alglucosidase alfa: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/36/14919\">",
"           Aliskiren and amlodipine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/51/3895\">",
"           Aliskiren and hydrochlorothiazide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/23/5494\">",
"           Aliskiren and valsartan: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/20/9544\">",
"           Aliskiren, amlodipine and hydrochlorothiazide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/59/9142\">",
"           Aliskiren: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/45/25299\">",
"           Alitretinoin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/22/29032\">",
"           All trans retinoic acid (tretinoin): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/40/25223\">",
"           Allopurinol: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/26/20901\">",
"           Almotriptan: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/50/2849\">",
"           Alogliptin and metformin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/62/3041\">",
"           Alogliptin and pioglitazone: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/53/30545\">",
"           Alogliptin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/61/8149\">",
"           Alosetron: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/46/15076\">",
"           Alpha-1 proteinase inhibitor: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/31/31224\">",
"           Alprazolam: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/0/40966\">",
"           Alprostadil: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?11/41/11929\">",
"           Alteplase: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/48/21253\">",
"           Altretamine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/50/4898\">",
"           Aluminum chloride (dental): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/48/28418\">",
"           Aluminum chloride hexahydrate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/30/16870\">",
"           Aluminum hydroxide and magnesium carbonate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/54/1895\">",
"           Aluminum hydroxide and magnesium hydroxide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/23/41333\">",
"           Aluminum hydroxide and magnesium trisilicate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/44/25287\">",
"           Aluminum hydroxide, magnesium hydroxide, and simethicone: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/16/27910\">",
"           Aluminum hydroxide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/7/127\">",
"           Aluminum sulfate calcium acetate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/7/5236\">",
"           Alvimopan: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/46/13031\">",
"           Amantadine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/6/21603\">",
"           Ambenonium: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/60/29637\">",
"           Ambrisentan: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?11/51/12084\">",
"           Amcinonide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/42/678\">",
"           Amifostine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/16/34056\">",
"           Amikacin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/51/40757\">",
"           Amiloride and hydrochlorothiazide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/12/38085\">",
"           Amiloride: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/12/26821\">",
"           Amino acid injection: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/38/30311\">",
"           Aminocaproic acid: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/22/3428\">",
"           Aminolevulinic acid: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/19/14648\">",
"           Aminophylline: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/58/23466\">",
"           Amiodarone: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/44/41671\">",
"           Amitriptyline and chlordiazepoxide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/51/824\">",
"           Amitriptyline and perphenazine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/30/27112\">",
"           Amitriptyline: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/27/26035\">",
"           Amlexanox: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/4/19529\">",
"           Amlodipine and atorvastatin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/54/41831\">",
"           Amlodipine and benazepril: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/26/12711\">",
"           Amlodipine and olmesartan: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/36/20039\">",
"           Amlodipine and valsartan: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/2/8232\">",
"           Amlodipine, olmesartan, and hydrochlorothiazide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?17/53/18264\">",
"           Amlodipine, valsartan, and hydrochlorothiazide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/18/296\">",
"           Amlodipine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/52/25411\">",
"           Ammonium chloride: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/7/36982\">",
"           Amobarbital: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/52/13127\">",
"           Amoxapine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/56/43912\">",
"           Amoxicillin and clavulanate potassium: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/10/42152\">",
"           Amoxicillin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/53/43863\">",
"           Amphotericin B (conventional): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/57/26518\">",
"           Amphotericin B cholesteryl sulfate complex: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/27/18871\">",
"           Amphotericin B lipid complex: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/8/1160\">",
"           Ampicillin and sulbactam: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/51/13112\">",
"           Ampicillin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/5/37973\">",
"           Amsacrine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/1/33813\">",
"           Amyl nitrite: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/19/6454\">",
"           Anagrelide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/18/294\">",
"           Anakinra: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/49/22294\">",
"           Anastrozole: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/51/20276\">",
"           Anidulafungin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/18/20771\">",
"           Anthralin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?17/58/18342\">",
"           Anthrax vaccine adsorbed: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/12/198\">",
"           Antihemophilic factor concentrates (human): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/0/39942\">",
"           Antihemophilic factor/von Willebrand factor complex (human): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/51/11060\">",
"           Antipyrine and benzocaine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/15/12529\">",
"           Antiseptic mouthwash (dental): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/36/8774\">",
"           Antithrombin III: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/40/20102\">",
"           Antithymocyte globulin (equine, Atgam): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/36/2629\">",
"           Antithymocyte globulin (rabbit derived, Thymoglobulin): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/62/39911\">",
"           Apixaban: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/40/34436\">",
"           Apixaban: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/14/21734\">",
"           Apomorphine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/28/36291\">",
"           Apraclonidine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/28/33222\">",
"           Aprepitant: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/46/38630\">",
"           Aprepitant: Pediatric drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/52/6982\">",
"           Aprotinin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/50/30500\">",
"           Arformoterol: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/57/20375\">",
"           Argatroban: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/55/4980\">",
"           Arginine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/11/43193\">",
"           Aripiprazole: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/43/31413\">",
"           Armodafinil: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/60/39873\">",
"           Aromatic ammonia spirit: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/47/16119\">",
"           Arsenic trioxide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/1/24598\">",
"           Arsenic trioxide: Pediatric drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/58/37798\">",
"           Artemether and lumefantrine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/54/4965\">",
"           Artesunate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/52/3911\">",
"           Articaine and epinephrine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/59/37811\">",
"           Artificial saliva: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/41/24211\">",
"           Artificial tears: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/15/38131\">",
"           Artificial tears: Pediatric drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/56/2951\">",
"           Asenapine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/54/33636\">",
"           Aspirin and diphenhydramine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/52/19271\">",
"           Aspirin and extended-release dipyridamole: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/7/24698\">",
"           Aspirin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/31/506\">",
"           Atazanavir: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?43/45/44758\">",
"           Atenolol and chlorthalidone: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/46/30440\">",
"           Atenolol: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/62/999\">",
"           Atomoxetine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/37/35417\">",
"           Atorvastatin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/56/902\">",
"           Atovaquone and proguanil: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?11/5/11350\">",
"           Atovaquone: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/14/6374\">",
"           Atracurium: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?43/24/44421\">",
"           Atropine and pralidoxime: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?11/23/11640\">",
"           Atropine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/18/34082\">",
"           Attapulgite: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/47/31476\">",
"           Auranofin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?43/8/44165\">",
"           Avanafil: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/54/41828\">",
"           Avanafil: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/17/21780\">",
"           Avian influenza virus vaccine (H5N1): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/13/43222\">",
"           Axitinib: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/61/19414\">",
"           Axitinib: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/40/12935\">",
"           Azacitidine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/3/38967\">",
"           Azathioprine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/46/38627\">",
"           Azelaic acid: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/53/8022\">",
"           Azelastine (nasal): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/47/17139\">",
"           Azelastine (ophthalmic): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/31/36341\">",
"           Azelastine and fluticasone: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/1/38932\">",
"           Azelastine and fluticasone: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/15/33008\">",
"           Azelastine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/12/12486\">",
"           Azilsartan and chlorthalidone: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/24/32133\">",
"           Azilsartan and chlorthalidone: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/37/32342\">",
"           Azilsartan: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/11/21683\">",
"           Azithromycin (ophthalmic): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?17/25/17817\">",
"           Azithromycin (systemic): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/43/33456\">",
"           Azithromycin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/25/43414\">",
"           Aztreonam: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/30/28135\">",
"           Bacillus Calmette-Guerin (BCG) vaccine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?11/14/11491\">",
"           Bacitracin and polymyxin B: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/14/18660\">",
"           Bacitracin, neomycin, and polymyxin B: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?17/0/17413\">",
"           Bacitracin, neomycin, polymyxin B, and hydrocortisone: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/39/32369\">",
"           Bacitracin, neomycin, polymyxin B, and pramoxine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/20/6469\">",
"           Bacitracin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/31/36342\">",
"           Baclofen: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/62/30690\">",
"           Balanced salt solution: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/53/8021\">",
"           Balsalazide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/17/12564\">",
"           Barium: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/54/22374\">",
"           Basiliximab: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/13/26834\">",
"           Beano (alpha-galactosidase): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/61/30675\">",
"           Becaplermin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/39/21109\">",
"           Beclomethasone (nasal): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/31/30199\">",
"           Beclomethasone (oral inhalation): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/7/33904\">",
"           Beclomethasone: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/36/12869\">",
"           Bedaquiline: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?43/2/44068\">",
"           Bedaquiline: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/41/43669\">",
"           Belatacept: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/26/1445\">",
"           Belatacept: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/31/37365\">",
"           Belimumab: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/41/26261\">",
"           Belladonna and opium: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/19/19767\">",
"           Benazepril and hydrochlorothiazide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/19/16696\">",
"           Benazepril: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/20/32071\">",
"           Bendamustine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/55/13170\">",
"           Bentoquatam: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/5/26706\">",
"           Benzalkonium chloride and benzocaine (topical): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/7/25715\">",
"           Benzalkonium chloride and benzocaine (topical): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/19/41267\">",
"           Benzocaine, butamben, and tetracaine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/7/6264\">",
"           Benzocaine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/32/27137\">",
"           Benzoin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/1/18451\">",
"           Benzonatate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/3/59\">",
"           Benzoyl peroxide and hydrocortisone: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/24/42373\">",
"           Benzoyl peroxide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/56/36741\">",
"           Benzphetamine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/55/3958\">",
"           Benztropine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/45/6867\">",
"           Benzydamine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/61/20435\">",
"           Benzyl alcohol: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/15/7411\">",
"           Bepotastine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?17/22/17763\">",
"           Beractant: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/4/16451\">",
"           Besifloxacin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/50/21283\">",
"           Beta-carotene: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/42/17059\">",
"           Betahistine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/49/41747\">",
"           Betaine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?11/47/12022\">",
"           Betamethasone and clotrimazole: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?43/5/44120\">",
"           Betamethasone: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/53/4950\">",
"           Betaxolol (ophthalmic): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/24/37255\">",
"           Betaxolol (systemic): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/11/32944\">",
"           Betaxolol: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/56/25476\">",
"           Bethanechol: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/20/2377\">",
"           Bevacizumab: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/11/28854\">",
"           Bexarotene (systemic): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/15/28916\">",
"           Bexarotene (topical): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/10/31904\">",
"           Bexarotene: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/40/12933\">",
"           Bezafibrate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/2/30758\">",
"           Bicalutamide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?43/5/44115\">",
"           Bimatoprost: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/4/6213\">",
"           Bisacodyl: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/63/31733\">",
"           Bismuth subsalicylate, metronidazole, and tetracycline: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/29/35285\">",
"           Bismuth: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/28/26055\">",
"           Bisoprolol and hydrochlorothiazide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/29/2520\">",
"           Bisoprolol: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?17/48/18184\">",
"           Bivalirudin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/12/31941\">",
"           Black widow spider (Latrodectus mactans) antivenom: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/15/39159\">",
"           Bleomycin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/40/27273\">",
"           Boceprevir: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/63/11257\">",
"           Bortezomib: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/16/40200\">",
"           Bosentan: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/45/23254\">",
"           Bosutinib: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/10/23717\">",
"           Bosutinib: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/39/12916\">",
"           Botulism immune globulin (intravenous human): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/44/7875\">",
"           Bovine lipid extract surfactant: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/6/16486\">",
"           Brentuximab vedotin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/23/3445\">",
"           Brentuximab vedotin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/63/8183\">",
"           Brimonidine and timolol: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/32/15877\">",
"           Brimonidine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/59/19382\">",
"           Brinzolamide and timolol: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/35/29235\">",
"           Brinzolamide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?17/17/17686\">",
"           Bromazepam: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/5/25683\">",
"           Bromfenac: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/40/8840\">",
"           Bromocriptine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?11/42/11937\">",
"           Bromopride: International drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/20/32067\">",
"           Brompheniramine and phenylephrine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/50/36645\">",
"           Brompheniramine and pseudoephedrine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/9/3222\">",
"           Brompheniramine, pseudoephedrine, and dextromethorphan: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/29/39381\">",
"           Brompheniramine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/55/19317\">",
"           Budesonide (nasal): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/39/10873\">",
"           Budesonide (systemic therapy and oral inhalation): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/21/8536\">",
"           Budesonide and formoterol: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/7/32880\">",
"           Budesonide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/9/43158\">",
"           Bumetanide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/22/38246\">",
"           Bupivacaine and epinephrine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/60/34758\">",
"           Bupivacaine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/51/24375\">",
"           Buprenorphine and naloxone: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/53/41816\">",
"           Buprenorphine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/29/26073\">",
"           Bupropion: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?17/10/17573\">",
"           Buserelin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/19/30006\">",
"           Buspirone: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/10/10408\">",
"           Busulfan: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/37/20054\">",
"           Butabarbital: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/61/16343\">",
"           Butalbital and acetaminophen: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/46/28392\">",
"           Butalbital compound and codeine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/15/36087\">",
"           Butalbital compound: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/21/38231\">",
"           Butalbital, acetaminophen, and caffeine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/30/3560\">",
"           Butalbital, acetaminophen, caffeine, and codeine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/61/31699\">",
"           Butenafine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/23/40306\">",
"           Butoconazole: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/20/9543\">",
"           Butorphanol: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/57/23444\">",
"           C1 inhibitor concentrate (human): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/47/31478\">",
"           Cabazitaxel: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/2/7206\">",
"           Cabergoline: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/22/7526\">",
"           Cabozantinib: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/29/10710\">",
"           Cabozantinib: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/34/25126\">",
"           Caffeine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/11/33969\">",
"           Calamine lotion: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/49/29462\">",
"           Calcipotriol (calcipotriene) and betamethasone: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/54/5988\">",
"           Calcipotriol (calcipotriene): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/9/28821\">",
"           Calcitonin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/13/40152\">",
"           Calcitriol: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/48/39685\">",
"           Calcium acetate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/62/7143\">",
"           Calcium and vitamin D: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/59/28598\">",
"           Calcium carbonate and magnesium hydroxide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/51/27446\">",
"           Calcium carbonate and simethicone: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/32/42504\">",
"           Calcium carbonate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/27/15799\">",
"           Calcium chloride: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/46/38628\">",
"           Calcium citrate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/46/37604\">",
"           Calcium glubionate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/11/18616\">",
"           Calcium gluconate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/38/16996\">",
"           Calcium lactate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/58/21412\">",
"           Calcium phosphate, tribasic: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/8/24708\">",
"           Calcium polystyrene sulfonate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/41/2707\">",
"           Calfactant: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?43/0/44034\">",
"           Camphor and menthol: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/50/24354\">",
"           Camphor and phenol: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/53/42832\">",
"           Canagliflozin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/52/41796\">",
"           Canakinumab: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/6/14437\">",
"           Canakinumab: Pediatric drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/25/21911\">",
"           Candesartan and hydrochlorothiazide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/48/38663\">",
"           Candesartan: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/61/21462\">",
"           Candesartan: Pediatric drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/0/40961\">",
"           Candida albicans (Monilia) skin test: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/35/20019\">",
"           Cantharidin, podophyllin resin, and salicylic acid: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/29/18899\">",
"           Cantharidin, podophyllin resin, and salicylic acid: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/57/8083\">",
"           Cantharidin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/0/40967\">",
"           Capecitabine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/59/11189\">",
"           Capreomycin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/44/14022\">",
"           Capsaicin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/45/23255\">",
"           Captopril and hydrochlorothiazide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/59/9145\">",
"           Captopril: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/52/30531\">",
"           Carbachol: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/10/25770\">",
"           Carbamazepine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/30/16867\">",
"           Carbamide peroxide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/45/33491\">",
"           Carbetocin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/9/3221\">",
"           Carbidopa: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/36/36423\">",
"           Carbidopa-levodopa: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/25/37270\">",
"           Carbidopa-levodopa-entacapone: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?11/8/11398\">",
"           Carbinoxamine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/61/38873\">",
"           Carboplatin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/29/20948\">",
"           Carboprost tromethamine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/34/29218\">",
"           Carboxymethylcellulose: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/24/13702\">",
"           Carfilzomib: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/5/15444\">",
"           Carfilzomib: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/43/31411\">",
"           Carglumic acid: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/49/38675\">",
"           Carglumic acid: Pediatric drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/9/35990\">",
"           Carisoprodol and aspirin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?11/21/11607\">",
"           Carisoprodol, aspirin, and codeine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/59/32693\">",
"           Carisoprodol: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/39/33399\">",
"           Carmustine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/31/1525\">",
"           Carteolol (ophthalmic): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/22/9577\">",
"           Carvedilol: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/15/10486\">",
"           Caspofungin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/3/21554\">",
"           Castor oil: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/11/27829\">",
"           Cefaclor: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/7/10357\">",
"           Cefadroxil: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/2/4136\">",
"           Cefazolin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/21/5461\">",
"           Cefdinir: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/19/38196\">",
"           Cefditoren: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/33/16919\">",
"           Cefepime: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/44/16070\">",
"           Cefixime: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/57/35735\">",
"           Cefotaxime: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/55/17269\">",
"           Cefotetan: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/53/11094\">",
"           Cefoxitin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/44/27333\">",
"           Cefpodoxime: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/22/14693\">",
"           Cefprozil: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/33/4628\">",
"           Ceftaroline: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?17/0/17415\">",
"           Ceftazidime: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/58/8101\">",
"           Ceftibuten: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/17/10521\">",
"           Ceftriaxone: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/61/26583\">",
"           Cefuroxime: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/11/40120\">",
"           Celecoxib: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/50/22307\">",
"           Centruroides antivenom: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/10/16547\">",
"           Centruroides antivenom: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/44/39619\">",
"           Centruroides antivenom: Pediatric drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/37/37462\">",
"           Cephalexin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/6/39014\">",
"           Certolizumab pegol: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/27/35253\">",
"           Cetirizine and pseudoephedrine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/34/36390\">",
"           Cetirizine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/3/22580\">",
"           Cetrorelix: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/58/10151\">",
"           Cetuximab: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/18/25889\">",
"           Cetylpyridinium and benzocaine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/11/26802\">",
"           Cetylpyridinium: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/40/12932\">",
"           Cevimeline: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/19/33076\">",
"           Chenodeoxycholic acid (chenodiol): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/26/5542\">",
"           Chloral hydrate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/52/35654\">",
"           Chlorambucil: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/54/1897\">",
"           Chloramphenicol: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/36/4679\">",
"           Chlordiazepoxide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/36/12870\">",
"           Chlorhexidine gluconate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/12/38081\">",
"           Chlorophyll: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/17/3350\">",
"           Chloroprocaine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/54/25447\">",
"           Chloroquine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/2/35878\">",
"           Chlorothiazide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/43/17077\">",
"           Chlorpheniramine and acetaminophen: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/48/773\">",
"           Chlorpheniramine and phenylephrine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/25/13718\">",
"           Chlorpheniramine and pseudoephedrine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/60/24517\">",
"           Chlorpheniramine, phenylephrine, and dextromethorphan: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/44/25285\">",
"           Chlorpheniramine, pseudoephedrine, and codeine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/37/19030\">",
"           Chlorpheniramine, pseudoephedrine, and dextromethorphan: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/52/24390\">",
"           Chlorpheniramine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/38/30312\">",
"           Chlorpromazine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/0/6151\">",
"           Chlorpropamide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/14/26854\">",
"           Chlorthalidone: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/46/35557\">",
"           Chlorthalidone: Pediatric drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/37/40532\">",
"           Chlorzoxazone: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/33/36374\">",
"           Cholestyramine resin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/43/42677\">",
"           Choline magnesium trisalicylate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/47/36594\">",
"           Chondroitin sulfate-sodium hyaluronate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/61/36818\">",
"           Chromic phosphate P 32: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/25/35220\">",
"           Ciclesonide (nasal): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/33/3604\">",
"           Ciclesonide (nasal): Pediatric drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/5/34902\">",
"           Ciclesonide (oral inhalation): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/26/22949\">",
"           Ciclesonide (oral inhalation): Pediatric drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/45/33488\">",
"           Ciclesonide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/43/21169\">",
"           Ciclesonide: Pediatric drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?43/40/44676\">",
"           Ciclopirox: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/2/20517\">",
"           Cidofovir: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/60/6088\">",
"           Cilazapril and hydrochlorothiazide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/7/39031\">",
"           Cilazapril: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/38/38502\">",
"           Cilostazol: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/54/2921\">",
"           Cimetidine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/23/26998\">",
"           Cinacalcet: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/7/26740\">",
"           Ciprofloxacin (ophthalmic): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/20/27971\">",
"           Ciprofloxacin (otic): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/5/20570\">",
"           Ciprofloxacin (systemic): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/13/16595\">",
"           Ciprofloxacin and dexamethasone: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/63/35826\">",
"           Ciprofloxacin and hydrocortisone: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/45/35536\">",
"           Ciprofloxacin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/46/29414\">",
"           Cisapride (United States - available via limited-access protocol only): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/1/26646\">",
"           Cisatracurium: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/51/21305\">",
"           Cisplatin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/56/13193\">",
"           Citalopram: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/21/33109\">",
"           Citric acid bladder mixture: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/22/19815\">",
"           Cladribine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/57/10138\">",
"           Clarithromycin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/62/7142\">",
"           Clemastine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/25/39317\">",
"           Clevidipine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/62/22502\">",
"           Clidinium and chlordiazepoxide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/46/41704\">",
"           Clindamycin (systemic): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/46/5862\">",
"           Clindamycin (topical): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/33/36371\">",
"           Clindamycin and benzoyl peroxide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/54/13155\">",
"           Clindamycin and tretinoin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/39/26227\">",
"           Clindamycin and tretinoin: Pediatric drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/21/33104\">",
"           Clindamycin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/13/29907\">",
"           Clioquinol and flumethasone: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/49/40727\">",
"           Clobazam: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/4/32839\">",
"           Clobazam: Pediatric drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/16/10502\">",
"           Clobetasol: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/38/23139\">",
"           Clocortolone: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/3/9270\">",
"           Clodronate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/5/33879\">",
"           Clofarabine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/22/23909\">",
"           Clomiphene: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/20/43336\">",
"           Clomipramine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/45/26328\">",
"           Clonazepam: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/21/15702\">",
"           Clonidine and chlorthalidone: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/53/19289\">",
"           Clonidine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/9/34969\">",
"           Clopidogrel: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/44/14023\">",
"           Clorazepate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/60/35780\">",
"           Clotrimazole (oral): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/61/29652\">",
"           Clotrimazole (topical): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/18/33056\">",
"           Clotrimazole: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/45/31446\">",
"           Cloxacillin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/21/35161\">",
"           Clozapine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/1/26642\">",
"           Coal tar and salicylic acid: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?43/43/44724\">",
"           Coal tar: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/0/35848\">",
"           Codeine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/61/36821\">",
"           Colchicine and probenecid: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/13/32983\">",
"           Colchicine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/57/35734\">",
"           Colesevelam: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/26/12710\">",
"           Colestipol: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/14/43238\">",
"           Colistin (colistimethate): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/20/40258\">",
"           Collagen hemostat: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/29/5588\">",
"           Collagenase (systemic): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/11/41138\">",
"           Collagenase (topical): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/28/33216\">",
"           Collagenase: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/36/38464\">",
"           Collagenase: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/62/42980\">",
"           Combined hepatitis A and typhoid vaccine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/25/18835\">",
"           Combined hepatitis A and typhoid vaccine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/17/18711\">",
"           Conivaptan: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/51/28472\">",
"           Conjugated equine estrogens (systemic): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/60/19399\">",
"           Conjugated equine estrogens (topical): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/23/35184\">",
"           Conjugated equine estrogens: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/31/5619\">",
"           Continuous renal replacement therapy solution: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/19/38195\">",
"           Corticorelin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/62/2023\">",
"           Corticotropin injection gel: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/16/39174\">",
"           Cortisone acetate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/20/24902\">",
"           Cosyntropin (tetracosactide): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/58/30631\">",
"           Crizotinib: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/53/29525\">",
"           Crizotinib: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/56/21379\">",
"           Crofelemer: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/27/34227\">",
"           Crofelemer: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/27/23987\">",
"           Cromolyn sodium (nasal): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/3/28723\">",
"           Cromolyn sodium (ophthalmic): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?17/12/17605\">",
"           Cromolyn sodium (systemic therapy and oral inhalation): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/53/37712\">",
"           Cromolyn sodium: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/45/13011\">",
"           Crotamiton: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/16/14598\">",
"           Cyanide antidote kit: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/10/28838\">",
"           Cyanocobalamin (vitamin B12): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/54/32612\">",
"           Cyclizine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/60/13254\">",
"           Cyclobenzaprine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/51/25394\">",
"           Cyclopentolate and phenylephrine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/34/24100\">",
"           Cyclopentolate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/20/9546\">",
"           Cyclophosphamide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/30/43492\">",
"           Cycloserine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/26/14756\">",
"           Cyclosporine (ophthalmic): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/8/30858\">",
"           Cyclosporine (systemic): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/39/32368\">",
"           Cyclosporine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/25/19862\">",
"           Cyproheptadine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/22/9576\">",
"           Cyproterone and ethinyl estradiol: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/2/14374\">",
"           Cyproterone: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/7/43122\">",
"           Cysteamine (ophthalmic): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/40/8836\">",
"           Cysteamine (ophthalmic): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?11/56/12164\">",
"           Cysteamine (systemic): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/49/16148\">",
"           Cysteamine (systemic): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/20/37184\">",
"           Cysteamine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/61/7124\">",
"           Cysteamine: Pediatric drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/8/24707\">",
"           Cysteine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/53/20314\">",
"           Cytarabine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/20/24901\">",
"           Cytomegalovirus immune globulin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/39/8825\">",
"           Dabigatran: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/49/4887\">",
"           Dacarbazine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/21/14679\">",
"           Dactinomycin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/36/6725\">",
"           Dalfampridine (fampridine): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/56/32648\">",
"           Dalteparin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/18/41254\">",
"           Danaparoid: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/0/26629\">",
"           Danazol: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/22/22887\">",
"           Dantrolene: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/7/29814\">",
"           Dapsone (systemic): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?43/34/44579\">",
"           Dapsone (topical): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/59/32688\">",
"           Dapsone: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/10/20646\">",
"           Daptomycin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/49/33560\">",
"           Darbepoetin alfa: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/45/43733\">",
"           Darifenacin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/39/36473\">",
"           Darunavir: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/39/22136\">",
"           Dasatinib: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/15/43254\">",
"           Daunorubicin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/59/39861\">",
"           Decitabine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/19/2360\">",
"           Deferasirox: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/18/3365\">",
"           Deferiprone: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/43/30388\">",
"           Deferiprone: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/10/22695\">",
"           Deferoxamine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/8/41091\">",
"           Defibrotide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/42/15013\">",
"           Degarelix: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/10/27816\">",
"           Delavirdine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/4/10310\">",
"           Demeclocycline: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/57/918\">",
"           Denileukin diftitox: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/53/21335\">",
"           Denosumab: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/44/5830\">",
"           Desflurane: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/14/39144\">",
"           Desipramine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/60/25541\">",
"           Desirudin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/63/25589\">",
"           Desloratadine and pseudoephedrine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/40/12934\">",
"           Desloratadine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/60/10184\">",
"           Desmopressin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/32/13828\">",
"           Desonide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/10/24740\">",
"           Desoximetasone: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/33/18967\">",
"           Desvenlafaxine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/62/997\">",
"           Dexamethasone (ophthalmic): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/45/14042\">",
"           Dexamethasone (systemic): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/4/33856\">",
"           Dexamethasone: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/43/20149\">",
"           Dexchlorpheniramine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/9/27799\">",
"           Dexlansoprazole: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/53/33622\">",
"           Dexmedetomidine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/44/23238\">",
"           Dexmethylphenidate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/43/36530\">",
"           Dexpanthenol: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/28/30150\">",
"           Dexrazoxane: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/5/21588\">",
"           Dextran: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/26/31138\">",
"           Dextranomer and hyaluronic acid: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?43/41/44695\">",
"           Dextroamphetamine and amphetamine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/44/32454\">",
"           Dextroamphetamine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?11/30/11749\">",
"           Dextromethorphan and chlorpheniramine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?11/40/11908\">",
"           Dextromethorphan and phenylephrine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/13/26839\">",
"           Dextromethorphan and quinidine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/20/13637\">",
"           Dextromethorphan, chlorpheniramine, phenylephrine, and guaifenesin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?17/46/18150\">",
"           Dextromethorphan: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?43/15/44278\">",
"           Diatrizoate meglumine and diatrizoate sodium: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?43/19/44338\">",
"           Diatrizoate meglumine and iodipamide meglumine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/0/14340\">",
"           Diatrizoate meglumine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/46/16105\">",
"           Diazepam: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/38/13924\">",
"           Diazoxide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/37/35410\">",
"           Dibucaine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/63/15348\">",
"           Diclofenac (ophthalmic): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/43/8890\">",
"           Diclofenac (systemic): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/21/24920\">",
"           Diclofenac (topical): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?17/28/17864\">",
"           Diclofenac and misoprostol: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/29/38352\">",
"           Diclofenac: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/11/3253\">",
"           Dicloxacillin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/6/27749\">",
"           Dicyclomine (dicycloverine): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/38/14952\">",
"           Didanosine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/46/27366\">",
"           Dienogest: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/43/693\">",
"           Dienogest: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/2/36900\">",
"           Diethylene triamine penta-acetic acid: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/23/8565\">",
"           Diethylpropion: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/30/33251\">",
"           Difenoxin and atropine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/56/24451\">",
"           Diflorasone: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/41/25240\">",
"           Diflunisal: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/16/20739\">",
"           Difluprednate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/15/27895\">",
"           Digoxin immune Fab: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/27/29113\">",
"           Digoxin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/32/36359\">",
"           Dihydrocodeine, aspirin, and caffeine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/20/8516\">",
"           Dihydrocodeine, chlorpheniramine, and phenylephrine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/13/15574\">",
"           Dihydroergotamine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/16/12554\">",
"           Diltiazem: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?11/46/12006\">",
"           Dimenhydrinate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/42/9893\">",
"           Dimercaprol: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/26/12709\">",
"           Dimercaptosuccinic acid (succimer): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/16/9476\">",
"           Dimethyl fumarate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/31/4596\">",
"           Dimethyl fumarate: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/22/33123\">",
"           Dimethyl sulfoxide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/38/13927\">",
"           Dinoprostone: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/33/7705\">",
"           Diphenhydramine (systemic): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/15/1269\">",
"           Diphenhydramine (topical): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/24/8582\">",
"           Diphenhydramine and phenylephrine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/2/33824\">",
"           Diphenhydramine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/56/9094\">",
"           Diphenoxylate and atropine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/17/10519\">",
"           Diphtheria and tetanus toxoid: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/15/21745\">",
"           Diphtheria antitoxin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/56/4998\">",
"           Diphtheria tetanus toxoids acellular pertussis inactivated poliovirus combination vaccine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/32/8710\">",
"           Diphtheria tetanus toxoids acellular pertussis inactivated poliovirus haemophilus influenzae type b conjugate vaccine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?11/10/11429\">",
"           Diphtheria tetanus toxoids acellular pertussis inactivated poliovirus Haemophilus influenzae type B hepatitis B conjugate vaccine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?17/57/18326\">",
"           Diphtheria, tetanus toxoids, acellular pertussis, recombinant hepatitis B, and inactivated poliovirus vaccine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/43/34488\">",
"           Diphtheria, tetanus toxoids, and acellular pertussis vaccine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/59/27571\">",
"           Dipivefrin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/25/41366\">",
"           Dipyridamole: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/49/35607\">",
"           Disopyramide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/17/5397\">",
"           Disulfiram: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/57/25494\">",
"           Dobutamine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/59/41913\">",
"           Docetaxel: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/57/6034\">",
"           Docosanol: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/59/8115\">",
"           Docusate and senna: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/41/22165\">",
"           Docusate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/2/6183\">",
"           Dofetilide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/49/16150\">",
"           Dolasetron: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/43/1717\">",
"           Domperidone: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/30/10726\">",
"           Donepezil: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/20/42310\">",
"           Dopamine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/42/6822\">",
"           Doripenem: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/13/29908\">",
"           Dornase alfa: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/39/13943\">",
"           Dorzolamide and timolol: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/30/23012\">",
"           Dorzolamide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/37/14933\">",
"           Doxapram: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/59/8119\">",
"           Doxazosin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/63/27638\">",
"           Doxazosin: Pediatric drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?43/32/44551\">",
"           Doxepin (systemic): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/8/14470\">",
"           Doxepin (topical): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/51/32560\">",
"           Doxepin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?43/12/44229\">",
"           Doxercalciferol: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/37/36440\">",
"           Doxorubicin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/18/2340\">",
"           Doxycycline hyclate periodontal extended-release liquid: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/41/2714\">",
"           Doxycycline: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/1/34836\">",
"           Doxylamine and pyridoxine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/52/17221\">",
"           Doxylamine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/49/30485\">",
"           Dronabinol: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/3/5176\">",
"           Dronedarone: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/19/9527\">",
"           Droperidol: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/13/21719\">",
"           Drospirenone and estradiol: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/62/37864\">",
"           Duloxetine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/46/33509\">",
"           Dutasteride and tamsulosin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/33/36372\">",
"           Dutasteride: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/46/26338\">",
"           Dyclonine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/24/30083\">",
"           Dyphylline and guaifenesin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/11/41139\">",
"           Dyphylline: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/20/10567\">",
"           E. coli asparaginase: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/23/23923\">",
"           Ecallantide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/26/37283\">",
"           Echothiophate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/56/4995\">",
"           Econazole: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/63/28662\">",
"           Eculizumab: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/27/12726\">",
"           Edetate calcium disodium (calcium EDTA): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?11/27/11700\">",
"           Edrophonium and atropine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/21/35156\">",
"           Edrophonium: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/25/23961\">",
"           Efavirenz, tenofovir, and emtricitabine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/42/29353\">",
"           Efavirenz: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/49/37652\">",
"           Eflornithine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/29/42452\">",
"           Eletriptan: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?11/17/11543\">",
"           Eltrombopag: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/54/8041\">",
"           Elvitegravir, cobicistat, tenofovir and emtricitabine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/19/14645\">",
"           Elvitegravir, cobicistat, tenofovir and emtricitabine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/20/323\">",
"           Emedastine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/3/41010\">",
"           Emollients: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/15/5366\">",
"           Emtricitabine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/23/24951\">",
"           Enalapril and hydrochlorothiazide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/19/8505\">",
"           Enalapril: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/18/32040\">",
"           Enalapril: Pediatric drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/22/20839\">",
"           Enalaprilat (intravenous): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?17/24/17796\">",
"           Enalaprilat (intravenous): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/20/19783\">",
"           Enalaprilat (intravenous): Pediatric drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/47/34548\">",
"           Enflurane: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/2/7205\">",
"           Enfuvirtide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/24/36233\">",
"           Enoxaparin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/38/38501\">",
"           Entacapone: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/55/29557\">",
"           Entecavir: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/46/16103\">",
"           Enzalutamide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/25/34196\">",
"           Enzalutamide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?11/14/11493\">",
"           Ephedrine (systemic): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/60/16323\">",
"           Epinastine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/34/3620\">",
"           Epinephrine (adrenaline) (nasal): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?11/4/11337\">",
"           Epinephrine (adrenaline) (systemic therapy and oral inhalation): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/63/35824\">",
"           Epinephrine (adrenaline): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/27/4536\">",
"           Epirubicin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/58/5031\">",
"           Eplerenone: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/48/2825\">",
"           Epoetin alfa: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/22/359\">",
"           Epoprostenol: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/38/12903\">",
"           Eprosartan and hydrochlorothiazide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/13/31958\">",
"           Eprosartan: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/24/32135\">",
"           Eptifibatide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/37/37463\">",
"           Equine conjugated estrogens and medroxyprogesterone acetate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/13/16596\">",
"           Ergoloid mesylates: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/13/213\">",
"           Ergonovine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/51/39731\">",
"           Ergonovine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/56/42885\">",
"           Ergotamine and caffeine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/20/23877\">",
"           Ergotamine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/42/28325\">",
"           Eribulin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/13/36056\">",
"           Erlotinib: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/36/41542\">",
"           Ertapenem: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/39/12917\">",
"           Erwinia asparaginase: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/3/9268\">",
"           Erwinia asparaginase: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/51/26419\">",
"           Erythromycin (ophthalmic): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/6/25705\">",
"           Erythromycin (systemic): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/28/31171\">",
"           Erythromycin (topical): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/41/5779\">",
"           Erythromycin and benzoyl peroxide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/3/23607\">",
"           Erythromycin and sulfisoxazole: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/29/36304\">",
"           Erythromycin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/56/25481\">",
"           Escitalopram: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/37/40536\">",
"           Esmolol: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/17/34072\">",
"           Esomeprazole and naproxen: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/39/15993\">",
"           Esomeprazole: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/15/22774\">",
"           Estazolam: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/25/14743\">",
"           Esterified estrogen and methyltestosterone: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/39/29303\">",
"           Esterified estrogens: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/25/14746\">",
"           Estradiol (systemic): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/1/38935\">",
"           Estradiol (topical): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/14/22759\">",
"           Estradiol and dienogest: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/4/14407\">",
"           Estradiol and levonorgestrel: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/58/38823\">",
"           Estradiol and norethindrone: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/51/29495\">",
"           Estradiol and norgestimate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/26/34208\">",
"           Estradiol: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/4/35909\">",
"           Estramustine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/26/15783\">",
"           Estropipate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/11/15542\">",
"           Eszopiclone: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/31/28151\">",
"           Etanercept: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/10/7334\">",
"           Ethacrynic acid: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/7/12406\">",
"           Ethambutol: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/50/4904\">",
"           Ethanol (topical and injection): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/9/40082\">",
"           Ethanolamine oleate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/18/39209\">",
"           Ethinyl estradiol and desogestrel: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/62/42985\">",
"           Ethinyl estradiol and drospirenone: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/22/12649\">",
"           Ethinyl estradiol and ethynodiol diacetate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/27/25017\">",
"           Ethinyl estradiol and etonogestrel: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?17/2/17450\">",
"           Ethinyl estradiol and levonorgestrel: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/21/24921\">",
"           Ethinyl estradiol and norelgestromin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/43/32442\">",
"           Ethinyl estradiol and norethindrone: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/36/40521\">",
"           Ethinyl estradiol and norgestimate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/0/16393\">",
"           Ethinyl estradiol and norgestrel: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/41/35481\">",
"           Ethinyl estradiol, drospirenone, and levomefolate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/16/42244\">",
"           Ethionamide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/54/13158\">",
"           Ethosuximide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/17/6421\">",
"           Ethotoin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/2/14370\">",
"           Ethyl chloride: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/26/37284\">",
"           Etidronate and calcium: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/23/22902\">",
"           Etidronate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/35/13881\">",
"           Etodolac: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/34/15908\">",
"           Etomidate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/1/35863\">",
"           Etonogestrel: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/8/15495\">",
"           Etoposide phosphate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/57/30617\">",
"           Etoposide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/0/13320\">",
"           Etravirine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/8/9352\">",
"           Etravirine: Pediatric drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/4/6218\">",
"           Everolimus: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/41/20121\">",
"           Everolimus: Pediatric drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/4/7238\">",
"           Exemestane: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/2/14375\">",
"           Exenatide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/4/41031\">",
"           Ezetimibe and simvastatin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/42/4773\">",
"           Ezetimibe: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/13/41172\">",
"           Ezogabine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/59/43956\">",
"           Ezogabine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/61/8151\">",
"           Factor IX concentrates: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/56/28548\">",
"           Factor IX concentrates: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/48/772\">",
"           Factor XIII concentrates: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/23/37238\">",
"           Famciclovir: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/59/32695\">",
"           Famotidine, calcium carbonate, and magnesium hydroxide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/45/728\">",
"           Famotidine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?17/29/17878\">",
"           Fat emulsion: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/62/29668\">",
"           Febuxostat: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/31/25079\">",
"           Felbamate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/45/2775\">",
"           Felodipine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/48/8966\">",
"           Felodipine: Pediatric drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?17/23/17784\">",
"           Fenofibrate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/16/20742\">",
"           Fenofibric acid: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/29/35284\">",
"           Fenoldopam: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/52/27464\">",
"           Fenoprofen: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/8/31876\">",
"           Fenoterol and ipratropium: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/52/38730\">",
"           Fentanyl: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/53/31573\">",
"           Ferric gluconate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/39/31347\">",
"           Ferric hexacyanoferrate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/18/19747\">",
"           Ferric subsulfate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/39/7798\">",
"           Ferrous fumarate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/37/38485\">",
"           Ferrous gluconate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/11/37046\">",
"           Ferrous sulfate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/46/27364\">",
"           Ferumoxytol: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/53/28501\">",
"           Fesoterodine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/61/5078\">",
"           Fexofenadine and pseudoephedrine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/33/35350\">",
"           Fexofenadine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/8/5254\">",
"           Fibrin sealant kit: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/20/14659\">",
"           Fibrinogen concentrate (human): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/28/15812\">",
"           Fidaxomicin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/53/33619\">",
"           Fidaxomicin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/13/23767\">",
"           Filgrastim: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/24/39301\">",
"           Finasteride: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/11/26806\">",
"           Fingolimod: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?17/40/18053\">",
"           Five-grass pollen sublingual tablet: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/13/9428\">",
"           Five-grass pollen sublingual tablet: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/1/24595\">",
"           Flavocoxid (plant flavonoids and zinc): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/9/10388\">",
"           Flavoxate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/30/30182\">",
"           Flecainide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/1/14359\">",
"           Floctafenine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/60/19395\">",
"           Florbetapir F18: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/11/36018\">",
"           Florbetapir F18: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/21/39253\">",
"           Floxuridine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/12/16586\">",
"           Fluconazole: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/0/32773\">",
"           Flucytosine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/20/9545\">",
"           Fludarabine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/43/4786\">",
"           Fludeoxyglucose F-18: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/33/8723\">",
"           Fludeoxyglucose F-18: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/9/21655\">",
"           Fludrocortisone: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/6/41062\">",
"           Flumazenil: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/43/34484\">",
"           Flunarizine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/62/30691\">",
"           Flunisolide (nasal): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/34/9766\">",
"           Flunisolide (oral inhalation): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/49/34581\">",
"           Flunisolide (oral inhalation): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/39/33392\">",
"           Flunisolide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/18/29987\">",
"           Fluocinolone (ophthalmic): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/9/23699\">",
"           Fluocinolone (otic): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/28/25029\">",
"           Fluocinolone (topical): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/39/13940\">",
"           Fluocinolone, hydroquinone, and tretinoin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/22/36192\">",
"           Fluocinolone: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/56/30596\">",
"           Fluocinonide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/49/29458\">",
"           Fluorescein and benoxinate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/27/29108\">",
"           Fluorescein: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/33/4632\">",
"           Fluoride: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/49/41748\">",
"           Fluorometholone: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/42/10921\">",
"           Fluorouracil (systemic): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/58/13221\">",
"           Fluorouracil (topical): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/32/33280\">",
"           Fluorouracil: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/49/15130\">",
"           Fluoxetine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/34/41508\">",
"           Fluoxymesterone: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/62/34790\">",
"           Flupentixol: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/10/38055\">",
"           Fluphenazine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/55/20340\">",
"           Flurandrenolide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/3/27703\">",
"           Flurazepam: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/29/22995\">",
"           Flurbiprofen (ophthalmic): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/19/30008\">",
"           Flurbiprofen (systemic): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/42/33440\">",
"           Flurbiprofen: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/23/4470\">",
"           Flutamide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/3/30773\">",
"           Fluticasone (nasal): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/32/26120\">",
"           Fluticasone (oral inhalation): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?43/19/44340\">",
"           Fluticasone (topical): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/33/26136\">",
"           Fluticasone and salmeterol: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/45/39632\">",
"           Fluticasone: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/4/8264\">",
"           Fluvastatin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/50/29481\">",
"           Fluvoxamine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/41/32403\">",
"           Folic acid, cyanocobalamin, and pyridoxine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/61/9174\">",
"           Folic acid: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/21/37205\">",
"           Follitropin alfa (recombinant human follicle stimulating hormone): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/52/5958\">",
"           Follitropin beta (recombinant human follicle stimulating hormone): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/3/2102\">",
"           Fomepizole: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/35/40503\">",
"           Fondaparinux: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/45/2774\">",
"           Formoterol and mometasone: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/61/22485\">",
"           Formoterol and mometasone: Pediatric drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/52/14151\">",
"           Formoterol: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?43/11/44217\">",
"           Fosamprenavir: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/20/6471\">",
"           Fosaprepitant (intravenous aprepitant): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/40/2695\">",
"           Fosaprepitant (intravenous aprepitant): Pediatric drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/56/29575\">",
"           Foscarnet: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/36/6724\">",
"           Fosfomycin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/15/28919\">",
"           Fosinopril and hydrochlorothiazide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/30/16872\">",
"           Fosinopril: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/51/14138\">",
"           Fosphenytoin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/10/24741\">",
"           Fospropofol: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/55/9077\">",
"           Frovatriptan: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/14/10466\">",
"           Fructose, dextrose, and orthophosphoric acid: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/54/4964\">",
"           Fulvestrant: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/21/2388\">",
"           Fulvestrant: Pediatric drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/52/28488\">",
"           Furosemide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?11/36/11843\">",
"           Fusidic acid and hydrocortisone: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/37/30291\">",
"           Fusidic acid and hydrocortisone: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/9/21651\">",
"           Fusidic acid: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/12/1222\">",
"           Gabapentin enacarbil: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/19/19768\">",
"           Gabapentin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/45/25301\">",
"           Gadobenate dimeglumine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/14/39141\">",
"           Gadobutrol: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/41/39573\">",
"           Gadodiamide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/49/29461\">",
"           Gadofosveset: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/45/24277\">",
"           Gadopentetate dimeglumine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/0/4097\">",
"           Gadoterate meglumine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/15/4341\">",
"           Gadoteridol: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/55/25461\">",
"           Gadoversetamide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/61/13269\">",
"           Gadoxetate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/27/6582\">",
"           Galantamine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/55/4978\">",
"           Gallium citrate Ga-67: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/1/38930\">",
"           Gallium citrate Ga-67: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/60/22467\">",
"           Gallium nitrate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/36/26181\">",
"           Galsulfase (recombinant human N-acetylgalactosamine-4 sulfatase): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/5/6228\">",
"           Ganciclovir (ophthalmic): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/3/24630\">",
"           Ganciclovir (systemic): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/30/33248\">",
"           Ganciclovir: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/25/30099\">",
"           Ganirelix: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/46/4836\">",
"           Gatifloxacin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/19/35123\">",
"           Gatifloxacin: Pediatric drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/12/19654\">",
"           Gefitinib: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/3/5169\">",
"           Gelatin, pectin, and methylcellulose: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/1/31769\">",
"           Gemcitabine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/42/43686\">",
"           Gemfibrozil: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?11/60/12231\">",
"           Gemifloxacin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/3/1078\">",
"           Gemtuzumab ozogamicin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/21/3412\">",
"           Gentamicin (ophthalmic): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/47/761\">",
"           Gentamicin (systemic): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/46/17123\">",
"           Gentamicin (topical): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/10/36000\">",
"           Gentamicin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/5/41042\">",
"           Gentian violet: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/3/16437\">",
"           Glatiramer acetate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/42/34470\">",
"           Gliclazide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/39/8823\">",
"           Glimepiride: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/37/39510\">",
"           Glipizide and metformin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/28/40391\">",
"           Glipizide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/32/25093\">",
"           Glucagon: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/27/7605\">",
"           Glucarpidase: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/43/8883\">",
"           Glucarpidase: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/35/35380\">",
"           Glucarpidase: Pediatric drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/9/27793\">",
"           Glucose polymers: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/3/19507\">",
"           Glutamine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/9/10391\">",
"           Glyburide and metformin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/6/29800\">",
"           Glyburide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/32/14852\">",
"           Glycerin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/8/2177\">",
"           Glycerol phenylbutyrate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?11/20/11591\">",
"           Glycopyrrolate (glycopyrronium): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/15/41204\">",
"           Gold sodium thiomalate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/24/35206\">",
"           Golimumab: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/31/9715\">",
"           Gonadorelin acetate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/22/9574\">",
"           Goserelin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/50/32550\">",
"           Granisetron: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/61/6102\">",
"           Griseofulvin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?43/15/44277\">",
"           Guaifenesin and codeine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/0/30726\">",
"           Guaifenesin and dextromethorphan: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/63/26612\">",
"           Guaifenesin and phenylephrine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/40/22148\">",
"           Guaifenesin and pseudoephedrine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?43/16/44292\">",
"           Guaifenesin, dextromethorphan, and phenylephrine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/24/41349\">",
"           Guaifenesin, pseudoephedrine, and codeine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/4/2117\">",
"           Guaifenesin, pseudoephedrine, and dextromethorphan: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/46/16101\">",
"           Guaifenesin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/17/32023\">",
"           Guanfacine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/5/31826\">",
"           Guanidine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/35/16949\">",
"           Haemophilus influenzae type b conjugate and hepatitis B vaccine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/14/230\">",
"           Haemophilus influenzae type b conjugate vaccine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/21/41300\">",
"           Haemophilus influenzae type b-meningococcal serogroups CY combination vaccine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/29/40404\">",
"           Haemophilus influenzae type b-meningococcal serogroups CY combination vaccine: Pediatric drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/45/15060\">",
"           Halcinonide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/44/9925\">",
"           Halobetasol: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/50/32553\">",
"           Haloperidol: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/39/21107\">",
"           Hemin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/34/40489\">",
"           Heparin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?43/30/44518\">",
"           Hepatitis A vaccine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/39/43637\">",
"           Hepatitis A virus and recombinant hepatitis B virus vaccine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/49/28437\">",
"           Hepatitis B immune globulin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/36/27207\">",
"           Hepatitis B vaccine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/13/9430\">",
"           Hetastarch: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/62/33763\">",
"           Hexachlorophene: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/11/9395\">",
"           Hexaminolevulinate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/63/38897\">",
"           Hexylresorcinol: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/60/19397\">",
"           Histrelin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/57/917\">",
"           Histrelin: Pediatric drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/43/35508\">",
"           Homatropine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/60/26564\">",
"           Human chorionic gonadotropin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/46/40677\">",
"           Human papillomavirus bivalent (types 16, 18) recombinant vaccine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/35/43574\">",
"           Human papillomavirus quadrivalent (types 6, 11, 16, 18) recombinant vaccine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/43/1719\">",
"           Hyaluronate derivatives: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/33/42512\">",
"           Hyaluronidase: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/57/15254\">",
"           Hydralazine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/58/22438\">",
"           Hydrochlorothiazide and spironolactone: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/41/34454\">",
"           Hydrochlorothiazide and triamterene: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/4/8263\">",
"           Hydrochlorothiazide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/51/43832\">",
"           Hydrocodone and acetaminophen: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/1/6167\">",
"           Hydrocodone and chlorpheniramine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/33/34326\">",
"           Hydrocodone and homatropine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/2/8233\">",
"           Hydrocodone and ibuprofen: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/7/114\">",
"           Hydrocodone and phenyltoloxamine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/22/23910\">",
"           Hydrocodone and pseudoephedrine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/20/4421\">",
"           Hydrocodone and pseudoephedrine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/62/8167\">",
"           Hydrocodone, chlorpheniramine, and pseudoephedrine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?11/48/12037\">",
"           Hydrocodone, chlorpheniramine, and pseudoephedrine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/48/8969\">",
"           Hydrocortisone (systemic): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/54/21352\">",
"           Hydrocortisone (topical): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/49/32528\">",
"           Hydrocortisone: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/48/25353\">",
"           Hydromorphone: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/59/36788\">",
"           Hydroquinone: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/46/43749\">",
"           Hydroxocobalamin (vitamin B12 supplement and cyanide antidote ): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/23/36210\">",
"           Hydroxyamphetamine and tropicamide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/26/2471\">",
"           Hydroxychloroquine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/60/30661\">",
"           Hydroxyethyl starch (tetrastarch) 130/0.4: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/60/42948\">",
"           Hydroxyprogesterone caproate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/22/20836\">",
"           Hydroxyprogesterone caproate: Pediatric drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/1/29714\">",
"           Hydroxypropyl cellulose: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/35/43570\">",
"           Hydroxypropyl methylcellulose: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/16/16648\">",
"           Hydroxyurea: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/24/391\">",
"           Hydroxyzine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/39/39541\">",
"           Hyoscyamine, atropine, scopolamine, and phenobarbital: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/9/29846\">",
"           Hyoscyamine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/8/12423\">",
"           Ibandronate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/30/40422\">",
"           Ibritumomab: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/63/30709\">",
"           Ibuprofen and diphenhydramine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/41/17045\">",
"           Ibuprofen and diphenhydramine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/35/23096\">",
"           Ibuprofen and famotidine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/40/10888\">",
"           Ibuprofen, pseudoephedrine, and chlorpheniramine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/38/15978\">",
"           Ibuprofen: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/32/13829\">",
"           Ibutilide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/36/4675\">",
"           Icatibant: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/32/34307\">",
"           Icatibant: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?43/36/44612\">",
"           Icodextrin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/26/8612\">",
"           Icosapent ethyl (E-EPA): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/58/11172\">",
"           Icosapent ethyl (E-EPA): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/43/40630\">",
"           Idarubicin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/29/36307\">",
"           Idursulfase: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/25/38297\">",
"           Ifosfamide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/59/35767\">",
"           Iloperidone: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/53/37716\">",
"           Iloprost: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?17/1/17434\">",
"           Imatinib: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/8/27780\">",
"           Imiglucerase (glucocerebrosidase): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/36/38472\">",
"           Imipenem and cilastatin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/41/41624\">",
"           Imipramine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/59/20406\">",
"           Imiquimod: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/23/1402\">",
"           Immune globulin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/55/15226\">",
"           Immune globulin: Pediatric drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/48/43781\">",
"           IncobotulinumtoxinA (botulinum toxin type A, Xeomin): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/59/26549\">",
"           Indacaterol: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/43/4790\">",
"           Indacaterol: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/0/35846\">",
"           Indapamide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/10/15522\">",
"           Indigo carmine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/36/25161\">",
"           Indinavir: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/40/13955\">",
"           Indium In-111 oxyquinoline: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/6/37986\">",
"           Indium In-111 oxyquinoline: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/19/32050\">",
"           Indium In-111 pentetreotide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/33/15891\">",
"           Indium In-111 pentetreotide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/44/32450\">",
"           Indocyanine green: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/50/36649\">",
"           Indomethacin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/6/28776\">",
"           Infliximab: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/61/985\">",
"           Influenza virus vaccine (inactivated): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/54/19303\">",
"           Influenza virus vaccine (live attenuated): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/35/38451\">",
"           Ingenol mebutate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/23/16756\">",
"           Ingenol mebutate: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/34/8739\">",
"           Inosine pranobex: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/31/42483\">",
"           Inosine pranobex: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/51/40754\">",
"           Insect sting kit: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/40/13958\">",
"           Instant glucose and intravenous dextrose: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/36/3655\">",
"           Insulin aspart protamine and insulin aspart: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/42/10920\">",
"           Insulin aspart: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/49/25367\">",
"           Insulin detemir: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/30/34279\">",
"           Insulin glargine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/9/1176\">",
"           Insulin glulisine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/16/12551\">",
"           Insulin lispro protamine and insulin lispro: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/48/17160\">",
"           Insulin lispro: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/26/18855\">",
"           Insulin NPH and insulin regular: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/7/10359\">",
"           Insulin NPH: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/45/8922\">",
"           Insulin regular: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/56/29576\">",
"           Interferon alfa-2b: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/15/24822\">",
"           Interferon alfacon-1 (consensus interferon): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/27/38323\">",
"           Interferon alfa-n3: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/10/8358\">",
"           Interferon beta-1a: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/13/16597\">",
"           Interferon beta-1b: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/53/20308\">",
"           Interferon gamma-1b: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/13/21715\">",
"           Intravenous copper: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/26/30115\">",
"           Intravenous copper: Pediatric drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/23/32117\">",
"           Iobenguane: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/59/7090\">",
"           Iodinated I-131 albumin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/25/2451\">",
"           Iodinated I-131 albumin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/19/10548\">",
"           Iodine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/3/24627\">",
"           Iodipamide meglumine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/63/13301\">",
"           Iodixanol: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/53/24403\">",
"           Iodoquinol and hydrocortisone: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/38/21091\">",
"           Iodoquinol: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/4/21572\">",
"           Ioflupane I-123: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/9/40083\">",
"           Ioflupane I-123: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/14/30949\">",
"           Iohexol: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/45/36565\">",
"           Iopamidol: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/46/17126\">",
"           Iopromide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/25/4499\">",
"           Iothalamate meglumine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/57/34709\">",
"           Ioversol: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/16/40194\">",
"           Ioxaglate meglumine and ioxaglate sodium: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/41/31380\">",
"           Ioxilan: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/52/19270\">",
"           Ipilimumab: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/7/21620\">",
"           Ipratropium (nasal): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/39/36469\">",
"           Ipratropium (oral inhalation): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/51/28469\">",
"           Ipratropium and albuterol: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/37/33360\">",
"           Ipratropium: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/19/20791\">",
"           Irbesartan and hydrochlorothiazide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/37/21079\">",
"           Irbesartan: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/41/7834\">",
"           Irinotecan: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/46/21222\">",
"           Iron dextran: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/31/41461\">",
"           Iron sucrose: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/15/8439\">",
"           Isocarboxazid: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/63/17397\">",
"           Isoflurane: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/21/40279\">",
"           Isoniazid: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/31/23029\">",
"           Isoproterenol: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/11/41141\">",
"           Isosorbide dinitrate and hydralazine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/22/36198\">",
"           Isosorbide dinitrate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/24/19846\">",
"           Isosorbide mononitrate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/26/420\">",
"           Isosulfan blue: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/62/1000\">",
"           Isotretinoin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/36/10819\">",
"           Isoxsuprine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/56/903\">",
"           Isradipine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/15/20730\">",
"           Itraconazole: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/58/22437\">",
"           Ivacaftor: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/1/30740\">",
"           Ivacaftor: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/43/8885\">",
"           Ivacaftor: Pediatric drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/42/40613\">",
"           Ivermectin (systemic): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/43/12980\">",
"           Ivermectin (systemic): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/49/33557\">",
"           Ivermectin (systemic): Pediatric drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/16/1283\">",
"           Ivermectin (topical): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/34/9764\">",
"           Ivermectin (topical): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/53/37714\">",
"           Ivermectin (topical): Pediatric drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/13/32976\">",
"           Ivermectin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/11/10423\">",
"           Ixabepilone: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/38/40549\">",
"           Japanese encephalitis virus vaccine (inactivated): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/10/40102\">",
"           Kanamycin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/45/10967\">",
"           Ketamine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/58/28585\">",
"           Ketoconazole (systemic): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/38/38500\">",
"           Ketoconazole (topical): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/34/33312\">",
"           Ketoconazole: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/36/43592\">",
"           Ketoprofen: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/48/4872\">",
"           Ketorolac (nasal): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/32/35332\">",
"           Ketorolac (ophthalmic): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/1/21529\">",
"           Ketorolac (systemic): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/62/35808\">",
"           Ketorolac: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?43/26/44453\">",
"           Ketotifen (ophthalmic): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/1/3092\">",
"           Ketotifen (ophthalmic): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/53/25428\">",
"           Ketotifen (ophthalmic): Pediatric drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/29/39379\">",
"           Ketotifen (systemic): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/16/33024\">",
"           Ketotifen: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/44/35520\">",
"           Ketotifen: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/45/35544\">",
"           Labetalol: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/19/35125\">",
"           Lacosamide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/62/33765\">",
"           Lacosamide: Pediatric drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/62/14306\">",
"           Lactase: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/48/29442\">",
"           Lactic acid and sodium-PCA: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/39/19059\">",
"           Lactic acid with ammonium hydroxide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/16/32004\">",
"           Lactobacillus: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/34/33316\">",
"           Lactulose: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/7/38007\">",
"           Lamivudine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/28/6602\">",
"           Lamotrigine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/32/2562\">",
"           Lanolin, cetyl alcohol, glycerin, and petrolatum: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/34/7717\">",
"           Lanreotide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/27/33209\">",
"           Lansoprazole, amoxicillin, and clarithromycin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/14/3305\">",
"           Lansoprazole: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/37/28244\">",
"           Lanthanum carbonate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/23/9592\">",
"           Lapatinib: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?11/43/11957\">",
"           Laronidase: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/39/23158\">",
"           Latanoprost and timolol: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/42/41635\">",
"           Latanoprost: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/16/21766\">",
"           L-carnitine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/36/19015\">",
"           Leflunomide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/25/16793\">",
"           Lenalidomide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/45/4823\">",
"           Lepirudin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/26/36261\">",
"           Letrozole: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/54/24423\">",
"           Leucovorin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/27/29110\">",
"           Leuprolide and norethindrone: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/41/4760\">",
"           Leuprolide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/27/43445\">",
"           Levalbuterol: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/52/43847\">",
"           Levetiracetam: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/55/28533\">",
"           Levobunolol: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/49/6932\">",
"           Levocabastine (nasal): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/42/22179\">",
"           Levocabastine (ophthalmic): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/56/33664\">",
"           Levocabastine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/58/38816\">",
"           Levocabastine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?43/45/44757\">",
"           Levocetirizine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/30/486\">",
"           Levodopa-benserazide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/11/37043\">",
"           Levofloxacin (ophthalmic): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/8/16521\">",
"           Levofloxacin (systemic): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/46/33504\">",
"           Levofloxacin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/63/14326\">",
"           LEVOleucovorin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/47/25336\">",
"           Levonorgestrel: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/22/29029\">",
"           Levorphanol: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/43/41656\">",
"           Levothyroxine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/30/4579\">",
"           Lidocaine (ophthalmic): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/54/14184\">",
"           Lidocaine (systemic): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/3/20535\">",
"           Lidocaine (topical): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/46/26339\">",
"           Lidocaine and chlorhexidine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?17/38/18019\">",
"           Lidocaine and chlorhexidine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/52/29510\">",
"           Lidocaine and epinephrine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/14/34020\">",
"           Lidocaine and hydrocortisone: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/25/32150\">",
"           Lidocaine and prilocaine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/57/43924\">",
"           Lidocaine and tetracaine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/34/35360\">",
"           Lidocaine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/17/20755\">",
"           Linaclotide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/37/27222\">",
"           Linagliptin and Metformin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/22/36197\">",
"           Linagliptin and Metformin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/21/35157\">",
"           Linagliptin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/24/43396\">",
"           Lincomycin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/34/37412\">",
"           Lindane: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/3/14393\">",
"           Linezolid: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/51/1846\">",
"           Liothyronine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/0/38917\">",
"           Liotrix: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/38/22118\">",
"           Liotrix: Pediatric drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/4/1096\">",
"           Liposomal amphotericin B: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/52/27460\">",
"           Liposomal bupivacaine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/26/18851\">",
"           Liposomal bupivacaine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/53/34645\">",
"           Liposomal cytarabine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/53/9046\">",
"           Liposomal daunorubicin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/13/10458\">",
"           Liposomal doxorubicin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/16/18694\">",
"           Liposomal morphine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/2/8231\">",
"           Liposomal vincristine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/1/33812\">",
"           Liposomal vincristine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/47/21238\">",
"           Liraglutide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/53/23382\">",
"           Lisdexamfetamine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/60/23495\">",
"           Lisinopril and hydrochlorothiazide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/58/937\">",
"           Lisinopril: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/11/23736\">",
"           Lithium: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/37/42577\">",
"           L-Lysine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/27/5555\">",
"           Lodoxamide tromethamine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/35/23095\">",
"           Lomitapide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/6/16485\">",
"           Lomitapide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/27/37302\">",
"           Lomustine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/15/16627\">",
"           Loperamide and simethicone: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/53/16214\">",
"           Loperamide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/57/20378\">",
"           Lopinavir and ritonavir: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/43/41653\">",
"           Loratadine and pseudoephedrine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/39/7799\">",
"           Loratadine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/8/8329\">",
"           Lorazepam: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/59/30646\">",
"           Lorcaserin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/47/7925\">",
"           Lorcaserin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/37/33367\">",
"           Losartan and hydrochlorothiazide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/35/26168\">",
"           Losartan: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/30/24035\">",
"           Loteprednol and tobramycin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/48/39684\">",
"           Loteprednol: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?43/1/44055\">",
"           Lovastatin and niacin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/20/42312\">",
"           Lovastatin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/2/27687\">",
"           Loxapine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/28/38339\">",
"           Lubiprostone: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/17/4371\">",
"           Lucinactant: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/2/2083\">",
"           Lucinactant: Pediatric drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/1/15383\">",
"           Lurasidone: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/49/32531\">",
"           Lutropin alfa: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/2/36899\">",
"           Mafenide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?43/39/44660\">",
"           Magaldrate and simethicone: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/33/38421\">",
"           Magnesium carbonate, calcium carbonate, and folic acid: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/22/24933\">",
"           Magnesium chloride: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/14/39140\">",
"           Magnesium citrate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/20/16708\">",
"           Magnesium glucoheptonate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/10/34980\">",
"           Magnesium gluconate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/2/13350\">",
"           Magnesium hydroxide and mineral oil emulsion: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/6/31847\">",
"           Magnesium hydroxide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/12/30916\">",
"           Magnesium L-aspartate hydrochloride: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?11/22/11620\">",
"           Magnesium L-lactate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/32/28165\">",
"           Magnesium oxide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/37/14932\">",
"           Magnesium salicylate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/25/27031\">",
"           Magnesium sulfate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/21/12627\">",
"           Malathion: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/23/10611\">",
"           Malathion: Pediatric drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/61/38865\">",
"           Maltodextrin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/31/38387\">",
"           Manganese: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/42/3752\">",
"           Mannitol: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/18/16678\">",
"           Maprotiline: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/45/20182\">",
"           Maraviroc: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/14/9442\">",
"           m-Cresyl acetate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/0/14343\">",
"           Measles, mumps, and rubella vaccines (combined): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/41/29334\">",
"           Measles, mumps, rubella, and varicella virus vaccine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/42/12965\">",
"           Mebendazole: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/55/22388\">",
"           Mecasermin (recombinant human insulin-like growth factor I): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/26/12708\">",
"           Mecasermin (recombinant human insulin-like growth factor I): Pediatric drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/57/40853\">",
"           Mechlorethamine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/17/37141\">",
"           Meclizine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/10/21672\">",
"           Meclofenamate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/51/19250\">",
"           Medium chain triglycerides: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/24/1417\">",
"           Medroxyprogesterone acetate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/63/41976\">",
"           Mefenamic acid: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?17/21/17751\">",
"           Mefloquine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/55/33653\">",
"           Megestrol acetate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/38/35432\">",
"           Meloxicam: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/54/22376\">",
"           Melphalan: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/16/24837\">",
"           Memantine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/3/38965\">",
"           Meningococcal polysaccharide vaccine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/28/37316\">",
"           Meningococcal serogroup C conjugate vaccine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/17/12565\">",
"           Menotropins: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?43/43/44722\">",
"           Menthol and zinc oxide (topical): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/39/9844\">",
"           Mepenzolate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?11/44/11976\">",
"           Meperidine (pethidine): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/16/27907\">",
"           Mepivacaine (dental): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/33/25109\">",
"           Mepivacaine and levonordefrin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/55/40821\">",
"           Mepivacaine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/43/19125\">",
"           Meprobamate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/43/37559\">",
"           Mercaptopurine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/38/32359\">",
"           Meropenem: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/44/22215\">",
"           Mesalamine (mesalazine): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/0/41989\">",
"           Mesna: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/45/13017\">",
"           Mestranol and norethindrone: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/22/19812\">",
"           Metaproterenol: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/61/41940\">",
"           Metaxalone: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/48/7944\">",
"           Metformin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/32/10756\">",
"           Methacholine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/57/36761\">",
"           Methadone: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/25/42390\">",
"           Methamphetamine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/6/29798\">",
"           Methamphetamine: Pediatric drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/43/41652\">",
"           Methazolamide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/14/31971\">",
"           Methenamine and sodium acid phosphate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/0/15366\">",
"           Methenamine, phenyl salicylate, methylene blue, benzoic acid, and hyoscyamine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/60/22470\">",
"           Methenamine, sodium biphosphate, phenyl salicylate, methylene blue, and hyoscyamine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/57/3989\">",
"           Methenamine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/39/19062\">",
"           Methimazole: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/6/24677\">",
"           Methocarbamol: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/15/24823\">",
"           Methohexital: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/38/24170\">",
"           Methotrexate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/27/4535\">",
"           Methotrimeprazine (levomepromazine): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/59/37813\">",
"           Methoxsalen (systemic): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/19/21811\">",
"           Methoxsalen (topical): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/23/33136\">",
"           Methoxsalen: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/45/17108\">",
"           Methscopolamine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/54/43876\">",
"           Methsuximide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/36/16965\">",
"           Methyclothiazide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/7/35955\">",
"           Methyl aminolevulinate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/26/21923\">",
"           Methyl salicylate and menthol: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/28/29123\">",
"           Methylcellulose: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/52/14150\">",
"           Methyldopa and hydrochlorothiazide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/15/28918\">",
"           Methyldopa: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/7/1143\">",
"           Methylene blue: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/50/32549\">",
"           Methylergonovine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/18/1314\">",
"           Methylfolate, methylcobalamin, and acetylcysteine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/5/32850\">",
"           Methylfolate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/29/2516\">",
"           Methylnaltrexone: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/60/39881\">",
"           Methylphenidate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/25/31129\">",
"           Methylprednisolone: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/36/3652\">",
"           Methyltestosterone: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/60/30660\">",
"           Metipranolol: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/13/216\">",
"           Metoclopramide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/32/1542\">",
"           Metolazone: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/27/31159\">",
"           Metoprolol and hydrochlorothiazide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/31/39417\">",
"           Metoprolol: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/7/34936\">",
"           Metronidazole (systemic): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/25/13717\">",
"           Metronidazole (topical): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/16/30979\">",
"           Metronidazole and nystatin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/38/20065\">",
"           Metronidazole: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/12/15556\">",
"           Metyrapone: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/25/2452\">",
"           Metyrosine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/9/10389\">",
"           Mexiletine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?43/31/44532\">",
"           Micafungin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/50/23334\">",
"           Miconazole (topical): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/27/4533\">",
"           Miconazole (topical): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/3/33844\">",
"           Miconazole (topical): Pediatric drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/19/27954\">",
"           Miconazole and zinc oxide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/60/4042\">",
"           Midazolam: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/35/2613\">",
"           Midodrine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/45/1753\">",
"           Mifepristone: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/0/3077\">",
"           Miglitol: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/13/24788\">",
"           Miglustat: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/32/36358\">",
"           Milnacipran: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/18/3366\">",
"           Milrinone: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/0/13316\">",
"           Mineral oil: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/43/43698\">",
"           Minocycline hydrochloride periodontal microspheres: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/10/3240\">",
"           Minocycline: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?11/38/11877\">",
"           Minoxidil (systemic): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/47/27379\">",
"           Minoxidil (topical): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/5/32848\">",
"           Minoxidil: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/25/16789\">",
"           Mipomersen: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/12/3269\">",
"           Mipomersen: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/60/5061\">",
"           Mirabegron: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/2/42019\">",
"           Mirabegron: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/41/32408\">",
"           Mirtazapine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/41/662\">",
"           Misoprostol: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/33/532\">",
"           Mitomycin (ophthalmic): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/62/14307\">",
"           Mitomycin (ophthalmic): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/32/28166\">",
"           Mitomycin (systemic): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/33/10773\">",
"           Mitomycin (systemic): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/16/38144\">",
"           Mitomycin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/58/16293\">",
"           Mitotane: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/31/37368\">",
"           Mitoxantrone: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/5/18518\">",
"           Moclobemide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/8/1159\">",
"           Modafinil: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/25/16791\">",
"           Moexipril and hydrochlorothiazide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/53/1880\">",
"           Moexipril: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/23/38261\">",
"           Mometasone (nasal): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/11/34998\">",
"           Mometasone (oral inhalation): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/46/43748\">",
"           Mometasone (topical): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/15/36080\">",
"           Mometasone: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/40/21122\">",
"           Monobenzone: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/49/37654\">",
"           Montelukast: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/31/19962\">",
"           Morphine sulfate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/10/18595\">",
"           Moxifloxacin (ophthalmic): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/50/5924\">",
"           Moxifloxacin (ophthalmic): Pediatric drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/29/21976\">",
"           Moxifloxacin (systemic): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/51/33584\">",
"           Moxifloxacin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?11/41/11923\">",
"           Mucosal barrier gel: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/11/31923\">",
"           Mucosal barrier gel: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/52/26434\">",
"           Multiple vitamins (injectable): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/3/6195\">",
"           Multiple vitamins (pediatric): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/26/4516\">",
"           Multiple vitamins (prenatal): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/10/19619\">",
"           Multiple vitamins: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/30/33252\">",
"           Mupirocin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/29/4569\">",
"           Mycophenolate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/63/6133\">",
"           Nabilone: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/44/15046\">",
"           Nabiximols: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/18/39208\">",
"           Nabumetone: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/8/36998\">",
"           Nadolol and bendroflumethiazide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/15/35063\">",
"           Nadolol: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/41/27286\">",
"           Nadroparin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/61/26580\">",
"           Nafarelin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/36/1608\">",
"           Nafcillin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/28/8643\">",
"           Naftifine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/45/14038\">",
"           Nalbuphine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/24/35207\">",
"           Naloxone: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/16/39173\">",
"           Naltrexone: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/53/29523\">",
"           Naphazoline (nasal): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/60/15300\">",
"           Naphazoline (ophthalmic): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/31/32243\">",
"           Naphazoline and pheniramine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/24/33152\">",
"           Naphazoline: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?17/62/18407\">",
"           Naproxen and pseudoephedrine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/43/43705\">",
"           Naproxen: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/9/6293\">",
"           Naratriptan: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/15/1271\">",
"           Natalizumab: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/39/43634\">",
"           Natamycin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?11/21/11606\">",
"           Nateglinide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/34/32295\">",
"           Nebivolol: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/43/691\">",
"           Nedocromil: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/0/2057\">",
"           Nefazodone: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/45/21206\">",
"           Nelarabine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/62/19433\">",
"           Nelfinavir: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/7/9332\">",
"           Neomycin and polymyxin B: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/39/38514\">",
"           Neomycin, colistin, hydrocortisone, and thonzonium: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/31/34291\">",
"           Neomycin, polymyxin B, and dexamethasone: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/58/34723\">",
"           Neomycin, polymyxin B, and gramicidin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/42/24228\">",
"           Neomycin, polymyxin B, and hydrocortisone: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/57/14229\">",
"           Neomycin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/41/10901\">",
"           Neostigmine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/3/39987\">",
"           Nepafenac: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/16/33029\">",
"           Nesiritide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/12/18633\">",
"           Nevirapine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/42/35495\">",
"           Niacin and simvastatin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/61/42969\">",
"           Nicardipine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/27/38322\">",
"           Nicotinamide (niacinamide): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/4/34887\">",
"           Nicotine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/5/12377\">",
"           Nifedipine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/1/29720\">",
"           Nilotinib: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/27/33204\">",
"           Nilutamide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/20/16710\">",
"           Nimodipine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/49/22295\">",
"           Nisoldipine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/24/5508\">",
"           Nitazoxanide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/43/24244\">",
"           Nitisinone: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/42/21158\">",
"           Nitrazepam: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/15/22772\">",
"           Nitric oxide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/22/25958\">",
"           Nitrofurantoin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?11/24/11656\">",
"           Nitroglycerin (glyceryl trinitrate): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/51/21302\">",
"           Nitroprusside: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?11/29/11732\">",
"           Nitrous oxide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/16/29958\">",
"           Nizatidine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/17/37139\">",
"           Nonoxynol 9: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/28/16838\">",
"           Norepinephrine (noradrenaline): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/52/16199\">",
"           Norethindrone: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/9/16536\">",
"           Norfloxacin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/57/34708\">",
"           North American coral snake (Micrurus fulvius) antivenom: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/21/30040\">",
"           Nortriptyline: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/46/38625\">",
"           Nylidrin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?11/17/11539\">",
"           Nystatin (oral): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/39/14963\">",
"           Nystatin (topical): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/37/26195\">",
"           Nystatin and triamcinolone: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/53/32592\">",
"           Nystatin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/32/27139\">",
"           Ocriplasmin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/24/4483\">",
"           Ocriplasmin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/7/43128\">",
"           Octreotide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/13/35029\">",
"           Ofatumumab: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/2/31780\">",
"           Ofloxacin (ophthalmic): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/30/484\">",
"           Ofloxacin (otic): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/41/1688\">",
"           Ofloxacin (systemic): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/60/35776\">",
"           Ofloxacin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/13/30937\">",
"           Olanzapine and fluoxetine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/36/37449\">",
"           Olanzapine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/63/6135\">",
"           Olmesartan and hydrochlorothiazide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/24/8583\">",
"           Olmesartan: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/41/32404\">",
"           Olopatadine (nasal): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/43/20147\">",
"           Olopatadine (ophthalmic): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/25/33168\">",
"           Olopatadine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/3/43059\">",
"           Olsalazine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/13/13526\">",
"           Omacetaxine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/11/20660\">",
"           Omacetaxine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/46/38629\">",
"           Omalizumab: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/46/21221\">",
"           Omega-3-acid ethyl esters (fish oil): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/28/10697\">",
"           Omeprazole and sodium bicarbonate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/52/33609\">",
"           Omeprazole, clarithromycin, and amoxicillin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/51/33588\">",
"           Omeprazole, clarithromycin, and amoxicillin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/62/26601\">",
"           Omeprazole: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/27/10681\">",
"           OnabotulinumtoxinA (botulinum toxin type A, Botox): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/2/21544\">",
"           Ondansetron: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/58/34724\">",
"           Oprelvekin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/32/5638\">",
"           Orlistat: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/36/36422\">",
"           Orphenadrine, aspirin, and caffeine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/11/36021\">",
"           Orphenadrine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/20/40263\">",
"           Oseltamivir: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/33/4629\">",
"           Ospemifene: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/58/25508\">",
"           Ospemifene: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/8/26757\">",
"           Ovine polyvalent crotalidae North and South American snake antivenom: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/24/19845\">",
"           Ovine polyvalent crotalidae North and South American snake antivenom: Pediatric drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/15/8437\">",
"           Oxacillin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/11/2233\">",
"           Oxaliplatin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/28/39364\">",
"           Oxandrolone: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/58/30632\">",
"           Oxaprozin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/50/10022\">",
"           Oxazepam: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/25/40344\">",
"           Oxcarbazepine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/41/7827\">",
"           Oxiconazole: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/54/36706\">",
"           Oxidized regnerated cellulose: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/59/10167\">",
"           Oxybutynin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/18/33057\">",
"           Oxychlorosene: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/51/9016\">",
"           Oxycodone and acetaminophen: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/13/38103\">",
"           Oxycodone and aspirin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/52/26440\">",
"           Oxycodone and ibuprofen: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/34/10792\">",
"           Oxycodone: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/10/38049\">",
"           Oxygen: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/14/13541\">",
"           Oxymetazoline (nasal): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/46/9955\">",
"           Oxymetazoline (ophthalmic): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/54/33632\">",
"           Oxymetazoline: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/39/10868\">",
"           Oxymetholone: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/8/32903\">",
"           Oxymorphone: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/0/5125\">",
"           Oxytocin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/29/8664\">",
"           Paclitaxel (nanoparticle albumin bound): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/58/17320\">",
"           Paclitaxel: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/15/36084\">",
"           Palifermin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?43/43/44728\">",
"           Paliperidone: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/51/36663\">",
"           Paliperidone: Pediatric drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/27/40371\">",
"           Palivizumab: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/18/34085\">",
"           Palonosetron: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/50/21282\">",
"           Pamabrom: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/62/3048\">",
"           Pamidronate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/46/743\">",
"           Pancrelipase: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/33/19990\">",
"           Pancuronium: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/48/6918\">",
"           Panitumumab: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/16/32009\">",
"           Pantoprazole: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/2/37923\">",
"           Papaverine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/50/15141\">",
"           Para-aminosalicylic acid: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/35/24117\">",
"           Paraldehyde: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/32/20997\">",
"           Paregoric: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/0/32774\">",
"           Paricalcitol: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/46/16099\">",
"           Paromomycin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/50/15146\">",
"           Paroxetine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/21/27989\">",
"           Pasireotide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/20/41285\">",
"           Pasireotide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/2/1064\">",
"           Pazopanib: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/9/12435\">",
"           Pegademase bovine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/54/42851\">",
"           Pegaptanib: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/9/42133\">",
"           Pegaspargase: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/28/12741\">",
"           Pegfilgrastim: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/31/26102\">",
"           Peginesatide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/14/22757\">",
"           Peginesatide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/38/41572\">",
"           Pegloticase: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/23/24948\">",
"           Pegvisomant: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/15/1272\">",
"           Pegylated interferon (peginterferon) alfa-2a and ribavirin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/27/27064\">",
"           Pegylated interferon (peginterferon) alfa-2a: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/61/8152\">",
"           Pegylated interferon (peginterferon) alfa-2a: Pediatric drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/8/37000\">",
"           Pegylated interferon (peginterferon) alfa-2b and ribavirin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/36/24137\">",
"           Pegylated interferon (peginterferon) alfa-2b: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/27/36279\">",
"           Pemetrexed: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/46/15078\">",
"           Penbutolol: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/23/12659\">",
"           Penciclovir: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/6/4200\">",
"           Penicillamine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/42/22183\">",
"           Penicillin G (parenteral): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/38/25188\">",
"           Penicillin G benzathine and penicillin G procaine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?11/50/12070\">",
"           Penicillin G benzathine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/23/12661\">",
"           Penicillin G procaine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/46/23269\">",
"           Penicillin V potassium: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/56/17285\">",
"           Penicilloyl-polylysine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/15/1267\">",
"           Pentafluoropropane and tetrafluoroethane: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/43/22199\">",
"           Pentamidine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/27/14772\">",
"           Pentastarch: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/42/37542\">",
"           Pentazocine and acetaminophen: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/63/32757\">",
"           Pentazocine and naloxone: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/48/29446\">",
"           Pentazocine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/19/5426\">",
"           Pentetate indium disodium In-111: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/62/19427\">",
"           Pentetate indium disodium In-111: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/31/4601\">",
"           Pentobarbital: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/39/36467\">",
"           Pentosan polysulfate sodium: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/9/40086\">",
"           Pentostatin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/28/13765\">",
"           Pentoxifylline: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/18/7462\">",
"           Perampanel: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/4/20549\">",
"           Perampanel: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?17/40/18052\">",
"           Perflutren lipid microspheres: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/23/35187\">",
"           Perflutren protein type A: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?11/12/11462\">",
"           Pericyazine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/24/34183\">",
"           Perindopril and indapamide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/32/22024\">",
"           Perindopril: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/22/28004\">",
"           Permethrin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/49/19223\">",
"           Perphenazine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/61/25557\">",
"           Pertuzumab: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/44/36548\">",
"           Pertuzumab: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/7/41075\">",
"           Phenazopyridine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/13/8406\">",
"           Phendimetrazine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/42/20135\">",
"           Phenelzine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/40/29321\">",
"           Phenobarbital: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/14/27875\">",
"           Phenol: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/0/38916\">",
"           Phenoxybenzamine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/46/10983\">",
"           Phentermine and topiramate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/17/25877\">",
"           Phentermine and topiramate: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/32/26118\">",
"           Phentermine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/43/34485\">",
"           Phentolamine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/7/19572\">",
"           Phenylephrine (nasal): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/7/23668\">",
"           Phenylephrine (ophthalmic): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/47/6903\">",
"           Phenylephrine (systemic): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/53/30547\">",
"           Phenylephrine (topical): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/1/35859\">",
"           Phenylephrine and pyrilamine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/10/4258\">",
"           Phenylephrine and zinc sulfate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/44/43715\">",
"           Phenylephrine, pyrilamine, and dextromethorphan: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/36/39488\">",
"           Phenylephrine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/48/35594\">",
"           Phenytoin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/27/40372\">",
"           Physostigmine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/28/4548\">",
"           Pilocarpine (ophthalmic): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/55/33652\">",
"           Pilocarpine (systemic): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/36/33344\">",
"           Pilocarpine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/41/29332\">",
"           Pimecrolimus: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/20/6472\">",
"           Pimozide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/17/41234\">",
"           Pinaverium: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/21/7511\">",
"           Pindolol and hydrochlorothiazide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/15/10487\">",
"           Pindolol: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/23/34167\">",
"           Pioglitazone and glimepiride: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/56/25479\">",
"           Pioglitazone and metformin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/28/43463\">",
"           Pioglitazone: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/41/24216\">",
"           Piperacillin and tazobactam sodium: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/13/35030\">",
"           Piperacillin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/44/36550\">",
"           Pipotiazine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/57/20372\">",
"           Pirbuterol: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/26/31141\">",
"           Pirfenidone: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/2/34852\">",
"           Pirfenidone: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/25/9625\">",
"           Piroxicam: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/56/9095\">",
"           Pitavastatin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/15/40181\">",
"           Pizotifen: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/20/28994\">",
"           Plasma protein fraction: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/12/27844\">",
"           Plerixafor: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/52/3909\">",
"           Pneumococcal conjugate vaccine (10-valent): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/56/39814\">",
"           Pneumococcal conjugate vaccine (13-valent): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/8/12422\">",
"           Pneumococcal polysaccharide vaccine (23-valent): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/34/23074\">",
"           Podofilox: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/8/30851\">",
"           Podophyllum resin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/6/110\">",
"           Polidocanol: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/58/35749\">",
"           Poliovirus vaccine (inactivated): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/61/29651\">",
"           Polycarbophil: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?11/36/11844\">",
"           Polycarbophil: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/19/23860\">",
"           Polyethylene glycol 3350: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/27/2484\">",
"           Polyethylene glycol electrolyte solution and bisacodyl: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/52/43840\">",
"           Polyethylene glycol electrolyte solution and sulfate solution kit: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/17/4374\">",
"           Polyethylene glycol electrolyte solution: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/21/13651\">",
"           Poly-L-lactic acid: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?17/20/17733\">",
"           Polymyxin B: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/3/19508\">",
"           Polysaccharide-iron complex and folic acid: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/25/39316\">",
"           Polysaccharide-iron complex and folic acid: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/44/26308\">",
"           Polysaccharide-iron complex, vitamin B12, and folic acid: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/56/29572\">",
"           Polysaccharide-iron complex: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/33/33303\">",
"           Pomalidomide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/5/42069\">",
"           Pomalidomide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/55/2935\">",
"           Ponatinib: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/7/2166\">",
"           Ponatinib: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/13/25811\">",
"           Poractant alfa: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/15/39157\">",
"           Porfimer: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/60/33737\">",
"           Posaconazole: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/12/36036\">",
"           Potassium acetate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/41/17043\">",
"           Potassium acid phosphate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/37/22099\">",
"           Potassium bicarbonate and potassium chloride (effervescent): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/45/1748\">",
"           Potassium bicarbonate and potassium citrate (effervescent): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/35/7731\">",
"           Potassium bicarbonate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/57/34711\">",
"           Potassium chloride: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/55/26483\">",
"           Potassium citrate (powder or solution): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/59/7092\">",
"           Potassium citrate (tablet): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/2/20515\">",
"           Potassium gluconate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/36/35396\">",
"           Potassium iodide and iodine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/27/30134\">",
"           Potassium iodide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/15/28914\">",
"           Potassium p-aminobenzoate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/17/7444\">",
"           Potassium phosphate and sodium phosphate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/62/27622\">",
"           Potassium phosphate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/56/29570\">",
"           Povidone iodine (ophthalmic): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/35/28213\">",
"           Povidone iodine (topical): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/0/32768\">",
"           Povidone iodine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/43/29366\">",
"           Pralatrexate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/8/16517\">",
"           Pralidoxime: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/19/32055\">",
"           Pramipexole: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/22/13669\">",
"           Pramlintide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/61/39892\">",
"           Pramoxine and hydrocortisone: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?17/5/17491\">",
"           Pramoxine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/63/27639\">",
"           Prasugrel: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/27/25016\">",
"           Pravastatin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/16/25860\">",
"           Praziquantel: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/16/23814\">",
"           Prazosin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/31/6644\">",
"           Prednicarbate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/39/7796\">",
"           Prednicarbate: Pediatric drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/0/30723\">",
"           Prednisolone (ophthalmic): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/27/40376\">",
"           Prednisolone (systemic): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/44/6852\">",
"           Prednisolone and gentamicin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/48/33536\">",
"           Prednisolone: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/43/38585\">",
"           Prednisone: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/31/16887\">",
"           Pregabalin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/23/31093\">",
"           Prilocaine with epinephrine (dental): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/32/6660\">",
"           Prilocaine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/59/38837\">",
"           Primaquine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/14/30952\">",
"           Primidone: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/18/37157\">",
"           Probenecid: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/34/36391\">",
"           Procainamide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/45/24279\">",
"           Procarbazine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/28/22984\">",
"           Prochlorperazine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/43/19124\">",
"           Procyclidine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/59/6072\">",
"           Progesterone: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/10/29862\">",
"           Promethazine and codeine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?17/58/18341\">",
"           Promethazine and dextromethorphan: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/44/22212\">",
"           Promethazine and phenylephrine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/29/22997\">",
"           Promethazine, phenylephrine, and codeine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/20/15688\">",
"           Promethazine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/51/26423\">",
"           Propafenone: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/4/14404\">",
"           Propantheline: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/63/13298\">",
"           Proparacaine and fluorescein: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/57/2963\">",
"           Proparacaine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?17/25/17816\">",
"           Propofol: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/30/29158\">",
"           Propranolol and hydrochlorothiazide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/49/8986\">",
"           Propranolol: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/44/10946\">",
"           Propylhexedrine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/9/5271\">",
"           Propylthiouracil: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?11/9/11413\">",
"           Protamine sulfate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/50/6949\">",
"           Protein C concentrate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/27/39349\">",
"           Protein C concentrate: Pediatric drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/5/10327\">",
"           Protriptyline: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/10/18596\">",
"           Prucalopride: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/3/16436\">",
"           Prucalopride: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/8/7302\">",
"           Pseudoephedrine and codeine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/10/7332\">",
"           Pseudoephedrine and dextromethorphan: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/59/36791\">",
"           Pseudoephedrine and ibuprofen: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/47/19190\">",
"           Pseudoephedrine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/26/8614\">",
"           Psyllium: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/62/4068\">",
"           Pyrantel pamoate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/34/31269\">",
"           Pyrazinamide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/9/12436\">",
"           Pyrethrins: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/55/27509\">",
"           Pyridostigmine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/51/23350\">",
"           Pyrimethamine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/2/39971\">",
"           Pyrithione zinc: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/35/10807\">",
"           Quadrivalent (A, C, Y, W-135) meningococcal conjugate vaccine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/39/30326\">",
"           Quazepam: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/56/20361\">",
"           Quetiapine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/23/42355\">",
"           Quinagolide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/19/26935\">",
"           Quinapril and hydrochlorothiazide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/29/24024\">",
"           Quinapril: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/24/42375\">",
"           Quinapril: Pediatric drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/48/777\">",
"           Quinidine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/46/15080\">",
"           Quinine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/17/34068\">",
"           Quinupristin and dalfopristin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?43/18/44327\">",
"           Rabeprazole: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/22/6500\">",
"           Rabies immune globulin (human): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/55/16246\">",
"           Rabies virus vaccine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/19/43313\">",
"           Racemic epinephrine and aluminum potassium sulfate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/15/6390\">",
"           Raloxifene: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/27/10678\">",
"           Raltegravir: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/1/21525\">",
"           Raltitrexed: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/49/15125\">",
"           Ramelteon: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/56/42887\">",
"           Ramipril and felodipine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/3/25655\">",
"           Ramipril and hydrochlorothiazide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/37/24152\">",
"           Ramipril: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/40/33413\">",
"           Ranibizumab: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/56/42888\">",
"           Ranitidine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/2/34854\">",
"           Ranolazine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/13/24791\">",
"           Rasagiline: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/54/34661\">",
"           Rasburicase: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/63/32755\">",
"           Raxibacumab: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/48/7939\">",
"           Raxibacumab: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/11/39093\">",
"           Recombinant hemagglutinin influenza vaccine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/36/23109\">",
"           Recombinant hemagglutinin influenza vaccine: Pediatric drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/18/43299\">",
"           Recombinant human chorionic gonadotropin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/20/34118\">",
"           Recombinant human factor IX: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/40/20100\">",
"           Recombinant human factor IX: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/42/30373\">",
"           Recombinant human factor VIIa: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/1/23574\">",
"           Recombinant human factor VIII: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?11/54/12137\">",
"           Recombinant human growth hormone (somatropin): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/38/23140\">",
"           Regadenoson: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/16/32006\">",
"           Regorafenib: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/33/2582\">",
"           Regorafenib: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/50/5927\">",
"           Remifentanil: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/2/9255\">",
"           Repaglinide and metformin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/25/4503\">",
"           Repaglinide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/35/16950\">",
"           Reserpine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/47/4851\">",
"           Retapamulin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/25/30101\">",
"           Reteplase: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/58/11175\">",
"           Rho(D) immune globulin (intramuscular): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/25/27033\">",
"           Ribavirin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/63/32760\">",
"           Rifabutin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/31/10746\">",
"           Rifampin (rifampicin): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/46/27368\">",
"           Rifampin and isoniazid: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/6/18537\">",
"           Rifampin, isoniazid, and pyrazinamide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/51/15160\">",
"           Rifapentine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/17/37140\">",
"           Rifaximin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/21/16724\">",
"           Rilonacept: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/9/14484\">",
"           Rilonacept: Pediatric drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?43/38/44646\">",
"           Rilpivirine, emtricitabine, and tenofovir: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/3/28725\">",
"           Rilpivirine, emtricitabine, and tenofovir: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/27/15798\">",
"           Rilpivirine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/14/32996\">",
"           Rilpivirine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/31/22004\">",
"           Riluzole: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/30/7653\">",
"           RimabotulinumtoxinB (botulinum toxin type B, Myobloc): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/10/30885\">",
"           Rimantadine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/13/20691\">",
"           Rimexolone: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/41/17047\">",
"           Risedronate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?11/33/11802\">",
"           Risperidone: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?11/58/12202\">",
"           Ritonavir: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/12/41161\">",
"           Rituximab: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/16/5384\">",
"           Rivaroxaban: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/26/6567\">",
"           Rivastigmine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/14/29925\">",
"           Rizatriptan: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/24/8581\">",
"           Rizatriptan: Pediatric drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/26/19879\">",
"           Rocuronium: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/15/35060\">",
"           Roflumilast: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/2/3110\">",
"           Romidepsin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/58/20389\">",
"           Romiplostim: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/11/18615\">",
"           Ropinirole: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/38/7782\">",
"           Ropivacaine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/60/26567\">",
"           Rosiglitazone and glimepiride: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/39/27255\">",
"           Rosiglitazone and metformin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/26/2472\">",
"           Rosiglitazone: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/11/10424\">",
"           Rosuvastatin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/50/42789\">",
"           Rotavirus vaccine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/45/5846\">",
"           Rotigotine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?17/54/18277\">",
"           Rotigotine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/30/5606\">",
"           Rufinamide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/12/29893\">",
"           Rufinamide: Pediatric drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/35/29239\">",
"           Ruxolitinib: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/12/37060\">",
"           Ruxolitinib: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/39/25203\">",
"           Saccharomyces boulardii: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/41/41619\">",
"           Sacrosidase: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/63/34806\">",
"           Salmeterol: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/14/5350\">",
"           Salsalate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/58/5027\">",
"           Samarium Sm-153 lexidronam: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/62/23523\">",
"           Samarium Sm-153 lexidronam: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/21/29012\">",
"           Sapropterin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/9/31892\">",
"           Sapropterin: Pediatric drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/25/3482\">",
"           Saquinavir: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/43/5814\">",
"           Sargramostim: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/55/40822\">",
"           Saxagliptin and metformin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/26/26022\">",
"           Saxagliptin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/58/24484\">",
"           Scopolamine (ophthalmic): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/39/32375\">",
"           Scopolamine (systemic): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/31/33264\">",
"           Scopolamine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/27/32182\">",
"           Secobarbital: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/49/28435\">",
"           Secretin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/54/25448\">",
"           Selegiline: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/49/34579\">",
"           Selenium sulfide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/37/13907\">",
"           Selenium: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/21/40276\">",
"           Senna: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/11/23731\">",
"           Sertaconazole: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?43/3/44089\">",
"           Sertraline: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/44/40645\">",
"           Sevelamer: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/47/23286\">",
"           Sevoflurane: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/19/33080\">",
"           Sildenafil: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?17/15/17653\">",
"           Silodosin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/53/42834\">",
"           Silver nitrate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/45/10964\">",
"           Silver sulfadiazine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/35/33332\">",
"           Simethicone: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?17/36/17993\">",
"           Simvastatin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/15/8435\">",
"           Sincalide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/35/15923\">",
"           Sinecatechins: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/18/12581\">",
"           Sipuleucel-T: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/39/5753\">",
"           Sirolimus: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/58/2983\">",
"           Sitagliptin and metformin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/17/280\">",
"           Sitagliptin and simvastatin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/53/36693\">",
"           Sitagliptin and simvastatin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/31/5622\">",
"           Sitagliptin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/24/18823\">",
"           Smallpox vaccine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/43/12979\">",
"           Sodium acetate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/52/840\">",
"           Sodium bicarbonate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/47/15097\">",
"           Sodium chloride preparations (saline and oral salt tablets): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/44/22211\">",
"           Sodium citrate and potassium citrate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/13/14547\">",
"           Sodium citrate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/21/26963\">",
"           Sodium citrate: Pediatric drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/52/4931\">",
"           Sodium fluoride F18: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/48/37634\">",
"           Sodium fluoride F18: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/23/29042\">",
"           Sodium hypochlorite solution: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/58/25506\">",
"           Sodium iodide I-123: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?43/44/44738\">",
"           Sodium iodide I-123: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/41/1685\">",
"           Sodium iodide I-131: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/21/8530\">",
"           Sodium lactate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/21/43346\">",
"           Sodium morrhuate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/52/838\">",
"           Sodium nitrite and sodium thiosulfate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/33/32277\">",
"           Sodium nitrite and sodium thiosulfate: Pediatric drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/34/16933\">",
"           Sodium nitrite: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/49/21267\">",
"           Sodium nitrite: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/39/15990\">",
"           Sodium oxybate (gamma hydroxybutyrate): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/21/7509\">",
"           Sodium phenylacetate and sodium benzoate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/39/9845\">",
"           Sodium phenylbutyrate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/22/5480\">",
"           Sodium phosphate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?43/0/44037\">",
"           Sodium picosulfate, magnesium oxide, and citric acid: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/16/43269\">",
"           Sodium polystyrene sulfonate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/36/1603\">",
"           Sodium tetradecyl: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?17/18/17700\">",
"           Sodium thiosulfate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/58/38820\">",
"           Sodium, potassium and magnesium sulfates bowel preparation kit: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/33/39445\">",
"           Solifenacin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/25/4500\">",
"           Solvent detergent treated fresh frozen plasma: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/45/9944\">",
"           Sorafenib: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/0/29699\">",
"           Sorbitol: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/13/21721\">",
"           Sotalol: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/55/17267\">",
"           Spinosad: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/54/2915\">",
"           Spinosad: Pediatric drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/18/14628\">",
"           Spiramycin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?17/22/17767\">",
"           Spironolactone: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/45/43734\">",
"           Stavudine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/63/39920\">",
"           Steviocalcitriol: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/9/18583\">",
"           Streptomycin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/30/9702\">",
"           Streptozocin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/14/26851\">",
"           Strontium-89: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/46/33510\">",
"           Succinylcholine (suxamethonium): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/29/29141\">",
"           Sucralfate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/41/31378\">",
"           Sucrose: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/47/15094\">",
"           Sufentanil: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/46/2787\">",
"           Sulconazole: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/19/25906\">",
"           Sulfabenzamide, sulfacetamide, and sulfathiazole: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/61/32723\">",
"           Sulfacetamide (ophthalmic): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/42/26276\">",
"           Sulfacetamide (topical): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/54/3940\">",
"           Sulfacetamide and prednisolone: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/57/33680\">",
"           Sulfacetamide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/41/20118\">",
"           Sulfadiazine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/37/34389\">",
"           Sulfadoxine and pyrimethamine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/17/39186\">",
"           Sulfanilamide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/28/8647\">",
"           Sulfasalazine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/63/30706\">",
"           Sulfonated phenolics in aqueous solution: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/36/36418\">",
"           Sulfur and salicylic acid: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/27/41395\">",
"           Sulfur and salicylic acid: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/56/11141\">",
"           Sulfur and sulfacetamide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?43/17/44312\">",
"           Sulindac: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/35/41527\">",
"           Sumatriptan and naproxen: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/38/5736\">",
"           Sumatriptan: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?43/10/44200\">",
"           Sunitinib: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/50/30498\">",
"           Suramin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/28/32199\">",
"           Synthetic conjugated estrogens A: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/37/19031\">",
"           Synthetic conjugated estrogens B: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/42/4778\">",
"           Tacrolimus (systemic): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/30/6630\">",
"           Tacrolimus (topical): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/14/32992\">",
"           Tacrolimus: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/4/19528\">",
"           Tadalafil: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/51/5939\">",
"           Tafluprost: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/45/41684\">",
"           Tafluprost: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/39/28274\">",
"           Talc (sterile): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/9/7316\">",
"           Taliglucerase alfa (glucocerebrosidase): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/6/22627\">",
"           Taliglucerase alfa (glucocerebrosidase): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/27/33208\">",
"           Tamoxifen: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/6/43111\">",
"           Tamoxifen: Pediatric drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/28/39365\">",
"           Tamsulosin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/20/27975\">",
"           Tapentadol: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/17/19732\">",
"           Tazarotene: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/36/28227\">",
"           Technetium Tc 99m Diethylene Triamine Penta-Acetic Acid: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/59/6067\">",
"           Technetium Tc 99m Diethylene Triamine Penta-Acetic Acid: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/0/36866\">",
"           Technetium Tc-99m exametazime: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/61/43986\">",
"           Technetium Tc-99m exametazime: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/52/1858\">",
"           Technetium Tc-99m gluceptate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/52/42818\">",
"           Technetium Tc-99m gluceptate: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/60/23490\">",
"           Technetium Tc-99m labeled red blood cells: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/50/37666\">",
"           Technetium Tc-99m labeled red blood cells: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/8/28802\">",
"           Technetium Tc-99m mebrofenin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/0/3075\">",
"           Technetium Tc-99m mebrofenin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/7/22642\">",
"           Technetium Tc-99m medronate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/63/23539\">",
"           Technetium Tc-99m medronate: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/23/5491\">",
"           Technetium Tc-99m oxidronate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/24/387\">",
"           Technetium Tc-99m oxidronate: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/35/33330\">",
"           Technetium Tc-99m pyrophosphate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/41/37522\">",
"           Technetium Tc-99m pyrophosphate: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/61/29650\">",
"           Technetium Tc-99m succimer: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/48/42754\">",
"           Technetium Tc-99m succimer: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/47/37618\">",
"           Technetium Tc-99m tetrofosmin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/51/4915\">",
"           Technetium Tc-99m tetrofosmin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/51/3889\">",
"           Technetium Tc-99m tilmanocept: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/33/10772\">",
"           Teduglutide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/26/29092\">",
"           Teduglutide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/4/4164\">",
"           Tegaserod: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/6/20585\">",
"           Telaprevir: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/42/27301\">",
"           Telavancin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/15/3317\">",
"           Telbivudine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/16/41224\">",
"           Telithromycin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/46/21223\">",
"           Telmisartan and amlodipine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/20/15687\">",
"           Telmisartan and hydrochlorothiazide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/38/27239\">",
"           Telmisartan: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/44/27334\">",
"           Temazepam: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/47/11000\">",
"           Temozolomide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/1/14360\">",
"           Temsirolimus: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/39/14966\">",
"           Tenecteplase: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/55/4983\">",
"           Teniposide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/52/1863\">",
"           Tenofovir and emtricitabine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/47/19191\">",
"           Tenofovir: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/15/36085\">",
"           Terazosin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/14/43236\">",
"           Terazosin: Pediatric drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/35/34358\">",
"           Terbinafine (systemic): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/47/6900\">",
"           Terbinafine (topical): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/22/33120\">",
"           Terbinafine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?11/55/12151\">",
"           Terbutaline: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/15/26867\">",
"           Terconazole: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/45/8918\">",
"           Teriflunomide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/40/30341\">",
"           Teriflunomide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/22/6501\">",
"           Teriparatide (recombinant human parathyroid hormone (1-34)): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/29/32212\">",
"           Tesamorelin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/11/1209\">",
"           Testosterone: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/18/293\">",
"           Tetanus immune globulin (human): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/22/3430\">",
"           Tetanus toxoid (adsorbed): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/31/32246\">",
"           Tetrabenazine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/45/27347\">",
"           Tetracaine (ophthalmic): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/37/24148\">",
"           Tetracaine (systemic): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/30/29155\">",
"           Tetracaine (topical): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/12/36032\">",
"           Tetracaine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/49/2840\">",
"           Tetracycline: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/18/24867\">",
"           Tetrahydrozoline (nasal): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/21/19795\">",
"           Tetrahydrozoline (ophthalmic): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/17/34064\">",
"           Tetrahydrozoline: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/62/29673\">",
"           Thalidomide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/31/30200\">",
"           Theophylline: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/54/35685\">",
"           Thioguanine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/63/1015\">",
"           Thiopental: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/35/32311\">",
"           Thioridazine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/37/35414\">",
"           Thiotepa: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/35/41526\">",
"           Thiothixene: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/39/9846\">",
"           Thyroid extract (desiccated thyroid): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/57/22422\">",
"           Thyroid extract (desiccated thyroid): Pediatric drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/18/19749\">",
"           Thyrotropin alfa (recombinant human thyrotropin): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/22/26982\">",
"           Tiagabine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/40/30343\">",
"           Tiaprofenic acid: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/0/38919\">",
"           Ticagrelor: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/27/8629\">",
"           Ticagrelor: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/45/42710\">",
"           Ticarcillin and clavulanate potassium: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/27/35255\">",
"           Ticlopidine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/7/40053\">",
"           Tigecycline: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/51/38709\">",
"           Tiludronate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/60/28615\">",
"           Timolol (ophthalmic): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/41/27287\">",
"           Timolol (systemic): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/2/31776\">",
"           Timolol: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/3/35893\">",
"           Tincture of opium: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/14/5349\">",
"           Tinidazole: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/44/21191\">",
"           Tinzaparin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/6/34914\">",
"           Tioconazole: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/12/21699\">",
"           Tiopronin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/34/27173\">",
"           Tiotropium: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/33/19992\">",
"           Tipranavir: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/2/13351\">",
"           Tirofiban: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/35/12855\">",
"           Tizanidine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/20/41283\">",
"           Tobramycin (ophthalmic): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/27/13753\">",
"           Tobramycin (systemic therapy and oral inhalation): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/50/38691\">",
"           Tobramycin and dexamethasone: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/35/34352\">",
"           Tobramycin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?43/19/44342\">",
"           Tocilizumab: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/14/9446\">",
"           Tocilizumab: Pediatric drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?17/49/18198\">",
"           Tofacitinib: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/32/7685\">",
"           Tofacitinib: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/48/16134\">",
"           Tolazamide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/49/42774\">",
"           Tolbutamide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/47/33526\">",
"           Tolcapone: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/46/33512\">",
"           Tolmetin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/61/28627\">",
"           Tolnaftate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/19/14646\">",
"           Tolterodine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?11/24/11654\">",
"           Tolvaptan: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/54/8038\">",
"           Topical cocaine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?43/44/44737\">",
"           Topical polyureaurethane: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/23/30072\">",
"           Topical salicylic acid: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/42/40612\">",
"           Topical thrombin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/52/1862\">",
"           Topical tretinoin (topical all trans retinoic acid): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/27/5561\">",
"           Topiramate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/2/32807\">",
"           Topotecan: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/30/30181\">",
"           Toremifene: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/13/28886\">",
"           Torsemide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/45/29398\">",
"           Tositumomab radioconjugate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/40/42628\">",
"           Total parenteral nutrition: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/52/41798\">",
"           Trabectedin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/40/34435\">",
"           Trace metals: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/50/42792\">",
"           Tramadol: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/29/37336\">",
"           Trandolapril and verapamil: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/41/12952\">",
"           Trandolapril: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/58/14248\">",
"           Tranexamic acid: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/29/32215\">",
"           Tranylcypromine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/39/6776\">",
"           Trastuzumab: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/10/15525\">",
"           Travelers' diarrhea and cholera vaccine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/31/14838\">",
"           Travoprost and timolol: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/52/22339\">",
"           Travoprost: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/0/24584\">",
"           Trazodone: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/52/25414\">",
"           Treprostinil: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/32/5637\">",
"           Triamcinolone (nasal): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/55/8052\">",
"           Triamcinolone (ophthalmic): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/1/31768\">",
"           Triamcinolone (systemic): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/30/32229\">",
"           Triamcinolone (topical): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/38/39520\">",
"           Triamcinolone: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/60/43973\">",
"           Triamterene: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/49/23319\">",
"           Triazolam: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/39/7794\">",
"           Trichloroacetic acid: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/32/31234\">",
"           Trichophyton skin test: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/63/4081\">",
"           Triclabendazole: International drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/20/25922\">",
"           Triclosan and fluoride (dental): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/46/14052\">",
"           Trientine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/2/19495\">",
"           Trifluoperazine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?17/33/17939\">",
"           Trifluridine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/1/6165\">",
"           Trihexyphenidyl: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/43/33458\">",
"           Trimebutine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/63/4085\">",
"           Trimethobenzamide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/19/5429\">",
"           Trimethoprim and polymyxin B: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/36/26182\">",
"           Trimethoprim: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/58/5034\">",
"           Trimethoprim-sulfamethoxazole (co-trimoxazole): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/34/31271\">",
"           Trimipramine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/40/35462\">",
"           Triprolidine and pseudoephedrine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/36/24134\">",
"           Triprolidine, pseudoephedrine, and codeine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/11/9398\">",
"           Triptorelin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/58/1955\">",
"           Trolamine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/29/43475\">",
"           Tromethamine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/58/8100\">",
"           Tropicamide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/9/26773\">",
"           Trospium: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/50/27426\">",
"           Trypan blue: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/24/33154\">",
"           Trypsin, balsam peru, and castor oil: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/35/15924\">",
"           Tuberculin skin test: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/7/25718\">",
"           Typhoid vaccine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/31/39412\">",
"           Ulipristal: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/30/18919\">",
"           Unactivated prothrombin complex concentrates (3 factors: IX, II, X [and trace VII]): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/20/25924\">",
"           Unactivated prothrombin complex concentrates (4 factors: II, VII, IX, and X with proteins C and S): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?11/55/12146\">",
"           Undecylenic acid and derivatives: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/36/27203\">",
"           Unoprostone: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/31/8691\">",
"           Urea and hydrocortisone: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/3/22582\">",
"           Urea: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/60/32708\">",
"           Urofollitropin (purified human follicle stimulating hormone): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/5/12373\">",
"           Ursodiol: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/46/742\">",
"           Ustekinumab: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/33/6677\">",
"           Vaccinia immune globulin (intravenous): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/44/39622\">",
"           Valacyclovir: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/37/5718\">",
"           Valganciclovir: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/11/25785\">",
"           Valproate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/49/22292\">",
"           Valrubicin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/7/19575\">",
"           Valsartan and hydrochlorothiazide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/4/31815\">",
"           Valsartan: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/41/42649\">",
"           Vancomycin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/42/17063\">",
"           Vandetanib: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/40/21127\">",
"           Vardenafil: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/2/15398\">",
"           Varenicline: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/28/4551\">",
"           Varicella virus vaccine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/8/8326\">",
"           Varicella-zoster immune globulin (human): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/7/41076\">",
"           Varicella-zoster immune globulin (human): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/24/5511\">",
"           Vasopressin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/46/15079\">",
"           Vecuronium: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/4/36931\">",
"           Velaglucerase alfa (glucocerebrosidase): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/48/17159\">",
"           Vemurafenib: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/4/31813\">",
"           Vemurafenib: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/45/22233\">",
"           Venlafaxine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/18/9514\">",
"           Verapamil: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/18/33060\">",
"           Verteporfin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/8/27783\">",
"           Vigabatrin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/16/39175\">",
"           Vilazodone: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/3/4152\">",
"           Vinblastine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/29/1498\">",
"           Vincristine (conventional): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/25/31123\">",
"           Vindesine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/59/953\">",
"           Vinorelbine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?17/59/18357\">",
"           Vismodegib: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/26/28068\">",
"           Vismodegib: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?43/25/44433\">",
"           Vistonuridine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/23/371\">",
"           Vitamin A and vitamin D (systemic): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/56/19331\">",
"           Vitamin A and vitamin D (systemic): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/21/13650\">",
"           Vitamin A and vitamin D (topical): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/17/41235\">",
"           Vitamin A and vitamin D (topical): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/15/37104\">",
"           Vitamin A and vitamin D: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/59/24502\">",
"           Vitamin A: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/10/25762\">",
"           Vitamin B complex: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/9/147\">",
"           Vitamin B1 (thiamine): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?17/15/17651\">",
"           Vitamin B2 (riboflavin): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/50/6951\">",
"           Vitamin B3 (niacin): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/13/18642\">",
"           Vitamin B5 (pantothenic acid): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/21/39254\">",
"           Vitamin B6 (pyridoxine): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/45/38614\">",
"           Vitamin C (ascorbic acid): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/45/7895\">",
"           Vitamin D2 (ergocalciferol): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/52/38725\">",
"           Vitamin D3 (cholecalciferol): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/28/19910\">",
"           Vitamin E: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/25/3479\">",
"           Vitamin K (phytonadione): Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/38/17002\">",
"           Voriconazole: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/29/27093\">",
"           Vorinostat: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/41/28314\">",
"           Warfarin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/54/16227\">",
"           Wheat dextrin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/34/14882\">",
"           Witch hazel: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/13/14550\">",
"           Yellow fever vaccine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/54/20325\">",
"           Zafirlukast: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/61/15318\">",
"           Zaleplon: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/27/26038\">",
"           Zanamivir: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/55/38773\">",
"           Ziconotide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/56/901\">",
"           Zidovudine and lamivudine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/28/24008\">",
"           Zidovudine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?17/33/17940\">",
"           Zileuton: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/19/308\">",
"           Zileuton: Pediatric drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?11/12/11460\">",
"           Zinc acetate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/56/38787\">",
"           Zinc acetate: Pediatric drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/25/32146\">",
"           Zinc chloride: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/50/29475\">",
"           Zinc chloride: Pediatric drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/14/23777\">",
"           Zinc gelatin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/53/15187\">",
"           Zinc oxide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/57/17300\">",
"           Zinc sulfate: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/39/29301\">",
"           Zinc sulfate: Pediatric drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/39/4728\">",
"           Ziprasidone: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/1/9241\">",
"           Zoledronic acid: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/40/2694\">",
"           Zolmitriptan: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/48/13064\">",
"           Zolpidem: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/2/10279\">",
"           Zonisamide: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?17/24/17798\">",
"           Zopiclone: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/4/5190\">",
"           Zoster vaccine: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/62/42978\">",
"           Zucapsaicin: Drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/12/42179\">",
"           Zucapsaicin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/19/10551\">",
"           Zuclopenthixol: Drug information",
"          </a>",
"         </li>",
"        </ul>",
"       </tds>",
"      </trs>",
"     </div>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     <img height=\"10\" src=\"./../images/spacer.myextg\" width=\"1\"/>",
"    </tds>",
"   </trs>",
"  </div>",
"  <div id=\"footer\">",
"   <div id=\"footerNav\">",
"    <ul>",
"     <li>",
"      <a href=\"file://www.wolterskluwerhealth.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Wolters Kluwer Health",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.factsandcomparisons.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Facts &amp; Comparisons&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medispan.com\" rel=\"nofollow\" target=\"_blank\">",
"       Medi-Span&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationordersets.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Order Sets",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationmedical.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Medical",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://pharmacyonesource.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Pharmacy OneSource&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medicom.com.cn/\" rel=\"nofollow\" target=\"_blank\">",
"       Medicom",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.lexi.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Lexicomp",
"      </a>",
"     </li>",
"     <li class=\"last\">",
"      <a href=\"/home/privacy-policy\">",
"       Privacy Policy",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"   <div id=\"footerLogo\">",
"    <a href=\"./toc\">",
"     Wolters Kluwer Health | UpToDate",
"    </a>",
"   </div>",
"   <div id=\"supportFooter\">",
"    <span class=\"sfInfo\">",
"     &copy; 2013 UpToDate, Inc. All rights reserved.",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Release: 21.3 - C21.34",
"    </span>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <span class=\"sfInfo\">",
"     <a href=\"/home/terms-use\">",
"      Terms of Use",
"     </a>",
"    </span>",
"    <br/>",
"    <span class=\"sfInfo\">",
"     Licensed to:",
"     <span class=\"emphasis\">",
"      UpToDate Marketing Professional",
"     </span>",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Support Tag: [0605-95.154.198.148-545A575423-14]",
"     <br/>",
"    </span>",
"   </div>",
"  </div>",
" </div>",
" <!-- rightPanel -->",
"</body>"].join("\n");
var script_f43_6_44138=[""].join("\n");
var outline_f43_6_44138=null;
var title_f43_6_44139="Side effects of NMBAs";
var content_f43_6_44139=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F75857&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F75857&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Cardiovascular side effects of neuromuscular blocking agents",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1\">",
"       Drug",
"      </td>",
"      <td class=\"subtitle1\">",
"       Cardiovascular side effects",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Atracurium",
"      </td>",
"      <td>",
"       Moderate risk of hypotension secondary to histamine release and sympathetic ganglionic blockade",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Cisatracurium",
"      </td>",
"      <td>",
"       Minimal risk of histamine-associated hypotension",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Doxacurium",
"      </td>",
"      <td>",
"       Minimal risk of histamine-associated hypotension",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Metocurine",
"      </td>",
"      <td>",
"       Moderate risk of hypotension secondary to histamine release and sympathetic ganglionic blockade",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Mivacurium",
"      </td>",
"      <td>",
"       Minimal risk of histamine-associated hypotension with low doses (0.15 mg/kg); increased risk with larger doses",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Pancuronium",
"      </td>",
"      <td>",
"       Moderate risk of tachycardia, hypertension, and increased cardiac output due to vagal blockade",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Pipecuronium",
"      </td>",
"      <td>",
"       Minimal risk of histamine-associated hypotension",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Rocuronium",
"      </td>",
"      <td>",
"       Minimal risk of histamine-associated hypotension",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Succinylcholine",
"      </td>",
"      <td>",
"       Significant risk of elevated blood pressure, tachycardia, bradycardia, ventricular arrhythmias",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Tubocurarine",
"      </td>",
"      <td>",
"       Significant risk of histamine-associated hypotension, decreased systemic vascular resistance, and hypotension secondary to ganglionic blockade after prolonged use of high doses",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Vecuronium",
"      </td>",
"      <td>",
"       Minimal risk of histamine-associated hypotension",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f43_6_44139=[""].join("\n");
var outline_f43_6_44139=null;
var title_f43_6_44140="Poisoning syndromes - toxidromes";
var content_f43_6_44140=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F71268&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F71268&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Poisoning syndromes (toxidromes)",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Toxidrome",
"       </td>",
"       <td class=\"subtitle1\">",
"        Mental status",
"       </td>",
"       <td class=\"subtitle1\">",
"        Pupils",
"       </td>",
"       <td class=\"subtitle1\">",
"        Vital signs",
"       </td>",
"       <td class=\"subtitle1\">",
"        Other manifestations",
"       </td>",
"       <td class=\"subtitle1\">",
"        Examples of toxic agents",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Sympathomimetic",
"       </td>",
"       <td>",
"        Hyperalert, agitation, hallucinations, paranoia",
"       </td>",
"       <td>",
"        Mydriasis",
"       </td>",
"       <td>",
"        Hyperthermia, tachycardia, hypertension, widened pulse pressure, tachypnea, hyperpnea",
"       </td>",
"       <td>",
"        Diaphoresis, tremors, hyperreflexia, seizures",
"       </td>",
"       <td>",
"        Cocaine, amphetamines, cathinones, ephedrine, pseudoephedrine, phenylpropanolamine, theophylline, caffeine",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Anticholinergic",
"       </td>",
"       <td>",
"        Hypervigilance, agitation, hallucinations, delirium with mumbling speech, coma",
"       </td>",
"       <td>",
"        Mydriasis",
"       </td>",
"       <td>",
"        Hyperthermia, tachycardia, hypertension, tachypnea",
"       </td>",
"       <td>",
"        Dry flushed skin, dry mucous membranes, decreased bowel sounds, urinary retention, myoclonus, choreoathetosis, picking behavior, seizures (rare)",
"       </td>",
"       <td>",
"        Antihistamines, tricyclic antidepressants, cyclobenzaprine, orphenadrine, antiparkinson agents, antispasmodics, phenothiazines, atropine, scopolamine, belladonna alkaloids (eg, Jimson Weed)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hallucinogenic",
"       </td>",
"       <td>",
"        Hallucinations, perceptual distortions, depersonalization, synesthesia, agitation",
"       </td>",
"       <td>",
"        Mydriasis (usually)",
"       </td>",
"       <td>",
"        Hyperthermia, tachycardia, hypertension, tachypnea",
"       </td>",
"       <td>",
"        Nystagmus",
"       </td>",
"       <td>",
"        Phencyclidine, LSD, mescaline, psilocybin, designer amphetamines (eg, MDMA, MDEA)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Opioid",
"       </td>",
"       <td>",
"        CNS depression, coma",
"       </td>",
"       <td>",
"        Miosis",
"       </td>",
"       <td>",
"        Hypothermia, bradycardia, hypotension, apnea, bradypnea",
"       </td>",
"       <td>",
"        Hyporeflexia, pulmonary edema, needle marks",
"       </td>",
"       <td>",
"        Opiates (eg, heroin, morphine, methadone, oxycodone, hydromorphone), diphenoxylate",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Sedative-hypnotic",
"       </td>",
"       <td>",
"        CNS depression, confusion, stupor, coma",
"       </td>",
"       <td>",
"        Miosis (usually)",
"       </td>",
"       <td>",
"        Hypothermia, bradycardia, hypotension, apnea, bradypnea",
"       </td>",
"       <td>",
"        Hyporeflexia",
"       </td>",
"       <td>",
"        Benzodiazepines, barbiturates, carisoprodol, meprobamate, glutethimide, alcohols, zolpidem",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cholinergic",
"       </td>",
"       <td>",
"        Confusion, coma",
"       </td>",
"       <td>",
"        Miosis",
"       </td>",
"       <td>",
"        Bradycardia, hypertension orhypotension, tachypnea or bradypnea",
"       </td>",
"       <td>",
"        Salivation, urinary and fecal incontinence, diarrhea, emesis, diaphoresis, lacrimation, GI cramps, bronchoconstriction, muscle fasciculations and weakness, seizures",
"       </td>",
"       <td>",
"        Organophosphate and carbamate insecticides, nerve agents, nicotine, pilocarpine, physostigmine, edrophonium, bethanechol, urecholine",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Serotonin syndrome",
"       </td>",
"       <td>",
"        Confusion, agitation, coma",
"       </td>",
"       <td>",
"        Mydriasis",
"       </td>",
"       <td>",
"        Hyperthermia, tachycardia, hypertension, tachypnea",
"       </td>",
"       <td>",
"        Tremor, myoclonus, hyperreflexia, clonus, diaphoresis, flushing, trismus, rigidity, diarrhea",
"       </td>",
"       <td>",
"        MAOIs alone or with: SSRIs, meperidine, dextromethorphan, TCAs, L-tryptophan",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     CNS: central nervous system.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f43_6_44140=[""].join("\n");
var outline_f43_6_44140=null;
var title_f43_6_44141="Contents: Geriatrics";
var content_f43_6_44141=[" <script type=\"text/javascript\">",
"  $$.inlineInitCustomer(",
"	false);",
"	var quirksmode = document.compatMode == \"CSS1Compat\";",
"	if (quirksmode) {",
"		$(\"html\").addClass(\"ie-standards\");",
"	}",
" </script>",
" <div id=\"message-wrap\">",
"  <div id=\"message-bg\">",
"  </div>",
"  <iframe id=\"message-bk\">",
"  </iframe>",
"  <dl id=\"message-container\">",
"   <dt id=\"message-title\">",
"   </dt>",
"   <dd id=\"message-body\">",
"   </dd>",
"   <dd id=\"message-controls\">",
"   </dd>",
"  </dl>",
" </div>",
" <div id=\"topPanel\">",
"  <div id=\"header\">",
"   <div id=\"header_container\">",
"    <h2 id=\"logo\">",
"     <a href=\"./toc\">",
"      Wolters Kluwer Health UpToDate",
"     </a>",
"    </h2>",
"    <div id=\"header_right\">",
"     <div id=\"searchpanel\">",
"      <a href=\"/login\" id=\"loginbutton\">",
"       Log in",
"      </a>",
"      <div id=\"cmsSearchBox\">",
"       <div class=\"header-search\">",
"        <form action=\"./search\" id=\"cmssearch\" method=\"get\" name=\"SearchForm\">",
"         <div class=\"header-search-left\">",
"          <input autocomplete=\"off\" class=\"searchfield\" id=\"cmsTxtBox\" name=\"search\" placeholder=\"Search UpToDate\" type=\"text\"/>",
"         </div>",
"         <div class=\"header-search-right\">",
"          <input alt=\"Search\" id=\"cmsSearchSubmit\" src=\"/sites/all/themes/uptodate/images/search_button.png\" type=\"image\"/>",
"         </div>",
"         <div class=\"clear\">",
"         </div>",
"        </form>",
"       </div>",
"      </div>",
"      <div id=\"cms_lang_dropdown\">",
"       <form accept-charset=\"UTF-8\" action=\"/\" id=\"lang-dropdown-form\" method=\"post\">",
"        <div class=\"form-item form-type-select form-item-lang-dropdown-select\">",
"         <select class=\"lang-dropdown-select-element form-select\" id=\"edit-lang-dropdown-select\" name=\"lang_dropdown_select\" style=\"width:100px\">",
"          <option selected=\"selected\" value=\"en\">",
"           English",
"          </option>",
"          <option value=\"ja\">",
"           ",
"          </option>",
"         </select>",
"        </div>",
"        <input name=\"lang_dropdown_type\" type=\"hidden\" value=\"language\">",
"         <input name=\"en\" type=\"hidden\" value=\"/\">",
"          <input name=\"ja\" type=\"hidden\" value=\"/ja\">",
"           <noscript>",
"            <div>",
"             <input class=\"form-submit\" id=\"edit-submit\" name=\"op\" type=\"submit\" value=\"Go\"/>",
"            </div>",
"           </noscript>",
"           <input name=\"form_build_id\" type=\"hidden\" value=\"form-on4lUWpxHun_wp6revUkjCG6rK2IBuCGME9Cw0HXeok\">",
"            <input name=\"form_id\" type=\"hidden\" value=\"lang_dropdown_form\">",
"            </input>",
"           </input>",
"          </input>",
"         </input>",
"        </input>",
"       </form>",
"      </div>",
"      <div class=\"clear\">",
"      </div>",
"     </div>",
"     <ul id=\"utility\">",
"      <li class=\"first\">",
"       <a href=\"/home/about-us\">",
"        About Us",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/news-events\">",
"        News &amp; Events",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/contact-us\">",
"        Contact Us",
"       </a>",
"      </li>",
"      <li class=\"last\">",
"       <a href=\"/help\">",
"        Help",
"       </a>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"nav\">",
"    <ul>",
"     <li id=\"productTab\">",
"      <a href=\"/home/product\">",
"       Product",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"editoralTab\">",
"      <a href=\"/home/editorial\">",
"       Editorial",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"whyUptodateTab\">",
"      <a href=\"/home/why-uptodate\">",
"       Why UpToDate",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"supscriptionOptionsTab\">",
"      <a href=\"/home/subscription-options\">",
"       Subscription Options",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"/store\">",
"       Subscribe",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"wkhcsTab\">",
"      <a href=\"/home/wolters-kluwer-health-clinical-solutions\">",
"       Wolters Kluwer Health Clinical Solutions",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"    </ul>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"greyBar\">",
"    <div id=\"greyBarTitle\">",
"     <span class=\"emphasis\">",
"      <a href=\"mobipreview.htm?3/3/3134\">",
"       Contents",
"      </a>",
"     </span>",
"     <img src=\"./../images/space_arrows.myextg\">",
"      Geriatrics",
"     </img>",
"    </div>",
"    <div id=\"greyBarButtons\">",
"     <div id=\"printGB\">",
"      <a class=\"icontxt\" href=\"?view=print\">",
"       <img align=\"middle\" alt=\"Print this page\" border=\"0\" height=\"20\" src=\"./../images/icn_print.myextg\" width=\"24\"/>",
"      </a>",
"      <a class=\"icontxt\" href=\"?view=print\" title=\"Print this page\">",
"       Print",
"      </a>",
"     </div>",
"    </div>",
"   </div>",
"   <!-- menuMessage.jsp -->",
"   <!-- /menuMessage.jsp -->",
"  </div>",
"  <!-- header -->",
" </div>",
" <!-- topPanel -->",
" <div id=\"leftPanel\">",
"  <ul>",
"   <li>",
"    <a href=\"mobipreview.htm?3/45/3806\">",
"     Specialties",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?18/22/18798\">",
"     Patient Information",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?3/13/3294\">",
"     What's New",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?0/37/606\">",
"     Calculators",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?0/40/654\">",
"     Authors and Editors",
"    </a>",
"   </li>",
"  </ul>",
" </div>",
" <!-- leftPanel -->",
" <div id=\"rightPanel\">",
"  <noscript>",
"   <div id=\"javascriptDisabled\">",
"    It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"   </div>",
"  </noscript>",
"  <div id=\"printHeader\">",
"   <div id=\"printHeaderLogo\">",
"    <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"    </img>",
"   </div>",
"   <div id=\"printHeaderText\">",
"    Official reprint from UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"    <a href=\"file://www.uptodate.com\">",
"     www.uptodate.com",
"    </a>",
"    <br>",
"     &copy;2013 UpToDate",
"     <sup>",
"      &reg;",
"     </sup>",
"    </br>",
"   </div>",
"   <div id=\"printHeaderLinks\">",
"    <a href=\"#\" id=\"printHeaderPrint\" rel=\"\" title=\"Click here to print\">",
"     Print",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"     Back",
"    </a>",
"   </div>",
"  </div>",
"  <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" id=\"tocTable\" width=\"100%\">",
"   <trs>",
"    <tds>",
"     <h1>",
"      Contents:",
"			Geriatrics",
"     </h1>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     You receive the entire UpToDate library of specialties with your ",
"							subscription. Click on a section below to view a detailed list of topics associated ",
"							with that particular section. If you'd like to see the table of contents for other ",
"							specialties,",
"     <a href=\"mobipreview.htm?3/3/3134\">",
"      click here",
"     </a>",
"     .",
"     <br/>",
"     <br/>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds valign=\"top\">",
"     <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\">",
"      <trs>",
"       <tds valign=\"top\" width=\"33%\">",
"        <a class=\"tocItem\" href=\"mobipreview.htm?33/28/34254\">",
"         Cardiovascular disease",
"        </a>",
"        <br/>",
"        <a class=\"tocItem\" href=\"mobipreview.htm?33/56/34701\">",
"         Dermatologic disease",
"        </a>",
"        <br/>",
"        <a class=\"tocItem\" href=\"mobipreview.htm?20/18/20782\">",
"         Endocrine disease",
"        </a>",
"        <br/>",
"        <a class=\"tocItem\" href=\"mobipreview.htm?26/38/27245\">",
"         Gastroenterology",
"        </a>",
"        <br/>",
"        <a class=\"tocItem\" href=\"mobipreview.htm?5/58/6063\">",
"         General geriatrics",
"        </a>",
"        <br/>",
"        <a class=\"tocItem\" href=\"mobipreview.htm?0/61/990\">",
"         Geriatric palliative care",
"        </a>",
"        <br/>",
"       </tds>",
"       <tds valign=\"top\" width=\"33%\">",
"        <a class=\"tocItem\" href=\"mobipreview.htm?31/6/31853\">",
"         Geriatric surgery",
"        </a>",
"        <br/>",
"        <a class=\"tocItem\" href=\"mobipreview.htm?36/49/37661\">",
"         Gynecologic disease",
"        </a>",
"        <br/>",
"        <a class=\"tocItem\" href=\"mobipreview.htm?5/45/5854\">",
"         Hematologic disease",
"        </a>",
"        <br/>",
"        <a class=\"tocItem\" href=\"mobipreview.htm?43/31/44541\">",
"         Infectious disease",
"        </a>",
"        <br/>",
"        <a class=\"tocItem\" href=\"mobipreview.htm?20/47/21246\">",
"         Neurologic disease",
"        </a>",
"        <br/>",
"        <a class=\"tocItem\" href=\"mobipreview.htm?4/4/4174\">",
"         Oncologic disease",
"        </a>",
"        <br/>",
"       </tds>",
"       <tds valign=\"top\" width=\"33%\">",
"        <a class=\"tocItem\" href=\"mobipreview.htm?33/52/34637\">",
"         Psychiatric disease",
"        </a>",
"        <br/>",
"        <a class=\"tocItem\" href=\"mobipreview.htm?26/5/26717\">",
"         Pulmonary disease",
"        </a>",
"        <br/>",
"        <a class=\"tocItem\" href=\"mobipreview.htm?28/13/28893\">",
"         Renal disease and hypertension",
"        </a>",
"        <br/>",
"        <a class=\"tocItem\" href=\"mobipreview.htm?16/23/16766\">",
"         Rheumatologic disease",
"        </a>",
"        <br/>",
"        <a class=\"tocItem\" href=\"mobipreview.htm?11/57/12180\">",
"         What's new in geriatrics",
"        </a>",
"        <br/>",
"       </tds>",
"      </trs>",
"      <trs>",
"       <tds>",
"        &nbsp;",
"       </tds>",
"      </trs>",
"      <trs>",
"       <tds>",
"        <a class=\"tocItem\" href=\"mobipreview.htm?18/22/18798\">",
"         Patient Information",
"        </a>",
"        <br/>",
"       </tds>",
"      </trs>",
"     </div>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     <img height=\"10\" src=\"./../images/spacer.myextg\" width=\"1\"/>",
"    </tds>",
"   </trs>",
"  </div>",
"  <div id=\"footer\">",
"   <div id=\"footerNav\">",
"    <ul>",
"     <li>",
"      <a href=\"file://www.wolterskluwerhealth.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Wolters Kluwer Health",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.factsandcomparisons.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Facts &amp; Comparisons&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medispan.com\" rel=\"nofollow\" target=\"_blank\">",
"       Medi-Span&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationordersets.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Order Sets",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationmedical.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Medical",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://pharmacyonesource.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Pharmacy OneSource&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medicom.com.cn/\" rel=\"nofollow\" target=\"_blank\">",
"       Medicom",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.lexi.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Lexicomp",
"      </a>",
"     </li>",
"     <li class=\"last\">",
"      <a href=\"/home/privacy-policy\">",
"       Privacy Policy",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"   <div id=\"footerLogo\">",
"    <a href=\"./toc\">",
"     Wolters Kluwer Health | UpToDate",
"    </a>",
"   </div>",
"   <div id=\"supportFooter\">",
"    <span class=\"sfInfo\">",
"     &copy; 2013 UpToDate, Inc. All rights reserved.",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Release: 21.3 - C21.34",
"    </span>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <span class=\"sfInfo\">",
"     <a href=\"/home/terms-use\">",
"      Terms of Use",
"     </a>",
"    </span>",
"    <br/>",
"    <span class=\"sfInfo\">",
"     Licensed to:",
"     <span class=\"emphasis\">",
"      UpToDate Marketing Professional",
"     </span>",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Support Tag: [0605-95.154.198.148-805CE6CE3E-14]",
"     <br/>",
"    </span>",
"   </div>",
"  </div>",
" </div>",
" <!-- rightPanel -->",
"</body>"].join("\n");
var script_f43_6_44141=[""].join("\n");
var outline_f43_6_44141=null;
var title_f43_6_44142="Triquetral fracture oblique xray";
var content_f43_6_44142=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F81364&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F81364&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Triquetral fracture on oblique x-ray",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 288px; height: 384px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    In this oblique radiograph of the wrist, the shadow of the pisiform does not overlap the triquetral fracture (arrow). Note the small fragment near the ulnar styloid. In this view the remainder of the wrist bones appear normal.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Kevin E Burroughs, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f43_6_44142=[""].join("\n");
var outline_f43_6_44142=null;
var title_f43_6_44143="PSC liver US";
var content_f43_6_44143=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F81306&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F81306&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Primary sclerosing cholangitis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 298px; height: 268px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Ultrasound image in a patient with primary sclerosing cholangitis shows dilation of segmental ducts (large arrows) and debris within the lumen of intrahepatic ducts (small arrows).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Jonathan Kruskal, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f43_6_44143=[""].join("\n");
var outline_f43_6_44143=null;
